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FUNCTION OF HISTONE CROTONYLATION 
Benjamin R. Sabari, Ph.D. 
The Rockefeller University 2016 
Histone lysine acetylation (Kac) plays a critical role in gene regulation by 
affecting the accessibility of the DNA wrapped around histones and by 
recruiting effector complexes. Three major classes of proteins are associated with 
Kac, namely “writers,” enzymes that covalently modify specific lysine residues, 
“readers,” protein domains that specifically bind modified residues, and 
“erasers,” enzymes that catalyze the removal of the modification. While histone 
acetylation is well characterized within this paradigm, little is known about the 
regulation and function of an expanding list of histone lysine acylations. Lysine 
propionylation, butyrylation, and crotonylation were all discovered by 
proteomics-based approaches as I started in the Allis Lab. With reports 
suggesting that lysine crotonylation (Kcr) was the most functionally distinct from 
Kac I embarked to purify and identify the writers, readers, and erasers and 
thereby characterize the regulation and function of histone Kcr.  
To identify writers of Kcr I purified a histone crotonyltransferase (HCT) 
activity from nuclear extract by fractionation, which resulted in the purification 
of p300, a well-studied transcriptional co-activator and histone acetyltransferase 
(HAT). Together with colleagues in the Roeder lab, we established that p300’s 
HCT activity directly stimulates transcription to a greater degree than p300’s 
HAT activity. This work is discussed in Chapter 2. 
I developed several genetic and chemical approaches to manipulate the 
cellular concentrations of acetyl-CoA and crotonyl-CoA and established that 
acyl-CoA metabolism determines the state of differential histone acylation (Kac 
versus Kcr) thereby coupling the metabolic state to gene regulation. This work is 
discussed in Chapter 3. 
With these methods, I next studied the impact of Kcr in the macrophage 
inflammatory response, a classic model of signal-dependent gene activation. 
Through bioinformatics analysis of RNA-seq and ChIP-seq of macrophages in 
various conditions, I established that increased histone Kcr leads to enhanced 
expression of p300-regulated genes. This work is discussed in Chapter 4. 
These data suggested that there was a reader for Kcr with positive 
regulatory activity. In collaboration with colleagues in the Li lab, we identified 
the YEATS domain as a novel Kcr reader. Through a series of structural, 
biophysical, bioinformatic, and genetic studies we showed that AF9 and the 
YEATS-Kcr interaction is responsible for the enhanced expression of increased 
Kcr. This work is discussed in Chapter 5. As discussed in Chapter 6, I have also 
identified and characterized several decrotonylase (eraser) activities. 
The regulation of histone crotonylation or the functional consequence of a 
histone being acetylated versus crotonylated (differential acylation) has 
remained unclear since the discovery of the modification was reported. In my 
thesis work, I have demonstrated that the differential acylation state of histones 
is an integration of environmental and metabolic information, which serves a 
functional role in the regulation of gene expression.  
For my first teachers, my parents 
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CHAPTER 1: GENERAL INTRODUCTION 
The physiological form of eukaryotic nuclear DNA is chromatin, a nucleic acid-
protein complex. In its simplest form, chromatin is composed of repeating 
nucleosomal units, each containing an octamer of histone proteins (two copies 
each of the core histones H3, H4, H2A, and H2B) and 147 base pairs (bp) of DNA 
(Kornberg, 1977). The nucleosome (Luger et al., 1997) is the first order of 
compaction mediated by histones required to fit the immense quantity of 
genomic DNA into the relatively small nuclear volume while maintaining 
appropriate access (Figures 1.1A and 1.1B). A wealth of discoveries over the past 
two decades has transformed the long-standing view of histones from being 
passive static scaffolds to dynamic modulators of virtually all DNA-templated 
events, such as replication, genomic maintenance, and transcription. Much of this 
progress in understanding the active role of histones has been due to the study of 
the regulation and function of histone post-translation modifications (PTMs).  
Histone proteins are subject to a wide variety of PTMs of both chemical 
type and site that, alone or in combination, are characteristic of functional 
chromatin states. The combinatorial potential of histone PTMs is often referred to 
as the “histone code,” a language written on the histone proteins distinct from 
the genetic code written within the DNA double helix. The identification and 
characterization of histone-modifying enzymes as the products of genes 
previously associated with transcriptional and epigenetic regulators led to the 
proposal that the information encoded in the patterns of histone PTMs represents 
a form of epigenetic regulation of gene expression and cellular memory 
(Jenuwein and Allis, 2001; Strahl and Allis, 2000).  
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Figure 1.1: Structural and Functional Organization of the Eukaryotic 
Genome by Histones and Histone PTMs. 
(A) Illustration of genomic compaction. Adapted from (Felsenfeld and 
Groudine, 2003). (B) Structure of the nucleosome. Adapted from (Luger et 
al., 1997). (C) Electron Micrograph of a guinea pig plasma cell. Electron 
dense heterochromatin is marked with an H and electron poor euchromatin 
is marked with an E. Adapted from Columbia University Histology Manual. 
(D) Designation of nine distinct chromatin states of the Drosophila 
melanogaster genome as defined by ChIP-seq for histone PTMs and other 
chromatin factors. Adapted from (Kharchenko et al., 2011). 
3 
Two distinct chromatin states can be defined visually as heterochromatin 
and euchromatin. Under electron microscopy heterochromatin appears 
condensed while euchromatin appears open (Figure 1.1C), these chromatin states 
are functionally distinct as heterochromatin is generally transcriptionally silent 
while euchromatin transcriptionally active. Particular histone PTMs associate 
with and determine these functional chromatin states (Felsenfeld and Groudine, 
2003). With advances in high-throughput sequencing, genome-wide maps of 
histone PTMs and other transcriptional machinery have been generated by 
chromatin immunoprecipitation followed by sequencing (ChIP-seq) (Zhou et al., 
2010). These data have allowed for a finer characterization of the functional 
organization of the eukaryotic genome (Figure 1.1D) (Kharchenko et al., 2011). 
From two states discernable by visual density with electron microscopy the field 
recently described nine or up to fifteen distinct chromatin states derived in large 
part from bioinformatics analysis of ChIP-Seq data of distinct subgroupings of 
histone PTMs genome-wide (Ernst et al., 2011). 
With the application of high-sensitivity mass spectrometry to the 
identification of histone PTMs the current catalogue of observed histone PTMs is 
immense and growing (Figure 1.2) (Huang et al., 2014). Taking into account data 
on all four core histone proteins (H3, H4, H2A, and H2B) and the linker histone 
H1, roughly 500 unique histone modifications have been detected comprising 23 
different types of chemical modification.   The direct function or the regulatory 
mechanisms for a majority of these modifications remains unknown. Three major 
classes of proteins are involved in the regulation and function of histone PTMs 
and they are colloquially termed “writers,” enzymes that catalyze the covalent 
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Figure 1.2: The Current “Snapshot” of Histone Modifications. 
Histone proteins are decorated by a variety of post-translational 
modifications (PTMs), which are critical to the dynamic modulation of 
chromatin structure and function, contributing to the cellular gene 
expression program. Histone PTMs can influence chromatin either directly, 
by changing the physical characteristic of the histone protein (e.g. lysine 
acetylation negates the residue's positive charge), or indirectly, by 
recruitment of modification- and site-specific effector proteins 
("readers"). The function of a given histone PTMs is therefore mediated by 
both the physical properties of the modification (i.e. size and charge) and 
the location of the modified residue within the quaternary structure of the 
nucleosome. Recent studies, many powered by high-sensitivity mass 
spectrometry, have expanded our understanding of the extent to which 
histone proteins are modified. These studies have not only expanded the 
sites of well-studied modification, but have also revealed several new 
types of histone PTMs with a large diversity of structure, charge, and site 
of modification. Presented here is a compilation of data for histone PTMs 
observed from studies on human, mouse, or rat. Red boxes highlight the 
chemical structures of acetyl-lysine and crotonyl-lysine, the subject of this 
thesis. This figure is adapted from the Cell SnapShot (Huang, Sabari, et al. 
2014). 
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modification of specific histone residues, “readers,” effector protein domains that 
bind histones in a modification specific manner, and “erasers,” enzymes that 
remove the modification. The combined activities of these three protein classes 
establish functional chromatin landscapes. Characterization and identification of 
the writers, readers, and erasers for any given modification is the first step to 
establishing the function of the modification. For example, the identification of a 
histone acetyltransferase (HAT) as a known transcriptional co-activator and a 
histone deacetylase (HDAC) as a transcriptional co-repressor prompted a 
breakthrough in the understanding of histone acetylation and its role in 
transcriptional regulation (Brownell et al., 1996; Taunton et al., 1996). This was 
followed soon thereafter by the identification of the bromodomain, a protein 
domain found in many transcriptional regulators with unknown function, as a 
reader of acetyl-lysine (Dhalluin et al., 1999). Together with a wave of 
subsequent research, these studies established a model for the function of histone 
acetylation in gene regulation, discussed in the next section (Figure 1.3). 
My thesis work has focused on characterizing the regulation and function 
of one of these recently described and under-studied histone PTMs, histone 
lysine crotonylation (Kcr). To this end I have identified writers, readers, and 
erasers of histone crotonylation, demonstrated that acyl-CoA metabolism 
regulates the abundance of the modification, and characterized its role in gene 
expression. Lysine crotonylation is chemically similar to lysine acetylation in its 
linkage to the ε amine of lysine, yet it is distinct in its extended and rigid 
hydrocarbon chain (Figure 1.2, see red boxes). The majority of my thesis work 
will be comparing the regulation and function of histone crotonylation to that of 
the more established histone acetylation. In this chapter, I will review the 
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literature on histone acetylation and its role in transcription, focus on the role of 
p300/CBP, provide background on the metabolic regulation of histone 
acetylation, and conclude with an introduction to histone crotonylation.  
A Brief History of Histone Acetylation 
In 1871 Friedrich Miescher published his work on extracts derived from purified 
nuclei of white blood cells that contained both acid and basic substances, what 
we would today consider DNA and histones, respectively. Meischer went on to 
study the nuclein of salmon sperm and prepare high purity preparation of its 
acidic component making him the first to isolate DNA (van Holde, 1989). In 1884 
Albrecht Kossel purified the basic component of nuclein from goose erythrocytes 
by extraction with hydrochloric acid and termed the acid-soluble protein histon 
(Doenecke and Karlson, 1984; Kossel, 1884). This simple purification of histones 
by acid extraction is still a commonly used lab practice and is used throughout 
this thesis.  
Through the early 20th century, histones were considered a homogenous 
group of proteins until Stedman and Stedman identified multiple forms of 
histone proteins in their analysis of histones extracted from various tissues and 
species (Stedman, 1950). This heterogeneity of histone proteins led to the 
proposal that distinct phenotypes could result from the type of histone(s) 
associated with DNA (Stedman and Stedman, 1951). Although the Stedmans’ 
claims were later dismissed, their hypothesis presented histones as more than 
mere scaffolds for DNA and inspired further research into the sequence and 
 8 
  
Figure 1.3: Reversible Histone Acetylation in Transcription. 
Ordered recruitment of transcription factors (DNA-binding activators) recruit 
p300 and other co-activators allowing for histone modifications and remodeling, 
which facilitates the recruitment and stabilization of the transcription apparatus 
(Txn) through protein-DNA (activator-DNA), protein-protein (activator-co-
activator), and protein-PTM (reader-histone) interactions allowing for the 
effective activation of transcription. This process is reversible by the recruitment 
of HDAC co-repressor complexes, which will deacetylate histones and non-
histone substrates.   
Ac 
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structure of the histone proteins (van Holde, 1989). In the 1960’s nucleosomal 
histones were shown to be generally repressive to RNA synthesis (Huang and 
Bonner, 1962). Around the same time chemical analysis of the composition of 
histone proteins identified acetyl-lysine (Phillips, 1963) and methyl-lysine 
(Murray, 1964) as constituents of histones. At The Rockefeller Institute, Vincent 
Allfrey and colleagues performed a series of critical experiments that established 
a new paradigm for the active role of histones in gene regulation. They first 
demonstrated that intact nuclei readily took up and incorporated labeled acetate 
(acetate-2-C14) into histone proteins, even in the presence of translation inhibitors. 
These experiments established that histone acetylation was post-translational. 
Allfrey and colleagues next reproduced the studies showing that histones 
inhibited RNA synthesis, but demonstrated that chemically acetylated histones 
were inert (Allfrey et al., 1964). These observations led Allfrey to the following 
statement: 
Specific (and presumably reversible) changes in histone structure … 
may permit DNA to serve as a template in the RNA polymerase 
reaction. This raises the possibility that relatively minor modifications 
of histone structure, taking place on the intact protein molecule, offer 
a means of switching-on or -off RNA synthesis at different loci along 
the chromosome. (Allfrey et al., 1964)
Allfrey’s prescient conclusions were not widely accepted for another thirty years, 
yet in that time many studies built upon this early hypothesis. 
In the mid-1970’s Riggs and colleagues showed that a previously reported 
butyrate-induced differentiation of Friend Leukemia cells into globin-secreting 
cells (Leder and Leder, 1975) was accompanied by an increase in histone 
acetylation (Riggs et al., 1977; 1978). Soon after, Davie and Allfrey demonstrated 
that butyrate was an inhibitor of histone deacetylase activity (Boffa et al., 1978; 
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Candido et al., 1978). These studies provided early evidence that the highly 
dynamic regulation of histone acetylation was involved in cellular 
differentiation. Furthermore, these studies illustrated the potential for small 
molecule intervention at the level of chromatin and provided an experimental 
tool to perturb histone acetylation by addition of butyrate to cells in culture.  
These observations also introduced the potential for histone modifications and 
their physiological output to be modulated by naturally occurring metabolites, in 
this case the short-chain fatty acid butyrate, a premise I raise in my thesis work. 
 The late 1980’s to early 1990’s provided a string of studies that further 
illustrated the importance of histone acetylation in regulation of gene expression. 
A number of groups utilizing the power of genetics in S. cerevisiae demonstrated 
that mutating the four highly conserved lysine residues on the histone H4 tail to 
either arginine or alanine resulted in growth defects, replication timing defects, 
abnormal silencing of telomeric chromatin, and defects in repression and 
activation of the mating type locus (Johnson et al., 1990; Megee et al., 1990; Park 
and Szostak, 1990). These four lysine residues were known to be acetylated to 
varying degrees in vivo yet, aside from substituting lysine for the acetyl-lysine 
mimic glutamine, these studies could not make direct claims on the role of 
histone acetylation per se.  
Development of acetyl-histone-specific antibodies further established the 
connection between histone acetylation and gene activity. By 
immunofluorescence, the transcriptionally silent micronucleus of Tetrahymena 
thermophila was shown to be hypo-acetylated as compared to the 
transcriptionally active macronucleus (Lin et al., 1989), the hyper-active 
Drosophila melanogaster X-chromosome was shown to be hyper-acetylated (Turner 
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et al., 1992), and the mammalian inactive X-chromosome was shown to be hypo-
acetylated (Jeppesen and Turner, 1993). By chromatin immunoprecipitation 
(ChIP), actively transcribed regions of the genome were shown to be hyper-
acetylated (Hebbes et al., 1988), while silenced regions were shown to be hypo-
acetylated (Braunstein et al., 1993). Furthermore, histone acetylation was shown 
to be generally coincident with DNaseI hypersensitivity (Hebbes et al., 1994), a 
classic characteristic of actively transcribed chromatin (Weintraub and Groudine, 
1976). 
In 1996 two studies established a direct link between the regulation of 
histone acetylation and gene regulation by purification and characterization of a 
histone acetyltransferase (HAT) and histone deacetylase (HDAC). Many 
unsuccessful attempts had been made by various groups to purify HAT and 
HDAC activities from extract and the success of these groups relied on the 
utilization of unique and novel techniques. Allis and colleagues used extracts 
from the macronuclei of the protozoan Tetrahymena thermophila, a source known 
to have enriched HAT activity (Vavra et al., 1982). Utilizing an elegant in-gel 
assay, they identified a 55 kDa protein from Tetrahymena macronuclear extracts 
with HAT activity (Brownell and Allis, 1995). Once the protein was sequenced 
and its gene cloned it was identified as a homolog of the yeast transcriptional co-
activator Gcn5 (Brownell et al., 1996).  Soon after, Schreiber and colleagues 
utilized a potent HDAC inhibitor, trapoxin, as an affinity matrix for the 
purification of HDAC activity that they identified as a homolog of the yeast 
transcriptional co-repressor Rpd3 (Taunton et al., 1996). Taken together, these 
studies provided a direct link between gene regulation and the regulation of 
histone acetylation, prompting a new wave of research focused on the writers 
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and erasers of histone acetylation. With sequence homology searches to the 
mapped active sites of Gcn5 and Rpd3, dozens of new enzymes were identified 
and characterized, generally reinforcing the original discovery that HATs and 
HDACs are positive and negative transcriptional regulators, respectively. In a 
later section I will explore the HATs p300/CBP, as they are the most relevant to 
my thesis work. HDACs will be discussed later in Chapter 6. 
The long-held mechanism for histone acetylation’s positive role in 
transcription was considered to be due to the charge negation that occurs to the 
lysine residue upon acetylation, thus disrupting electrostatic interactions 
between the histone tails and the phosphate backbone of DNA leading to a looser 
configuration and increased accessibility to DNA-binding activators (cis-
mechanisms). By observations with electron microscopy Woodcock and 
colleagues demonstrated that hyper-acetylated chromatin isolated from butyrate-
treated cells did not form the compacted 30nm fiber observed in untreated cells 
(Annunziato et al., 1988).  Wolffe and colleagues further demonstrated that 
histone acetylation facilitates transcription factor binding to nucleosomal DNA 
(Lee et al., 1993). These in vitro studies were corroborated by the previously 
mentioned ChIP studies by Crane-Robinson and colleagues showing that histone 
acetylation is found at sites of DNaseI hypersensitivity (Hebbes et al., 1994). 
A distinct trans-mechanism for histone acetylation function was proposed 
by Zhou and colleagues when they demonstrated that the bromodomain of 
P/CAF, a human homolog of Gcn5, bound acetylated histone peptides (Dhalluin 
et al., 1999). Several of the newly discovered HATs contained a conserved 
protein domain called the bromodomain also present in a number of 
transcriptional regulators, such as Brm/Brg, Swi/Snf, and TAF1 (Haynes et al., 
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1992; Jeanmougin et al., 1997). While its function remained unclear, the 
bromodomain was proposed to function as an interaction domain with 
chromatin, potentially facilitating recruitment and localization. Zhou and 
colleagues proposed that histone acetylation could generate docking platforms 
for effector proteins in a similar way previously observed for SH2-domains and 
tyrosine phosphorylation. Multiple reader domains have now been identified for 
the major classes of histone PTMs, including acetylation, methylation, and 
phosphorylation exhibiting exquisite site and modification type sensitivity and 
are now considered a major mechanism of histone PTM function (Patel and 
Wang, 2013). By 2000 a concise model for the regulation and function of histone 
acetylation was established (Figure 1.3).  
In the early 2000’s genome-wide profiles of histone acetylation were 
generated by ChIP followed by microarray analysis (ChIP-on-chip), which 
showed that acetylation marked active regions of the yeast and fly genome 
(Kurdistani et al., 2004; Schübeler et al., 2004). Higher resolution array data 
revealed that histone acetylation marked the promoters and distal regulatory 
elements of active genes (Pokholok et al., 2005; Roh et al., 2005). Following the 
increased output and efficiency of high-throughput sequencing ChIP-seq became 
the dominant technique for mapping histone modifications at high-resolution. 
ChIP-seq of histone acetylation has led to the high-confidence mapping of 
enhancers in a number of cell types (Creyghton et al., 2010; Heintzman et al., 
2009; Rada-Iglesias et al., 2011) and has led to the discovery of novel classes of 
regulatory elements involved in the regulation of key developmental genes 
(Parker et al., 2013; Whyte et al., 2013) and aberrant activation of oncogenic 
transcription factors (Lovén et al., 2013; Mansour et al., 2014). 
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As foreshadowed by studies with butyrate and other synthetic HDAC 
inhibitors, the chemical inhibition of writers, readers and erasers of histone PTMs 
in the treatment of cancer is a topic of major interest and promise (Cai et al., 2015; 
Dawson and Kouzarides, 2012).  The HDAC inhibitor, vorinostat, was clinically 
approved in 2006 for the treatment of T cell lymphoma. Since then,  other HDAC 
inhibitors have been approved or are in clinical trial for the treatment of various 
malignancies (Falkenberg and Johnstone, 2014). Following impressive preclinical 
data (Delmore et al., 2011; Filippakopoulos et al., 2011) small molecule inhibitors 
of the bromodomain proteins, particularly inhibitors of the BET family, are 
currently in clinical trial for treatment of NUT midline carcinoma and various 
hematological malignancies (Filippakopoulos and Knapp, 2014). Furthermore, 
recurrent mutations in the writers, readers, and erasers of histone acetylation and 
other histone PTM have been found in a number of patient derived tumors (Plass 
et al., 2013), establishing chromatin regulators as a major class of drug targets in 
the treatment of cancer.  
The Transcriptional Co-Activator p300/CBP 
Before being characterized as a HAT, p300 was identified as a binding partner of 
the adenovirus oncogene E1A and was shown to be required for the activity of 
certain enhancer elements (Eckner et al., 1994). Independently, CBP was 
identified as a cyclic-AMP and phosphorylation dependent binding partner of 
the transcription factor CREB with a role in transcriptional activity (Chrivia et al., 
1993). Once both factors were cloned and sequenced it became clear that p300 
and CBP were highly related proteins with shared sequence and function (Arany 
et al., 1994). Given their role as transcriptional co-activators and integrators of 
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signal-dependent transcriptional activity (Chakravarti et al., 1996; Kamei et al., 
1996), knockout of either CBP or p300, even heterozygous null of either gene, led 
to embryonic lethality in mice (Yao et al., 1998). In 1996, stoked by the 
identification of GCN5 as a HAT, two independent groups reported that 
CBP/p300 have intrinsic HAT activities, further highlighting the direct link 
between histone acetylation and transcriptional activation (Bannister and 
Kouzarides, 1996; Ogryzko et al., 1996). p300/CBP were shown to interact with a 
wide range of transcriptional activators (Shikama et al., 1997) and their HAT 
activities were also shown to be involved in activation of enhancer elements. 
Notably, studies utilizing the beta-interferon enhancer demonstrated a critical 
role for the recruitment of p300/CBP via specific interactions with the p65 
subunit of NF-κb and ordered histone acetylation followed by chromatin 
remodeling and promoter unmasking (Agalioti et al., 2000; Merika et al., 1998). 
These cell-based assays could not directly establish the role of p300’s histone 
acetylation per se in the activation of transcription as most of the observations 
were based on correlative and associative observations. Furthermore, it was 
reported that p300 also acetylated non-histone factors, such as p53, with 
functional consequences, calling into question whether histone tails were the 
direct functional targets of acetylation (Gu and Roeder, 1997).  
Direct testing came with the development of cell-free transcription assays 
utilizing a DNA template chromatinized with recombinant histones and purified 
factors, allowing for elegant and precise experimentation. In studies utilizing the 
synthetic activator Gal4-VP16, maximal RNA synthesis was shown to require the 
activator, p300, and acetyl-CoA (Kundu et al., 2000). Furthermore, by using 
recombinant histones with lysine to arginine mutations, the transcription 
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reaction was shown to be dependent on the acetylation of specific lysine residues 
on the histone tails (An et al., 2002), directly demonstrating that p300-catalyzed 
histone acetylation was critical for transcriptional activation.  
The current model presents an ordered recruitment of transcription 
factors (DNA-binding activators) that in turn recruit p300 and other co-activators 
allowing for histone modifications and remodeling, which facilitate the 
recruitment and stabilization of the transcription apparatus through protein-
DNA (activator-DNA), protein-protein (activator-co-activator), and protein-PTM 
(reader-histone) interactions (Figure 1.3).  More recently, Gerschbach and 
colleagues demonstrated that targeting the minimal HAT domain of p300 to 
specific genomic loci activated the expression of target genes in a HAT-
dependent manner (Hilton et al., 2015). Intriguingly, the activation mediated by 
p300 was more substantial than the activation induced by targeting a potent 
synthetic activator domain (VP64), suggesting that histone acetylation may be 
sufficient to nucleate the assembly of the transcriptional apparatus and activation 
of transcription.  
Metabolic Regulation of Histone Acetylation 
Histone PTMs, including histone acetylation, are part of a complex regulatory 
process that establishes gene expression programs during development and 
disease. Strikingly, almost all histone-modifying enzymes require metabolites as 
essential co-factors, suggesting a link between these two pathways. The histone 
methyl-transferases require S-adenosyl-methionine (SAM), a product of one-
carbon metabolism. The histone demethylases require either alpha-ketoglutarate, 
an intermediary product in the citric acid cycle, or flavin adenine dinucleotide 
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(FAD), a redox cofactor. The sirtuin class of deacetylases requires nicotine 
adenine dinucleotide (NAD+), a redox cofactor. And most relevant to my studies, 
the histone acetyltransferases require acetyl-CoA, a central metabolite in the 
citric acid cycle, fatty acid metabolism, and cholesterol biosynthesis.  
The regulation of enzymatic activity by the concentration of its cofactors 
requires that the Km of the enzyme be in range of the natural fluctuations of the 
cofactor within the cell. For example, phosphorylation catalyzed by protein 
kinases is not thought to be regulated by the cellular concentration of ATP, as 
this concentration is tightly regulated and well above the typical Km for a given 
kinase (Kaelin and McKnight, 2013). On the other hand, a series of landmark 
studies have established that levels of acetyl-CoA are within the range to 
influence histone acetylation (Fan et al., 2015; Su et al., 2016). The nuclear 
concentration of acetyl-CoA in cells grown in culture is estimated at 2-13$M (Lee 
et al., 2014) placing it below the Km of several mammalian HATs, such as p300. 
These accurate measurements of subcellular acetyl-CoA are fairly new and most 
of the literature has used levels of histone acetylation as proxy measurement of 
acetyl-CoA concentrations.  
Several studies in S. cerevisiae have illustrated the role of nuclear-localized 
synthesis of acetyl-CoA in the regulation of histone acetylation and thereby gene 
expression. Boeke and colleagues demonstrated that the acetyl-CoA used for 
histone acetylation was generated locally in the nucleus by Acetyl-CoA 
Synthetase (Acs2). This enzyme charges acetate to free CoA in an ATP-
dependent reaction. They demonstrated that Acs2 was predominantly nuclear-
localized and that knockout of Acs2 led to a reduction in global histone 
acetylation and a downregulation of ~70% of all genes assayed by microarray 
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(Takahashi et al., 2006). This work linked a metabolic enzyme to the regulation of 
gene expression, but it was unclear whether acetyl-CoA concentrations 
fluctuated in a regulated manner that could be exploited by gene regulatory 
networks.  
Yeast grown in the nutrient-limiting environment of a chemostat 
spontaneously enter a synchronized cycle where they go through robust 
oscillations in metabolism and gene expression (Tu et al., 2005). Tu and 
colleagues showed that during these cycles the levels of acetyl-CoA fluctuate 
rhythmically, increasing and peaking as the cell enters the growth phase. These 
acetyl-CoA peaks were coincident with peaks in global histone acetylation and in 
the local acetylation at promoters of critical growth-related genes, which they 
found to be dependent on Gcn5 (Cai et al., 2011). They concluded that these 6-
fold shifts in the concentration of acetyl-CoA and the concomitant histone 
acetylation represented a metabolic signal to the cell to induce cell growth and 
proliferation. These studies in yeast demonstrated that concentrations of acetyl-
CoA can regulate histone acetylation and that the natural fluctuations of acetyl-
CoA are sufficient to control this process.  
While single cell eukaryotes rely of acetate as the major source of acetyl-
CoA, metazoans use glucose as their main carbon source and have minimal 
exposure to extracellular acetate. While mammalian cells have a homolog of Acs2 
(ACSS2) they have evolved a novel pathway for generation of cytosolic and 
nuclear acetyl-CoA by conversion of glucose-derived citrate to acetyl-CoA. This 
reaction is catalyzed by ATP-Citrate Lyase (ACL), as enzyme Wellen and 
colleagues established as the dominant source of acetyl-CoA used for histone 
acetylation (Wellen et al., 2009). Wellen and colleagues demonstrated that 
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glucose availability affected histone acetylation in an ACL-dependent manner 
and that knockdown of ACL reduced global histone acetylation. Furthermore, 
they established that ACL, and not ACSS2, is required for dynamic histone 
acetylation in response to growth factor signaling and adipocyte differentiation. 
These studies demonstrated that nutrient availability regulates histone 
acetylation and thereby regulates gene expression programs involved in 
differentiation and environment sensing (Wellen et al., 2009). 
As demonstrated by Wellen and colleagues, for mammalian cells grown in 
culture, the concentration of acetyl-CoA in the nucleus and thereby histone 
acetylation is tied to the metabolic state of the cell through glucose (Evertts et al., 
2013; Wellen et al., 2009) (Figure 1.4). Glucose is converted into pyruvate through 
the process of glycolysis. Pyruvate is transported into the mitochondria where it 
is converted to acetyl-CoA in an irreversible reaction by the pyruvate 
dehydrogenase (PDH) complex. The acetyl-CoA generated by PDH in the 
mitochondria has no active transport out of the mitochondria, is too large for 
passive diffusion across the mitochondrial double membrane, and is therefore 
effectively trapped and ready to fuel the tricarboxylic acid (TCA) cycle.  The first 
step of the TCA cycle is the condensation of acetyl-CoA and oxaloacetate by 
citrate synthase to yield citrate and free CoA-SH. Citrate can be transported out 
of the mitochondria through the tricarboxylate transport system. ACL can then 
convert citrate into acetyl-CoA, in a reversal of the citrate synthase reaction. This 
ACL-derived acetyl-CoA can then be used for fatty acid synthesis (via Acetyl-
CoA Carboxylase, ACC1), cholesterol synthesis (via acetyl-CoA 
acetyltransferase, ACAT), or as the high-energy donor of acetyl to histone lysine 
acetylation (via p300 and other HATs) (Figure 1.4). A recent study found that  
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Figure 1.4: Cytosolic and Nuclear Metabolism of Acetyl-CoA. 
Simplified schematic of pathways involved in acetyl-CoA (AcCoA) 
synthesis and catabolism in the mammalian cyto/nuclear compartment. 
For mammalian cells in culture, the main source of cyto/nuclear acetyl-
CoA is through TCA-cycle generated citrate that is converted to acetyl-
CoA by ACL. The majority of these carbons originate as glucose, but the 
degradation of fatty acids and amino acids can also contribute (not drawn). 
Stress-induced PDH translocation out of the mitochondria can bypass the 
TCA cycle by converting cyto/nuclear pyruvate directly into acetyl-CoA. 
Acetyl-CoA can also be generated from acetate by ACSS2. Three major 
pathways utilize cyto/nuclear acetyl-CoA: cholesterol biosynthesis, fatty 
acid synthesis, and protein acetylation. The enzymes that initiate each 
pathway are indicated: Acetyl-CoA Acetyltransferase (ACAT), Histone 
Acetyltransferase (HAT), and Acetyl-CoA Carboxylase (ACC). 
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under stress the PDH complex could translocate into the nucleus where it would 
generate acetyl-CoA used for histone acetylation directly from pyruvate, 
bypassing the mitochondria (Sutendra et al., 2014). As in yeast, acetyl-CoA can 
also be generated by the cyto/nuclear localized acetyl-CoA synthetase (ACSS2) 
by charging acetate with free CoA-SH in an ATP-driven reaction. The ACL 
reaction is favored during energy rich states (Wellen et al., 2009) whereas the 
ACSS2 reaction is necessary under hypoxic conditions (Comerford et al., 2014).  
These two pathways are not mutually exclusive and can complement each 
other. For example, under conditions of depleted ACL, addition of excess acetate 
can rescue the levels of histone acetylation in an ACSS2-dependent manner 
(Wellen et al., 2009). These data suggest that both enzymes feed into the same  
pool of acetyl-CoA, but that under different growth conditions the dominance of 
either enzyme changes. My thesis work implicates ACSS2 in the generation of 
crotonyl-CoA used for histone crotonylation, even in normal growth conditions, 
suggesting that ACSS2 might have secondary roles in regulating acyl-CoA 
metabolism under high glucose conditions.  Furthermore, aberrant 
phosphorylation of ACL by constitutively active AKT allows for the continuous 
production of acetyl-CoA even under nutrient limiting states (Lee et al., 2014), 
which could explain the epigenomic reprogramming observed in tumors with 
oncogenic Kras and Akt.  
Histone Crotonylation 
With high-sensitivity mass spectrometry several groups have profiled the histone 
acetylation landscape (Choudhary et al., 2009; Kim et al., 2006) demonstrating 
the general importance of protein acetylation on non-histone substrates. 
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Thousands of acetylation sites on hundreds of proteins have now been identified, 
making lysine acetylation a globally important PTM with function outside the 
nucleus (Choudhary et al., 2014; Verdin and Ott, 2014). Another outcome of these 
proteomic studies has been the discovery of a range of novel modifications. The 
major novel class of histone modifications described has been lysine acylations, 
similar in ε-amine linkage to lysine acetylation yet distinct in the hydrocarbon 
chain attached (Figure 1.5). Dr. Yingming Zhao, himself a graduate of The 
Rockefeller University, and his colleagues at The University of Chicago have 
been at the forefront of identifying these novel histone acylations and have so far 
identified propionylation, butyrylation (Chen et al., 2007), 2-hydroxyiso-
butyrylation (Dai et al., 2014), succinylation, malonylation (Xie et al., 2012), and 
crotonylation (Tan et al., 2011) (Figure 1.5A).  
The identification of histone lysine crotonylation came out of a systematic 
approach to identify novel histone PTMs by tandem mass spectrometry 
(MS/MS) (Tan et al., 2011). The covalent modification of histone protein leads to 
a characteristic mass shift that can be identified by MS/MS and parsed by 
computational methods. In their analysis, Zhao and colleagues identified 
peptides with a mass shift of +68 Da, which did not correspond to any known 
histone PTM. Through a series of deductions they determined that the additional 
68 Da was likely due to the modification of lysine residues by crotonyl (trans-2-
butenyl). By comparing peptides extracted from histones with peptides 
synthesized to include crotonyl-lysine (Kcr), they demonstrated that the two had 
the same mass spectra and co-eluted off an HPLC column, suggesting that the 
+68 Da shift they observed was most likely due to crotonyl-lysine.  
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Figure 1.5: Diversity of Histone Lysine Acylation. 
(A) Chemical structures of all currently identified histone lysine 
acylations. (B) Three-dimensional representation of crotonyl-lysine and 
acetyl-lysine. Note that while acetyl-lysine is free to rotate, crotonyl-
lysine has a rigid planar orientation (represented by light blue plane) due 
to the presence of C-C %-bond. Figure 1.5B is adapted from (Tan et al., 
2011). 
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The Zhao group next generated and validated a pan-Kcr antibody, which 
stained histones extracted from human, mouse, worm, fly, and yeast cells. 
Furthermore, this immunoblot signal was competed away by a library of Kcr 
peptides, but not by a library of acetyl-lysine (Kac) peptides, demonstrating that 
Kcr was a conserved histone modification. Using the pan-Kcr antibody Zhao and 
coworkers performed ChIP-seq in IMR90, a well-characterized human fibroblast 
line. Kcr was enriched at promoters and putative enhancer elements of active 
genes generally coincident with Kac.  Like Kac, levels of Kcr generally correlated 
with gene expression.  
To explore the role of Kcr in a biological setting Zhao and colleagues 
characterized the modification in the highly dynamic spermatogenesis process. 
They performed ChIP-seq for Kcr in pre-meiotic spermatocytes (Spc) and in post-
meiotic round spermatid (RS) and observed a similar patterning of Kcr as in 
IMR90, marking promoters and enhancers. When they compared levels of Kcr in 
Spc and RS they observed that the set of genes that had increased Kcr signal 
through meiosis tended to be highly expressed testis genes, suggesting that Kcr 
marked testis-specific genes. Furthermore, about a third of these genes resided 
on the X chromosome, an enrichment not observed with ChIP-seq with pan-Kac. 
During the transition between Spc and RS, the X-chromosome is known to 
undergo meiotic sex chromosome inactivation (MSCI), which leads to 
heterochromatin formation over the sex chromosomes, yet some genes “escape” 
silencing. Zhao and colleagues’ data suggested that Kcr marked these “escapee” 
genes. This prompted them to perform immunohistochemistry on tissue 
enriched for RS, which exhibit MSCI, with pan-Kcr and markers for 
heterochromatin. This analysis demonstrated that Kcr signal marked small 
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sections of the heterochromatic X-chromosome. This localization was not 
observed with Kac staining. They conclude that Kcr may play an important role 
in epigenetically marking sex chromosomes in the post-meiotic stages of 
spermatogenesis (Tan et al., 2011). Several manuscripts have been published 
since the original discovery of histone Kcr in 2011, I will introduce them and 
discuss their findings within the relevant chapters of my thesis.  
The manuscript describing the discovery of Kcr (Tan et al., 2011) was 
published just as I had joined the Allis lab for my graduate work. I was intrigued 
by the unique properties reported for Kcr in spermatogenesis and was also 
excited by the potential for discovery inherent in the novelty of the subject. I was 
motivated to characterize this novel histone PTM within the paradigm set forth 
by the studies conducted with histone acetylation. In my Thesis Research 
Proposal, written at the start of my graduate work, I proposed to study the 
regulation and function of histone crotonylation by identifying and 
characterizing the writers (Chapter 2), readers (Chapter 5), and erasers (Chapter 
6) of the newly discovered histone PTM. Through these originally proposed
experiments I uncovered an unexpected role for acyl-CoA metabolism in the 
regulation of histone Kcr and its impact of gene activation (Chapters 3 and 4).  
Portions of Chapters 2-4 have been published as: 
Sabari, et al. (2015). Intracellular Crotonyl-CoA Stimulates Transcription 
through p300-Catalyzed Histone Crotonylation. Molecular Cell 58, 203–
215. 
Portions of Chapter 5 are currently under review as: 
Li, Sabari, Panchenko, et al. (2016). Molecular Coupling of Histone 
Crotonylation and Active Transcription by AF9 YEATS Domain. 
Molecular Cell (in review)
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CHAPTER 2: PURIFICATION OF A HISTONE CROTONYLTRANSFERASE 
ACTIVITY AND CHARACTERIZATION OF ITS ROLE IN 
TRANSCRIPTION 
INTRODUCTION 
Histones are subject to a vast range of post-translational modifications with 
specific genomic localizations and well-documented functional roles in the 
regulation of transcription and other DNA-templated processes. Critical to our 
understanding of how histone modifications are regulated has been the 
identification and characterization of enzyme systems that catalyze the covalent 
modification of specific target residues. Histone lysine acetylation has been 
particularly well characterized within this paradigm, with the purification and 
identification of histone acetyltransferases prompting a breakthrough in our 
understanding of targeted lysine-acetylation’s direct role in gene regulation 
(Brownell et al., 1996). Despite this progress, little is known about the cellular 
regulation and functional relevance of a rapidly-expanding group of chemically 
related modifications known as histone acylations, of which acetylation is a well-
studied member.  
Histone lysine propionylation, butyrylation, malonylation, succinylation, 
2-hydroxyisobutyrylation, and crotonylation have all been identified by tandem 
mass spectrometry (MS/MS) proteomic analysis over the past several years 
(Chen et al., 2007; Dai et al., 2014; Tan et al., 2011; Xie et al., 2012) (Figure 1.5). 
These discoveries have increased the potential complexity of histone lysine 
modifications and have prompted interest in the functional consequence of 
differential acylation, both on histone proteins and non-histone proteins. 
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Previous ChIP-seq analyses with “pan” acyl-specific antibodies have mapped 
histone crotonylation and histone 2-hydroxyisobutyrylation to regulatory 
elements of actively transcribed regions of the genome, generally coincident with 
the localization of histone acetylation (Dai et al., 2014; Tan et al., 2011). These 
studies demonstrate that histones flanking active regulatory elements are 
modified by a number of chemically distinct acylations, suggesting a role for 
these modifications in transcriptional regulation. Yet, the enzymes responsible 
for catalyzing crotonylation of histone lysine residues have not been 
characterized. Here I report the partial purification of a histone 
crotonyltransferase (HCT) activity from HeLa S3 nuclear extract by column 
fractionation. I show that the well-studied transcriptional co-activator and 
histone acetyltransferase (HAT) p300 also possesses histone crotonyltransferase 
(HCT) activity. In collaboration with Dr. Zhanyun Tang of the Roeder lab, we 
demonstrate that p300-catalyzed histone crotonylation directly stimulates 
transcription and does so to a greater degree than p300-catalyzed histone 
acetylation. 
RESULTS  
HAT and HCT Activities Co-Purify with p300 from HeLa S3 Nuclear Extract 
To identify enzyme(s) capable of catalyzing histone crotonylation, I sought to 
purify a histone crotonyltransferase (HCT) activity from HeLa S3 nuclear 
extracts. I employed an HCT assay that mirrors previously described histone 
acetyltransferase (HAT) assays (Mizzen et al., 1999), except that crotonyl-CoA, 
rather than acetyl-CoA was used as the high-energy acyl-donor, and 
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Figure 2.1: Purification of an HCT Activity. 
(A) HCT purification scheme. (B-C) HCT activity co-elutes with HAT 
activity. HCT and HAT activities were assayed by panKCr or panKAc 
immunoblot, respectively, at each round of fractionation and peak HCT 
activity was followed. The immublot readouts for HCT (B) and HAT 
activity (C) of the final Mono S fractions are shown here. S3 indicates 
crude unfractionated extract, L indicates the load/Mono S input, and FT 
indicates the column flow through. Equal volumes of each fraction were 
used in these assays. For MS/MS analysis of fractions with peak HCT 
activity (fractions 4, 5, and 6) see Figure 2.2.  
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immunoblotting of reaction products with a pan-crotonyl-lysine antibody 
(panKCr) was used as a measure of HCT activity. In parallel, HAT activity was 
determined by substituting acetyl-CoA in the reactions and immunoblotting 
reaction products with a pan-acetyl-lysine antibody (panKAc). Utilizing these 
assays, HCT activity was detected in crude HeLa S3 nuclear extracts and 
partially purified by the fractionation scheme outlined in Figure 2.1A. Briefly, a 
soluble nuclear extract was prepared from HeLa S3 cells grown in suspension 
(see Methods for details), which was subject to a 60% (NH4)2SO4 cut, followed by a 
three step column fractionation over a linear gradient of KCl (0.15M-1M). HCT 
assays were performed on collected fractions and those presenting HCT activity 
were pooled and subject to the next round of fractionation.  Unexpectedly, HAT 
activity co-purified with HCT activity through multiple purification steps, 
including the final step in the partial purification scheme (Figures 2.1B and 
2.1C). Co-elution of these two activities, albeit with subtle differences toward H3 
and H4, suggested either that distinct HAT and HCT activities co-eluted 
throughout this purification or, unexpectedly, that a “HAT” might be responsible 
for the observed HCT activity. 
To identify proteins that were enriched during the purification of the HCT 
activity, I worked with Dr. Henrik Molina, the director of The Rockefeller 
University Proteomics Facility. Dr. Molina subjected peak Mono S fractions 4-6, 
and the crude nuclear extract (fraction “S3”) to MS/MS analysis (see Methods for 
details). Our analysis focused on identifying proteins that had been significantly 
enriched over the course of the purification scheme. Seven previously described 
HATs were identified with high confidence in the crude nuclear extract, p300, 
CBP, MOF, TIP60, GCN5, HBO1, and HAT1. Interestingly, five of these HATs  
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Figure 2.2: Proteomics Analysis of Partially Purified HCT Activity.  
(A) Box and whisker plot representation of Intensity Based Absolute 
Quantification (iBAQ) values for all proteins identified in the crude nuclear 
extract, and in the three Mono S fractions with peak HCT activity (fractions 
4, 5, and 6). Calculated iBAQ values for all observed HATs (p300, CBP, 
MOF, TIP60, GCN5, HBO1, HAT1) are plotted onto the box plots. All 
shown HATs were confidently matched with between 7 and 46 unique 
peptides. (B) Enrichments of iBAQ values for Fraction 5 over crude nuclear 
extract for all observed proteins are plotted as log2 values. The observed 
HATs are highlighted in red. (C) Heatmap representation of the relative 
iBAQ value enrichment or depletion over crude nuclear extract of the 
seven observed HATs in Mono S fractions 4, 5, and 6. (D) Immunoblot for 
p300 in indicated fractions. S3 indicates crude unfractionated extract, L 
indicates the load/Mono S input, and FT indicates the column flow 
through. Equal volumes of each fraction were assayed. 
The data and analysis presented in Figures 2.2A-2.2C were generated by 
Dr. Henrik Molina. 
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were enriched over crude nuclear extract in all three peak-fractions, while HBO1 
and HAT1 were depleted. HAT1 went from being the most abundant HAT in 
crude extract to being below the detection limit in all three peak-fractions. Of all 
the HATs present in the final fractions, the transcriptional coactivator p300 was 
the most enriched (Figure 2.2A). Based on Intensity Based Absolute Quantitation 
(iBAQ) values (Schwanhäusser et al., 2011), p300 went from being among the 
10% least abundant of all detectible proteins in the crude extract to being among 
the 20% most abundant of all detectible proteins in the Mono S fraction 5. 
Utilizing iBAQ values, Dr. Molina assigned an enrichment value for each protein 
identified in the peak HCT fraction (fraction 5) defined as iBAQ(fraction 5) over 
iBAQ(crude input).  By plotting this enrichment value for all detected proteins, 
we observed that p300 is among the most enriched proteins and the most 
enriched HAT in fraction 5 (Figure 2.2B). Furthermore, p300 is the most enriched 
HAT in all three peak-HCT fractions (Figure 2.2C).  In support of the MS/MS 
data, immunoblot of the Mono S fractions for p300 showed that the protein is 
markedly enriched from nuclear extracts through the purification of HCT 
activity (compare S3 to Mono S fraction 5 in Figure 2.2D). These data highlight 
p300 as a strong candidate for the enzyme responsible for HCT activity observed 
in my partially purified nuclear extract.   
p300 has HCT Activity In Vitro and In Cells
To directly test whether p300, or any of the other HATs enriched by our HCT 
purification, have intrinsic HCT activity, I purified recombinant p300, GCN5, 
TIP60, and MOF, and assayed their capacity to crotonylate and/or acetylate 
recombinant histone octamers by our previously described HCT and HAT 
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Figure 2.3: p300 Has Intrinsic HCT activity. 
HATs identified as being enriched during the HCT purification (p300, 
GCN5, TIP60, and MOF) were purified as recombinant proteins and used as 
enzyme source in HCT and HAT activity assays.  (A) HCT activity assay 
with purified recombinant p300, GCN5, and TIP60. (B) HAT activity assay 
with same proteins as in (A). (C) HCT activity assay with purified 
recombinant MOF. (D) HAT activity assay with purified recombinant MOF. 
All reactions were performed with recombinant histone octamers as 
substrate. Reaction products were immunoblotted with the indicated 
antibodies.  
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assays. While all of these recombinant enzymes exhibited their well-
characterized HAT activities, only p300 showed measurable HCT activity (Figure 
2.3).  Taken together, these data suggest that p300 is most likely the responsible 
enzyme for the observed HCT activity derived from the purified nuclear extract. 
To determine the principal sites of p300-catalyzed crotonylation and 
acetylation, I worked with Dr. He Huang in Dr. Yingming Zhao’s Lab at the 
University of Chicago, experts in the proteomics of histone acylations. Using 
semi-quantitative MS/MS analysis of in vitro reaction products by spectral 
counting (Carvalho et al., 2008), they found that H3K18 is the dominant site of 
both p300 crotonylation and acetylation, under our reaction conditions (data not 
shown). To confirm activity on H3K18, I made use of available site-specific 
antibodies against H3K18Cr or H3K18Ac to probe p300-driven HCT and HAT 
reaction products. Each antibody reacted with its intended target and failed to 
cross-react with the unintended target, lending support to both our MS/MS data 
and the acetyl vs. crotonyl specificities of the antibodies (Figure 2.4A). To 
confirm the site-specificity of these antibodies, recombinant H3 with a H3K18R 
mutation was used as a substrate in p300-driven HAT and HCT assays. Signals 
from both H3K18Cr and H3K18Ac antibodies were attenuated on the p300-
modified H3K18R mutant as compared to the wild type H3, further confirming 
the antibody site-specificities (Figures 2.4B and 2.4C).  
I next sought to determine whether p300 regulates H3K18Cr in cells. 
Knockdown of p300 or its paralog CBP by siRNA reduced the global levels of 
H3K18Cr, H3K18Ac, and H3K27Ac and double knockdown of p300 and CBP 
reduced the signals even further, as measured by immunoblot of acid-extracted  
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Figure 2.4: p300 Catalyzes H3K18cr. 
(A) p300-mediated HCT and HAT reactions were performed with the 
indicated reaction conditions. Reaction products were probed with the 
indicated site-specific antibodies. (B-C) Recombinant H3 with lysine 18 
mutated to arginine (K18R) was used, in parallel with wild-type H3 (wt), as 
substrates in p300-driven HCT (B) or HAT (C) reactions. Products were 
immunoblotted with the indicated antibodies. (D) HeLa S3 cells were 
transfected with control or p300- and/or CBP-specific siRNA. 72 hours post-
transfection, whole cell lysates and histones were prepared and 
immunoblotted with the indicated antibodies. Immunoblots of acid extracts 
are shown above the black line, while immunoblots of whole cell lysates are 
shown below the black line. (E) Overexpression of p300 in HEK 293T cells 
increases global levels of H3K18Cr and H3K18Ac. 293T cells were transfected 
with p300 cDNA. 48 hours post-transfection histones were prepared and 
immunoblotted with the indicated antibodies. 
37 
38 
histones (Figure 2.4D). In addition, overexpression of full-length p300 by 
transient transfection increased both H3K18Cr and H3K18Ac signals (Figure 
2.4E). Taken together these data support the conclusion that p300 (and its 
paralog CBP) catalyze both H3K18Cr and H3K18Ac in vitro and in cells. 
p300-Catalyzed Histone Crotonylation Stimulates Transcription in a Cell-Free 
System 
To directly test whether p300-catalyzed histone crotonylation plays a role in 
transcriptional regulation, I worked with Dr. Zhanyun Tang. We took advantage 
of a cell-free transcription assay wherein the presence of either acetyl-CoA or 
crotonyl-CoA could be experimentally controlled. p300’s HAT activity has long 
been implicated in activator-dependent stimulation of transcription from 
chromatinized templates in a reaction where maximal RNA synthesis is 
dependent upon p300 and acetyl-CoA (An et al., 2002). More recently, this assay 
has been modified to include natural activators, such as p53, and has been 
exploited to further our mechanistic understanding of transcriptional regulation 
in the context of chromatin (An et al., 2004; Tang et al., 2013).  
Similar experiments were conducted using a p53-dependent transcription 
assay, but with acetyl-CoA replaced by crotonyl-CoA (see schematic in Figure 
2.5A). To ensure the integrity of these assays, I validated the purities of the 
acetyl-CoA and crotonyl-CoA by HPLC analysis, which showed that both 
cofactors were pure and showed no traces of cross-contamination (Figure 2.5B). 
Using the H3K18Cr and H3K18Ac antibodies, Dr. Tang confirmed crotonylation 
of the recombinant chromatin substrate by p300 and its p53-dependence in this 
system (Figure 2.5C). Dr. Tang next performed the transcription assay and 
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Figure 2.5: Histone Crotonylation Stimulates Transcription. 
(A) Schematic of the transcription template (top) and the transcription 
reaction order of addition (bottom).  (B) Acetyl-CoA or crotonyl-CoA were 
injected onto a C18 column and eluted over an acetonitrile gradient as 
previously described (King and Reiss, 1985).  CoA molecules were detected 
by UV absorbance at 254 nm. (C) p300 HAT and HCT reactions using 
recombinant chromatin with the indicated additions were analyzed by 
immunoblot. (D) Transcription assays were performed under the indicated 
conditions. RNA products were visualized by autoradiography. (E) 
Densitometry of autoradiographs comparing acetyl-CoA and crotonyl-
CoA containing transcription reactions. Data represent mean fold change 
from three independent experiments ± standard deviation, p-value = 
0.0013. (F) In vitro transcription assays using chromatin reconstituted with 
recombinant wild-type H3 or with lysine residues 9, 14, 18, 23, 27, 36, and 
56 mutated to arginine (K-to-R). RNA products were visualized by 
autoradiography. 
The data presented in Figures 2.5C-2.5F was generated by Dr. Zhanyun 
Tang.  
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observed that p300-catalyzed crotonylation stimulated transcription in this 
system to a greater extent than did p300-catalyzed acetylation (Figure 2.5D). 
Under identical assay conditions, crotonyl-CoA containing reactions produced, 
on average, 1.66-fold greater transcript than did acetyl-CoA containing reactions,  
as measured by densitometry of autoradiograms from three independent 
experiments  (Figure 2.5E). 
To confirm that p300’s crotonyltransferase activity stimulates transcription 
by crotonylation of histone proteins and not of auxiliary factors from the added 
nuclear extract, Dr. Tang reconstituted recombinant chromatin with either wild-
type histone H3 or histone H3 with lysine residues 9, 14, 18, 23, 27, 36, and 56 
mutated to arginine (K-to-R). For both acetylation and crotonylation, p300-driven 
RNA production was substantially inhibited when chromatin containing histone 
H3 K-to-R mutations was used as a template (Figure 2.5F), demonstrating that 
the acetylation or crotonylation of the mutated histone lysine residues is 
necessary for the production of transcript in this cell-free system. The modest, yet 
reproducible and statistically significant, difference between histone acetylation 
and histone crotonylation in the stimulation of transcription provided an early 
hint that p300-catalyzed histone acetylation and crotonylation are functionally 
distinct. 
DISCUSSION 
Here I present data on the purification and characterization of p300 as a histone 
crotonyltransferase. In collaboration with the Roeder Lab, we demonstrate that 
p300-catalyzed histone crotonylation directly stimulates transcription. While 
previous sequencing based studies have shown that histone crotonylation 
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associates with transcriptionally active regions of the genome (Tan et al., 2011), 
the studies presented here demonstrate the direct role of histone crotonylation in 
transcription. Through cell-free experimentation in a controlled environment we 
were able to make these observations, which would have been difficult in the 
complex milieu of the cell. For example, early in the investigation of histone 
crotonylation, I observed that the pan-Kcr antibody exhibited an undefined 
cross-reactivity with histone acetylation that confounded many early results 
using this reagent (data not shown). These early observations led to cautious use 
of this antibody only in cases where it was clear that histone crotonylation was 
being detected, as in HAT and HCT activity assays where the only source of 
acetyl or crotonyl is from the added acyl-CoAs. The focus on p300 and the p300-
catalyzed H3K18cr led to the adoption of the H3K18cr antibody, which I was 
able to carefully test and deem acyl-specific (Figure 2.4A, and unpublished 
results). These observations were critical for the next stage of experimentation, 
which dealt with the cellular regulation and function of p300-catalyzed histone 
crotonylation.   
The HCT activity of p300 is unique among HATs assayed. p300, along 
with its paralog CBP, occupies a distinct class of HAT proteins based on primary 
sequence (Lee and Workman, 2007; Roth et al., 2001). Members of the other two 
major HAT families GNAT (GCN5) and MYST (TIP60 and MOF) exhibited their 
well-documented HAT activities but did not display HCT activity under the 
same reaction conditions. Interestingly, p300’s HAT domain is structurally 
unique and utilizes a distinct catalytic method for acetyl transfer (Liu et al., 2008). 
While it is clear that p300 performs its HAT reaction through a distinct structure 
and catalytic mechanism, it remains unresolved what specifically allows p300 to 
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perform the HCT reaction while other HATs cannot. The p300 gene is mutated in 
a number of developmental disorders and cancers (Gayther et al., 2000; 
Pasqualucci et al., 2011; Roelfsema et al., 2005), mostly resulting in heterozygous 
truncation or inactivation. It remains unknown whether a particular mutation 
could alter p300’s preference for acetyl-CoA or crotonyl-CoA, thereby altering its 
HAT and HCT activities. Another potential for the regulation of p300’s HAT 
versus HCT activity would be conformational change due to signal-induced 
PTMs. While p300’s HAT and co-activator activities are regulated by PTM of 
various type (auto-acetylation, phosphorylation, and arginine methylation) at 
various sites (Karanam et al., 2006; Lee et al., 2005; Yang et al., 2001), the effect of 
these modifications on HCT activity is unknown.  
Given that p300 catalyzes both acetylation and crotonylation and barring 
the identification of a mutant or modified form that only catalyzes one or the 
other, initial functional characterization of p300’s HCT activity was limited to 
cell-free systems where the presence or absence of acetyl-CoA or crotonyl-CoA 
could be controlled. The cell-free chromatinized-template transcription assay 
championed by the Roeder lab (An et al., 2002; 2004; Tang et al., 2013) was an 
obvious choice. By utilizing this recombinant chromatin template transcription 
assay, we show that p300-catalyzed histone crotonylation directly stimulated 
transcription to a greater degree than p300-catalyzed histone acetylation. Our 
study focused largely on H3K18 because of its identification as the dominant site 
of p300-driven crotonylation in our in vitro assays, the clear regulation of its 
global levels in mammalian cells by p300/CBP, and the availability of acyl-
specific antibodies for this modification. It is currently unknown if one site or a 
minimal subset of these sites is responsible for the transcriptional stimulation 
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observed in our cell-free system. Since the multi-site H3 K-to-R mutations ablate 
this transcriptional response, I conclude that histone crotonylation per se is 
required for this response; but exactly how that response is mediated and how it 
may differ mechanistically from the stimulation associated with acetylation 
remains unclear. While the assays described here utilize purified DNA, histones, 
activator, and p300, a nuclear extract is added as a source of general 
transcriptional machinery. Therefore, the precise mechanism by which histone 
crotonylation is distinct from histone acetylation is not resolved by these 
experiments. A fully purified system, as detailed in (Guermah et al., 2006) would 
be necessary for a direct comparison of transcriptional activation observed in 
crotonyl-CoA containing reactions and acetyl-CoA containing reactions. 
Lysine crotonylation, like other acylations, including acetylation, will 
neutralize the positive charge of the ε-amino group of lysine, yet the “functional 
groups” of the various acylations are chemically distinct (Figure 1.5). For most 
acylations, as is the case for histone crotonylation, the difference from acetylation 
is in increased bulk and rigidity, but for malonylation and succinylation, the 
modification adds net negative charge to an existing positively charged lysine. It 
is currently unknown whether there are specific “readers” for crotonyl-lysine or 
the other histone acylations that take advantage of this increased bulk, rigidity, 
and/or negative charge, which would add functionality to these modifications 
through trans-effects. The surprising discoveries that methyl-lysine “readers” 
can distinguish mono-, di-, and tri-methylated lysines, a comparably small 
chemical difference compared to the diversity of acylations, provides precedent 
for such discrimination (Taverna et al., 2007). Identification and characterization 
of binding modules that selectively prefer crotonyl-lysine, or other acylations, 
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will be critical to our understanding of the mechanism by which differential 
histone acylation exerts function. Chapter 5 discusses collaborative work with 
Dr. Haitao Li (Tsinghua University; Beijing, China) on the characterization of the 
YEATS domain as a crotonyl-lysine reader. 
In addition to the potential recruitment of reader or effector proteins, the 
cis-effects of various acylations on nucleosome or chromatin structure remains 
unexplored. Histone acetylation has been shown to directly influence both inter-
nucleosomal structure (Robinson et al., 2008; Shogren-Knaak et al., 2006) and 
intra-nucleosomal structure (Tropberger et al., 2013) by charge neutralization. It 
is of interest to understand how the additional bulkiness, rigidity, or charge of 
the various acylations will directly affect nucleosomal or oligonucleosomal 
structures.  
The studies presented in Chapter 2 establish that p300-catalyzes both 
histone acetylation and crotonylation and demonstrate a role for histone 
crotonylation in stimulating the transcription reaction. The observations of 
p300’s dual activity immediately suggested that the levels of histone 
crotonylation would be determined by the concentration of crotonyl-CoA and 
acetyl-CoA, the subject of Chapter 3.  
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CHAPTER 3: THE RELATIVE CONCENTRATIONS OF CROTONYL-COA 
AND ACETYL-COA REGULATE GLOBAL HISTONE CROTONYLATION 
INTRODUCTION 
As described in Chapter 2, I identified that p300, a previously described HAT 
and transcriptional co-activator, also has HCT activity, yet it remained unclear 
how histone crotonylation could be regulated differently than histone 
acetylation. Given that the various histone acylations (acetylation, 
propionylation, butyrylation, crotonylation, etc.) are derived from their 
respective charged acyl-CoAs (acetyl-CoA, propionyl-CoA, butyryl-CoA, 
crotonyl-CoA, etc.), which populate various arms of intermediary metabolism, it 
has been proposed that differential histone acylation could be regulated by the 
cellular concentration of these metabolites and thereby act as a potential 
“integrator” of a cell’s metabolic state (Lin et al., 2012). However, this hypothesis 
has not been directly tested. With the identification of p300’s dual activity, a 
simple hypothesis could be proposed: while maintaining p300 (enzyme) and 
histone (substrate) concentrations, the relative concentrations of either co-
reactant (acetyl-CoA or crotonyl-CoA) would determine the rate of either 
reaction (acetylation or crotonylation), thereby regulating the amounts of either 
product (acetyl-lysine or crotonyl-lysine). In this model the relative metabolite 
concentration would determine the state of differential acylation (either acetyl or 
crotonyl). A number of studies have linked mammalian cellular metabolism to 
the regulation of histone acetylation (see Chapter 1). An early landmark paper 
demonstrated that in mammalian cells the enzyme ATP-Citrate Lyase (ACL) was 
responsible for generating acetyl-CoA used for histone acetylation (Wellen et al., 
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2009). Importantly, this study illustrated that the cyto/nuclear concentration of 
acetyl-CoA could affect histone acetylation and gene expression, providing a 
precedent for metabolite driven control of transcription mediated through 
histone modifications.  
Here I demonstrate that as a result of p300’s dual enzymatic activities, the 
level of histone crotonylation in the cell is sensitive to the relative cellular 
concentrations of crotonyl-CoA and acetyl-CoA. I demonstrate that treatment of 
cells with the neutralized salt of the short chain fatty acid crotonic acid, sodium 
crotonate (from here on referred to as crotonate), can be used to increase cellular 
concentrations of crotonyl-CoA. This increase in crotonyl-CoA leads to increased 
levels of histone crotonylation, which can be “tuned” by treating cells with 
different concentrations of crotonate. I implicate the cytoplasmic/nuclear 
metabolic enzyme acyl-CoA synthetase (ACSS2 or AceCS1) in the synthesis of 
crotonyl-CoA from crotonate in mammalian cells. Furthermore, by depletion of 
enzymes that produce acetyl-CoA levels of histone crotonylation increase, 
further demonstrating the balance between acetyl-CoA and crotonyl-CoA for 
p300’s catalytic activity. These data support the conclusion that differential 
acylation of histones is regulated metabolically, by the relative concentrations of 
acyl-CoAs.  
RESULTS 
Crotonyl-CoA and Acetyl-CoA Compete for p300’s Acyltransferase Activity 
I next sought to gain insights into how differential acylation is regulated in 
mammalian cells.  Given that p300 can catalyze both histone acetylation and 
crotonylation, I hypothesized that a differentially modified substrate would be  
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Figure 3.1: The Relative Concentrations of Acetyl-CoA and Crotonyl-CoA 
Determine the Reaction Products.  
In vitro p300 HAT/HCT reactions were performed with indicated 
concentrations of crotonyl-CoA and acetyl-CoA. Reaction products were 
immunoblotted with the indicated antibodies. 
49 
the direct result of the cellular concentrations of either acetyl-CoA or crotonyl-
CoA that would, in turn, be regulated by extracellular and intracellular sources 
of these cofactors. To provide a preliminary test of this hypothesis, p300 reactions 
were performed in which acetyl-CoA and crotonyl-CoA were mixed in varying 
ratios. Indeed, altering the relative concentrations of these two acyl-CoAs 
dictated how much of each modification was present in the final reaction product 
(Figure 3.1). I conclude that crotonyl-CoA can compete with acetyl-CoA for 
p300’s activity toward its substrate and, consequentially, the relative 
concentrations of crotonyl-CoA to acetyl-CoA will determine the enzyme’s 
reaction products. While H3K18 is not the exclusive site of either p300-catalyzed 
acetylation or crotonylation, the levels of H3K18Cr and H3K18Ac can be used as 
a surrogate for p300’s differential activity in vitro and in cell-based assays.  
LC-MS Measurements of Crotonyl-CoA and Acetyl-CoA 
To investigate the relative cellular concentrations of acetyl-CoA and crotonyl-
CoA, I worked with Dr. Justin Cross, Director of Memorial Sloan Kettering’s 
Cancer Metabolism Center, and his colleague Dr. Vladimir Yong-Gonzalez to 
establish a targeted LC-MS approach that would allow us to extract CoA species 
from whole cells in culture and measure the abundance of acetyl-CoA and 
crotonyl-CoA. We assayed HeLa S3 cells growing in full media under 
exponential growth conditions and observed a small yet measurable pool of 
crotonyl-CoA, which was approximately 1000x less abundant than acetyl-CoA 
(Figures 3.2A and 3.2B, first column). The pool of crotonyl-CoA was small in 
comparison to acetyl-CoA, the most abundant CoA-species measured and the 
product of several major biosynthetic pathways in multiple organelles. The low 
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basal abundance of crotonyl-CoA places it well below the Km of p300 (Meier, 
2013), which should allow any fluctuation in its concentration to affect 
downstream crotonyltransferase reactions.  
To test this prediction, I experimentally increased the concentration of 
crotonyl-CoA in HeLa S3 cells by adding crotonate to the culture media, and 
observed a dose-dependent increase in both the cellular concentration of 
crotonyl-CoA and the global levels of H3K18Cr (Figures 3.2A-3.2C). The 
relatively low abundance of cellular crotonyl-CoA allowed for this dramatic fold 
change in its availability. In contrast, addition of acetate to cells did not 
dramatically increase the abundance of cellular acetyl-CoA and had little to no 
effect on global levels of H3K18Ac (Figures 3.2B and 3.2C).  Here again, I utilized 
the site-specific and acyl-specific antibodies (H3K18Ac and H3K18Cr) as a 
tenable surrogate measure for the differential acylation state of histone residues 
modified by p300/CBP in the cell. Moreover, the increase in histone 
crotonylation was not specific to H3K18. A dose-dependent signal increase was 
also observed with the pan-crotonyl-lysine antibody, not only in H3, but also in 
the other core histones, upon crotonate addition (Figure 3.2C). I also observed a 
similar dose-dependent increase in global histone crotonylation in HEK293T 
cells, mouse embryonic stem cells, and RAW 264.7 cells, a mouse macrophage 
cell line, demonstrating that this is not a HeLa S3-specific phenomenon (Figures 
3.2D-3.2E). These data demonstrate that histone crotonylation is sensitive to 
fluctuations in crotonyl-CoA concentrations and that crotonate treatment is a 
general experimental method to specifically increase levels of histone 
crotonylation.  
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Figure 3.2: Manipulation of Intracellular Crotonyl-CoA Concentration by 
Treatment of Cells with Sodium Crotonate.  
(A-B) LC-MS analysis of cellular crotonyl-CoA (A) and acetyl-CoA (B) levels 
extracted from HeLa S3 cells cultured with the indicated concentration of 
sodium crotonate (pH 7.4) or sodium acetate (pH 7.4) added to full media for 12 
hours. The data represent mean peak area ± standard deviation of four 
independent experiments. Summary of p-value is as follows: ns (p>0.05), **** 
(p≤0.0001). (C-F) Histones were acid extracted from HeLa S3 cells (C), mouse 
embryonic stem cells (mESC) (D), RAW 264.7 cells (E), and HEK293T cells (F) 
treated as in (B) and immunoblotted by the indicated antibodies. 
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Sodium Crotonate Does Not Have HDAC Inhibitor Activity 
Given the chemical similarity between crotonate and butyrate, a compound with 
known histone deacetylase (HDAC) activity (Boffa et al., 1978; Candido et al., 
1978), I next sought to ensure that the increase in histone crotonylation was not 
due to the inhibition of an unknown crotonyl-specific HDAC activity. To rule out 
this possibility I carried out a fluorometric-based HDAC assay with HeLa S3 
nuclear extracts as a general source of HDAC activity in the presence of 
increasing concentrations of crotonate, acetate, or butyrate. While butyrate 
showed the expected inhibition of HDAC activity, crotonate and acetate showed 
minimal inhibition (Figure 3.3).  
 
  
Figure 3.3: Crotonate is Not an HDAC Inhibitor.  
Increasing concentration of either acetate, butyrate, or crotonate (0, 
0.5mM, 1mM, or 5mM) were added to a Fluorometric HDAC assay kit 
(Active Motif) where fluorescence intensity is an indirect measure of 
HDAC activity. Butyrate is a known HDAC inhibitor, while Acetate is not 
considered an HDAC inhibitor. HeLaS3 nuclear extract was used as a 
general source of HDAC activity. 
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ACSS2 is Responsible for Synthesizing Crotonyl-CoA from Crotonate 
To further demonstrate that addition of crotonate is increasing histone 
crotonylation through the direct production of crotonyl-CoA and not through an 
indirect mechanism, I asked whether knockdown of the Acyl-CoA Synthetase, 
ACSS2, would attenuate the increase in histone crotonylation. ACSS2 is known 
to charge acetate with free CoA-SH to form acetyl-CoA in mammalian cells, is 
known to localize to the cytosol and the nucleus (Wellen et al., 2009), and has 
been shown to charge longer chain SCFAs in vitro (Frenkel and Kitchens, 1977), 
making it an excellent candidate for the conversion of crotonate to crotonyl-CoA. 
Supporting this notion, knockdown of ACSS2 prior to addition of crotonate to 
HeLa S3 cells reduced the amount of crotonyl-CoA produced and the levels of 
H3K18Cr (Figures 3.4A and 3.4B, compare columns/lanes 2 and 4). Intriguingly, 
I also observed that ACSS2 knockdown reduced the global levels of H3K18Cr in 
untreated cells (Figure 3.4B, compare lanes 1 and 3). This suggests that basal 
concentrations of crotonyl-CoA used for histone crotonylation are synthesized 
from endogenous sources of crotonate. To further support this observation and 
to rule out potential complications due to siRNA off-target effects, I tested four 
separate ACSS2-specific RNAs that all showed a global reduction in H3K18Cr 
(Figure 3.4C). These data suggest that ACSS2 is responsible, at least in part, for 
the production of crotonyl-CoA to be used for histone crotonylation.  
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Figure 3.4: Knockdown of ACSS2 Reduces Cellular Levels of H3K18cr. 
(A) HeLa S3 cells were transfected with control or ACSS2-specific siRNA 
(pool of 5). 12 hours prior to harvest 10 mM crotonate was added to the 
media as indicated. 72 hours post-transfection cells were harvested and 
subject to LC-MS analysis. The data represent mean peak area ± standard 
deviation of four independent experiments. *, t-test derived p-value < 0.05. 
(B) Same as (A), except 72 hours post-transfection, histones and whole cell 
lysates were prepared, and immunoblotted with the indicated antibodies. 
Immunoblots of acid extracts are shown above the black line, while 
immunoblots of whole cell lysates are shown bellow the black line. (C) HeLa 
S3 cells were transfected with control or specific siRNAs to ACSS2. ACSS2 
#1-3 are unique single RNAs, and ACSS2 #4 is the pool of 5 used in (A-B).   
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Impairing Acetyl-CoA Synthesis Leads to Higher Levels of Histone 
Crotonylation 
I next asked whether impairing acetyl-CoA production would have an effect on 
histone crotonylation. My in vitro reactions would predict that lowering the 
concentration of acetyl-CoA will lead to an increase in H3K18Cr by reducing the 
competition for p300/CBP (Figure 3.1). A growing literature has shown that the 
cytoplasmic and nuclear enzyme ATP-Citrate Lyase (ACL) is responsible for 
producing acetyl-CoA used for histone acetylation in mammalian cells (Lee et al., 
2014; Wellen et al., 2009). Knockdowns of ACL by three unique siRNAs resulted 
in the expected reduction in global levels of H3K18Ac and, as predicted by my in 
vitro experiments, an increase in global levels of H3K18Cr (Figure 3.5A). 
Furthermore, the increase in H3K18Cr can be reversed by the addition of acetate, 
which has previously been shown to restore histone acetylation levels in the 
absence of ACL (Figure 3.5B) (Wellen et al., 2009).  
Recently, the pyruvate dehydrogenase (PDH) complex, which synthesizes 
acetyl-CoA for the TCA cycle in the mitochondria, has been shown to translocate 
to the nucleus where it can synthesize acetyl-CoA used for histone acetylation 
(Sutendra et al., 2014). Upon knockdown of PDHE1α, a critical subunit of the 
PDH complex, I observed both the previously reported reduction in H3K18Ac 
and the predicted increase in H3K18Cr (Figure 3.5C). Given the relatively low 
steady-state levels of crotonyl-CoA to acetyl-CoA in the cell and the decrease in 
acetyl-CoA observed with ACL knockdown, we do not suggest that crotonyl-
CoA is completely replacing acetyl-CoA, but rather that the crotonyl-CoA that is 
present has less competition for p300 and is therefore more often used for p300-
catalyzed histone acylation.  
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Figure 3.5: Reducing Acetyl-CoA Leads to an Increase in Histone 
Crotonylation.  
(A) HeLa S3 cells were transfected with non-target, or one of three unique 
ACL siRNAs, as indicated. 72hrs post-transfection histone extracts and whole 
cell lysates were prepared and immunoblotted with the indicated antibodies. 
Immunoblots of acid extracts are shown above the black line, while 
immunoblots of whole cell lysates are shown bellow the black line. Asterisks 
designate non-specific band in anti-ACL blots. (B) HeLa S3 cells were 
transfected with either non-target or ACL-specific siRNA (#1) using the same 
protocol as in (A), except 14 hours prior to harvest 10 mM acetate was added 
to the media as indicated. Analysis and labeling are as in (A). (C) HeLa S3 cells 
were transfected with non-target, PDHE1α, or ACL (#1) specific siRNA, as in 
(A-B). Analysis and labeling are as in (A-B). 
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DISCUSSION 
Regulation of histone PTMs by metabolite availability has been proposed as a 
mechanism for linking chromatin state to metabolism (Donohoe and Bultman, 
2012; Gut and Verdin, 2013; Kaelin and McKnight, 2013; Katada et al., 2012; Lu 
and Thompson, 2012; Meier, 2013). The basic premise is that many chromatin-
modifying enzymes utilize products of intermediary metabolism as cofactors 
essential for their activities.  Fluctuations in these metabolites could directly 
transduce a transcriptional response through the modification of chromatin state 
either by activating or inhibiting various chromatin-modifying enzymes. This 
study introduces a new dimension to this paradigm in that fluctuations in both 
acetyl-CoA and crotonyl-CoA are shown to affect levels of histone acylation. 
Here I show that crotonyl-CoA can compete with acetyl-CoA for p300’s acyl-
transferase activity, allowing the relative concentrations of either CoA to 
determine the reaction products. I implicate the cytoplasmic and nuclear 
localized metabolic enzyme ACSS2 as a source of intracellular crotonyl-CoA 
used for histone crotonylation. Together these data demonstrate the sensitivity of 
histone crotonylation to acyl-CoA metabolism and provide a toolkit for 
perturbing histone crotonylation in the cell. 
I propose that fluctuations in acyl-CoA metabolism and the ratios of these 
various metabolites will be “translated” by chromatin, through mechanisms 
described here and through mechanisms yet to be uncovered (Figure 3.6). 
Although I have focused on H3K18, I anticipate that these observations will hold 
for other enzyme-driven crotonylations, and acylations that share enzyme-
machineries. The ability to quantitatively measure the cellular concentrations of a 
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Figure 3.6: Metabolic Regulation of Histone Crotonylation 
Schematic diagram of the pathways involved in the enzymatic and 
metabolic regulation of histone crotonylation and histone acetylation 
(differential acylation). The differential acylation state of chromatin is 
regulated by the relative concentrations of acetyl-CoA and crotonyl-CoA, 
which are synthesized through distinct metabolic pathways, diagramed 
here. Branches of the diagram that are still unknown are marked by 
question marks. The PDH (pyruvate dehydrogenase), ACSS2 (Acyl-CoA 
synthetase), and ACL (ATP Citrate Lyase) reactions occur in both the 
cytosol and nuclear compartments. We favor the model that DNA-
sequence-specific transcription factors (TF) recruit p300/CBP to specific 
genomic loci where they will “translate” the nuclear/cytosolic acyl-CoA 
levels by differentially acylating histones. 
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variety of acyl-CoAs opens up the potential for a new avenue of research. 
Comparative profiling of acyl-CoAs from a variety of biological materials will be 
a valuable resource and will allow correlations to be drawn between basal 
concentrations and function and/or physiological state. For example, ChIP-seq 
data from developing spermatagonia show an interesting relationship between 
histone crotonylation and active gene expression programs in the development 
of male germ cells (Montellier et al., 2013; 2011; Tan et al., 2011). It remains to be 
tested whether a unique metabolic program underlies these observations or 
whether similar mechanisms are in play during other developmental or disease 
pathways.  Additionally, it has been long observed that the transformation of 
cells to a cancerous state requires a rewiring of metabolic pathways (Pavlova and 
Thompson, 2016; Warburg et al., 1927). Global and local changes in histone 
acetylation have been observed in a variety of tumors and cancer models 
(Horwitz et al., 2008; Seligson et al., 2009; 2005). It remains of interest to bridge 
these two observations and understand whether changes in acyl-CoA 
metabolism and thereby downstream histone acylations play a significant role in 
cancer or other aspects of human biology and disease.   
These data also suggest that both intra-cellular and extra-cellular 
concentrations of short chain fatty acids (SCFA), like crotonate, will influence 
chromatin state through the activity of ACSS2. Fluctuations in the concentration 
of a variety of SCFAs have been linked to metabolic disorders and diseases. For 
example, the concentration of 3-hydroxy-butyrate can rise to as high as 25mM in 
peripheral blood and has been implicated in chromatin regulation (Shimazu et 
al., 2013). Additionally, differences in the concentrations and makeup of SCFAs 
from environmental sources have been implicated in a variety of physiological 
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and disease states ranging from gut microbiota dysbiosis leading to obesity, 
colitis, and cancer predisposition to the regulation of immune cell development 
(Lee and Hase, 2014; Tan et al., 2014a).  Whether these observed fluctuations in 
SCFA lead to an increase in their corresponding histone acylation, as we have 
shown here with crotonate and histone crotonylation, remains untested. 
Furthermore, it is still unclear how crotonate or crotonic acid, are generated in 
mammalian cells. Finally, recent reports have highlighted the critical role of 
ACSS2 in tumor growth (Comerford et al., 2014; Mashimo et al., 2014), yet the 
role of differential histone acylation in this context was unexplored. 
The studies in Chapter 3 establish the metabolic regulation of histone 
crotonylation and develop tools to specifically perturb histone crotonylation in 
the cell. With these tools I was now able to ask how increasing or decreasing 
crotonyl-CoA affects p300-regulated gene activation, the subject of Chapter 4. 
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CHAPTER 4: EXPERIMENTAL MANIPULATION OF [CROTONYL-COA] 
AFFECTS ACTIVATION AND EXPRESSION OF P300 TRAGET GENES IN 
LPS-INDUCED INFLAMMATORY RESPONSE 
INTRODUCTION 
Having shown that p300-catalyzed histone crotonylation directly stimulates 
transcription in a cell-free system (chapter 2) and the metabolic regulation of 
histone crotonylation in cells (chapter 3), I next sought to investigate whether 
p300-catalyzed histone crotonylation is involved in the process of gene activation 
in a cellular context. The LPS-induced inflammatory response in macrophages is 
a classic model of signal-dependent gene activation, where the role of chromatin 
and chromatin modifying enzymes are well documented (Smale et al., 2014).  
The innate immune system protects an organism from pathogens and other 
environmental insults through a wide range of mechanisms. While many 
proteins involved in innate immunity are constitutively expressed other are 
induced only when needed. This induction is controlled by a series of pattern 
recognition receptors that specifically recognize pathogen-associated molecular 
patterns. The presence of receptors on the host cell surface allows the host cell to 
recognize and respond to specific pathogen-associated signals by activation of 
signaling cascades generally leading to a specific transcriptional response 
(Janeway and Medzhitov, 2002; Takeuchi and Akira, 2010).  
Lipopolysaccharide (LPS), found on the outer membrane of Gram-negative 
bacteria, stimulates multiple signaling cascades by engagement with the host 
receptor, TLR4. While there are transcription-independent responses to TLR4 
activation, most of the response is mediated through a signal-dependent 
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transcriptional cascade (Medzhitov and Horng, 2009; Smale, 2012), which I will 
refer to as the inflammatory response. The rapid and robust activation of 
inflammatory response genes provides a model for gene activation where the 
temporal control of transcription is dependent on the addition of LPS to cells in 
culture allowing manipulations to crotonyl-CoA concentrations to be made prior 
to gene activation. Furthermore, the inflammatory response induces the 
transcription of hundreds of genes through distinct mechanisms dependent on 
various factors. For example, some genes are primed and their chromatin fully 
modified before LPS stimulation, while other genes must go through chromatin 
modification and remodeling before the gene is expressed (Bhatt et al., 2012; 
Ramirez-Carrozzi et al., 2009). This provides genes that can be experimentally 
perturbed at the level of chromatin regulation and a series of genes that can act 
as internal controls that are LPS-responsive but insensitive to chromatin 
perturbations, as their chromatin is already primed. 
The wealth of previously published data profiling the transcriptomic and 
epigenomic aspects of the inflammatory response also made it an attractive 
model. Most important to my studies on p300-catalyzed histone crotonylation 
was a published ChIP-seq data set for p300 ± LPS (Ghisletti et al., 2010). This 
p300 ChIP-seq data set provided critical information on which LPS-induced 
genes are regulated by p300, as demonstrated by ChIP signal at promoter 
proximal or distal regulatory elements. From these ChIP-seq data I could also 
determine which p300-regulated genes had p300 localized prior to LPS (primed) 
and which ones had signal-dependent recruitment of p300. In this chapter, I refer 
to the former group of genes as “pre-activated” and the latter group of genes as 
“de novo-activated,” and define these categories based on the p300 ChIP-seq 
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data. This classification is important because while the genes that are “pre-
activated,” meaning they already have p300 bound at their associated regulatory 
elements, will not be dependent on p300 recruitment and subsequent histone 
acetylation and/or crotonylation for gene activation, the “de novo-activated” 
genes will be dependent on this process. This feature of “de novo-activated” 
genes provides a means to ask whether having more or less p300-catalyzed 
histone crotonylation affects expression, which can be accomplished through 
manipulations to crotonyl-CoA concentrations described in Chapter 3. 
Here, I show that increasing or decreasing the cellular concentration of 
crotonyl-CoA prior to LPS-stimulation causes local changes in histone 
crotonylation, specifically at the histones flanking regulatory elements that show 
the greatest increase in p300 localization during the inflammatory response (i.e. 
“de novo-activated” genes). This increase or decrease in crotonyl-CoA 
concentration also leads to enhanced or diminished levels, respectively, in 
expression of those specific activated genes. 
RESULTS 
H3K18Cr is Associated with Active Chromatin and Correlates with p300  
Localization 
To investigate the role of differential acylation in transcriptional activation 
within a cellular context, I turned to the LPS-induced inflammatory response in 
the macrophage cell line RAW 264.7. The macrophage LPS response involves a 
well-characterized transcriptional program that requires p300 recruitment to 
many sites of downstream gene activation to facilitate histone acetylation and 
chromatin remodeling that are critical for the inflammatory response (Ghisletti et 
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al., 2010; Ramirez-Carrozzi et al., 2009). I performed RNA-seq and ChIP-seq for 
H3K18Ac and H3K18Cr on cells pre- and post-LPS stimulation (120’). I also made 
use of published p300 ChIP-seq from macrophages under similar stimulation 
conditions (Ghisletti et al., 2010). 
I first assessed the ChIP-seq data for H3K18Ac and H3K18Cr under 
unstimulated conditions and observed that both histone modifications map to 
promoter-proximal and –distal regulatory elements associated with active genes 
(Figure 4.1). By mapping the average profile of both H3K18Ac and H318cr ± 2kb 
of the transcription start site (TSS) for four equal groups of genes ranked by 
expression levels (as determined by RNA-seq), both modifications showed a 
correlation with gene activity; the group of highest expressed genes exhibited the 
highest levels of H3K18Ac and H3K18Cr and vice versa (Figures 4.1A and 4.1B).  
Both modifications exhibited the common histone acetylation profile, two peaks 
flanking a putatively nucleosome depleted regulatory element where p300 is 
recruited. Levels of H3K18Ac and H3K18Cr followed a significant linear 
correlation (Figure 4.1C) and were enriched at peaks of p300 across the genome 
(Figure 4.1D), as predicted by my findings that both modifications are catalyzed 
by p300. The trends observed by average profiles of H3K18Ac and H3K18Cr 
reads were also clearly observed at individual genes (Figures 4.1E and 4.1F), 
where peaks of H3K18Ac and H3K18Cr flanked promoter-proximal and –distal 
regulatory elements, marked by p300. These data point to a role for p300-
catalyzed crotonylation in general transcriptional activation and reaffirm the 
notion that active regulatory elements are modified by a number of histone 
acylations. 
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Figure 4.1:  H3K18Cr, H3K18Ac, and p300 Co-Localize Genome-Wide.  
(A-B) All genes with FPKM >1 were split into 4 equal groups based on their 
expression levels calculated from RNA-seq of unstimulated RAW 264.7 cells. 
The average profile of H3K18Ac (A) and H3K18Cr (B) ChIP-seq data from 
unstimulated RAW 264.7 cells are plotted for each group at TSS ± 2kb. (C) 
Correlation between H3K18Ac and H3K18Cr ChIP-seq read counts within all 
H3K18Cr peaks (17,747). Plotted as normalized read counts (read counts per 
million mapped reads). (D) Average profile of H3K18Ac, H3K18Cr, and input 
ChIP-seq data from unstimulated RAW 264.7 around all annotated p300 peaks 
from unstimulated macrophages. (E-F) Genome browser representation of 
normalized ChIP-seq reads for p300, H3K18Ac, H3K18Cr, and input from 
unstimulated macrophages at a “housekeeping” gene (Actb) (E) and a lineage 
specific constitutively expressed (“pre-activated”) gene (Ccl3) (F). Normalized 
to total mapped reads. The y-axis maximum is given at the far left of each 
track. Arrow below refseq gene track indicates directionality of transcription.   
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H3K18Cr and H3K18Ac are Induced at “De Novo-Activated” Regulatory 
Elements Upon LPS Stimulation 
Stimulation of macrophages by LPS initiates a well-characterized, rapid, and 
robust transcription program (Bhatt et al., 2012; Ramirez-Carrozzi et al., 2009). 
For my interests in investigating differential acylation by p300, I focused on two 
unique classes of LPS-induced genes: I) those showing increased p300 
recruitment upon LPS stimulation (fold (reads) > 4), which I will term “de novo-
activated”, and II) those showing pre-localized levels of p300 (prior to LPS 
stimulation) that are not significantly changed upon stimulation (-1.3 < fold 
(reads) < 1.3), which I will term “pre-activated.” The ChIP-seq traces for p300, 
H3K18Ac, H3K18Cr, and RNA-seq of genes from both classes ± LPS stimulation 
(120’) demonstrate how the chromatin landscape at these two different classes of 
genes responds to LPS stimulation (Figure 4.2). While “de novo-activated” genes 
(Figures 4.2A and 4.2B) showed an induction in both modifications upon LPS 
stimulation, “pre-activated” genes (Figures 4.2C and 4.2D) had peaks of both 
H3K18Ac and H3K18Cr prior to LPS stimulation. These trends were also 
observed by average profiles of H3K18Ac and H3K18Cr centered on the TSS of 
all “pre-activated” and all “de novo-activated” genes (Figures 4.2E-4.2H).  
Increasing Crotonyl-CoA Concentrations by Crotonate Addition Increases 
H3K18Cr at “De Novo-Activated” Genes and Enhances Gene Expression  
To test whether altering the levels of histone crotonylation would affect 
gene activation, I asked whether increasing or decreasing the concentration of 
crotonyl-CoA in RAW 264.7 cells prior to LPS stimulation would alter the 
differential acylation state at the regulatory elements of “de novo-activated”  
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Figure 4.2: Two Classes of LPS-Stimulated Genes, as Defined by p300 
Localization.  
(A-D) Genome browser representation of RNA-seq reads and ChIP-seq 
reads for p300, H3K18Ac, and H3K18Cr from unstimulated (UT) and 120’ 
LPS-stimulated (LPS) macrophages at two “de novo-activated” genes (Il6 
and Ifit1) (A and B) and two “pre-activated” genes (Ccl3 and Nlrp3) (C and 
D). Normalized to total mapped reads. The y-axis maximum is given at the 
far left of each track. Arrow indicates directionality of transcription. (E-H) 
The average profile of H3K18Cr (E and F) and H3K18Ac (G and H) ChIP-
seq data plotted at the TSS ± 2kb of either all “de novo-activated” genes (E 
and G) or all “pre-activated” genes (G and H) with or without LPS 
stimulation. 
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genes. I focused on the “de novo-activated” genes because the above data 
suggest that for these genes the p300-catalyzed acylation of histones was a rate-
limiting step in the transcription reaction.  I hypothesized that “de novo-
activated” genes would be more responsive to changes in the concentrations of 
crotonyl-CoA than the “pre-activated” genes, which are both acetylated and 
crotonylated prior to LPS stimulation. 
RAW 264.7 cells were first treated with varying concentrations of sodium 
crotonate followed by LPS stimulation. The crotonate pretreatment increased the 
concentration of crotonyl-CoA within the cell in a dose-dependent manner 
without impacting the concentration of acetyl-CoA, as measured by LC-MS  
(Figure 4.3). After 2 hours of LPS stimulation, I performed ChIP for H3K18Cr  
Figure 4.3: LC-MS Measurements of Crotonyl-CoA and Acetyl-CoA in 
RAW264.7 Cells. LC-MS measurements of crotonyl-CoA (left) and acetyl-CoA 
(right) from RAW 264.7 cells pretreated with the indicated concentration of 
sodium crotonate, pH 7.4, for 12 hours. The data represent mean peak area ± 
standard deviation of four independent experiments. Summary of unpaired t-
test p-value: ns (p>0.05) and **** (p≤0.0001). These experiments were 
conducted by Drs. Justin Cross and Vladimir Yong-Gonzalez. 
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Figure 4.4: Crotonate Treatment Correlates With Increased H3K18Cr, Decreased 
H3K18Ac and Increased Gene Expression.  
(A) qPCR analysis of H3K18Cr ChIP products from RAW 264.7 cells pre-treated 
with the indicated concentration of sodium crotonate (pH 7.4) (mM) for 6 hours 
prior to a 2-hour LPS stimulation. Primers were designed for TSS-proximal ChIP-
seq peaks of H3K18Ac and H3K18Cr. ChIP-qPCR results for four “de novo-
activated” genes (Il6, Gbp2, Ifit1, and Rsad2) and one “pre-activated” gene (Ccl3) 
are shown.  Data are represented as mean of % input ± standard deviation of 
technical replicates. Summary of p-value is as follows: ns (p>0.05), ** (p≤0.01), *** 
(p≤0.001), **** (p≤0.0001). (B) Experiment and analysis are same as (A), except 
ChIP was performed with H3K18Ac antibody. (C) RT-qPCR analysis of LPS-
stimulated (120’) RAW 264.7 cells pre-treated with the indicated concentration of 
sodium crotonate (pH 7.4) (mM). Relative expression is normalized to Gapdh. RT-
qPCR data for the same set of genes as in (A-B). Data are represented as the mean 
fold-change in relative expression due to crotonate addition from three 
independent experiments ± standard deviation.  
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and H3K18Ac. In support of our hypothesis, I observed a dose-dependent 
increase in H3K18Cr at the promoters of four “de novo-activated” genes (Il6, 
Gbp2, Ifit1, and Rsad2) and no significant change in H3K18Cr at a “pre-activated” 
(pre-acylated) gene (Ccl3) (Figure 4.4A). Furthermore, I observed an associated 
dose-dependent decrease in H3K18Ac at the promoters of the “de novo-
activated” genes tested and no significant change in H3K18Ac at the “pre-
activated” gene (Figure 4.4B).  
With the ability to fine tune the amount of H3K18Cr present on the promoters of 
“de novo-activated” genes, I next measured mRNA by RT-qPCR from cells 
treated with varying concentrations of sodium crotonate prior to a 2 hour LPS 
stimulation. Gene expression of the “de novo-activated” genes was increased in a 
dose-dependent manner, while the “pre-activated” gene was only minimally 
affected (Figure 4.4C). Additional tested genes (“de novo-activated:” Cmpk2, 
Cxcl10, Ifnb, and Ccl5, and “pre-activated:” Pim1) followed the same trend 
(Figure 4.5). These data provide evidence correlating the abundance of H3K18Cr 
at the proximal regulatory elements of a gene to its expression, supporting the 
notion that the balance between histone crotonylation and histone acetylation 
(i.e. differential acylation) plays a functional role in gene expression. 
To explore the scope of LPS-induced genes that are further induced due to 
crotonate pre-treatment, I next performed RNA-seq on LPS stimulated (120’) 
cells with and without pre-treatment of crotonate (10mM). Consistent with the 
RT-qPCR data of select genes, “de novo-activated” genes were on average 
further stimulated by crotonate pre-treatment with a mean fold increase of 2.4 
over LPS-induction, whereas “pre-activated” genes were on average unaffected 
with a mean fold change of 1.0 (Figure 4.6A). I next asked whether all crotonate-
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responsive genes (>2-fold increase over LPS stimulation) also show a greater 
than average recruitment of p300 upon LPS stimulation. To do this, I compared 
the fold-change of p300 reads (± 2kb from TSS) of a list of all genes whose 
expression was induced >2-fold (“All LPS-induced”, n=850) to a subset of that 
list of genes that were further induced >2-fold over LPS-stimulation due to 
crotonate pre-treatment (“Further induced by crotonate”, n=48). Notably, I 
observed a significantly greater than average fold-change in p300 recruitment to 
crotonate-responsive genes (Figure 4.6B). I also observed a statistically 
significant positive correlation between the fold-change in p300-localization 
upon LPS and the fold-change in mRNA abundance due to crotonate treatment  
Figure 4.5: De Novo-Activated Genes Are Further Stimulated By Crotonate 
Pre-Treatment. RT-qPCR analysis of LPS-stimulated (120’) RAW 264.7 cells 
pre-treated with the indicated concentration of sodium crotonate (pH 7.4) 
(mM) for the indicated genes. Relative expression is normalized to Gapdh. 
Data are represented as the mean fold-change in relative expression due to 
crotonate addition from three independent experiments ± standard deviation. 
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Figure 4.6: RNA-seq Analysis of Crotonate Pre-Treatment.  
(A) The fold changes in FPKM over LPS-stimulation due to crotonate pre-
treatment, as measured by RNA-seq, are represented as a box and whisker 
plot (10th - 90th percentile) for both “pre-activated” and “de novo-activated” 
genes. ****, p-value < 0.0001. (B) Box and whisker plot representation (10th - 
90th percentile) of the fold change in p300 read counts, due to LPS 
stimulation, ± 2kb from the TSS of two sets of genes, (1) all LPS induced 
genes (fold change (FPKM) ≥2 upon LPS stimulation, n=850) and (2) a 
subset of (1) whose expression was further induced ≥2-fold due to pre-
treatment with crotonate (n=48). ****, p-value < 0.0001. (C) Scatter plot 
representation of all LPS-stimulated genes with annotated p300 peaks ± 
500bp from TSS (n=262), plotting fold change in p300 read counts due to 
LPS by fold change in expression (FPKM) over LPS-induction due to 
crotonate pre-treatment; both are plotted as log2 values.  Four “de novo-
activated” gene (Il6, Gbp2, Ifit1, and Rsad2) and one “pre-activated” gene 
(Ccl3) are highlighted in yellow. 
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(Figure 4.6C), further establishing the link between p300-mediated 
transcriptional activation and differential histone acylation.  
Increasing Cellular Concentrations of Crotonyl-CoA Prior to LPS Stimulation 
Enhances Cytokine and Chemokine Secretion Upon LPS Stimulation 
To test whether the effects observed in gene expression led to changes in the 
functional arm of the inflammatory response, I measured how pre-treating cells 
with crotonate affected cytokine and chemokine secretion upon LPS stimulation.  
I first performed an LPS time-course with or without crotonate treatment 
(10mM), collected supernatants 0, 3, 6, and 16 hours post LPS-stimulation, and 
observed a greater concentration of secreted Il6 in cells pre-treated with 
crotonate at every time point post-LPS-stimulation, as measured by a standard 
ELISA (Figure 4.7A). I next employed a multiplex bead-based immunoassay (see 
Methods for detail) to more broadly analyze the effect of crotonate treatment on 
cytokine and chemokine secretion. I collected supernatant from cells pre-treated 
with increasing concentrations of sodium crotonate followed by a 16hr LPS 
stimulation and measured the concentrations of a variety of LPS-induced 
chemokines and cytokines (Il6, Cxcl10, Cxcl1, Ccl5, and Ccl3). In agreement with 
the standard ELISA assay, I observed a dose-dependent increase in Il6 secretion 
due to crotonate addition (Figure 4.7B). I also observed a dose-dependent 
increase in Cxcl10, Cxcl1, and Ccl5 secretion, all of which are products of “de 
novo activated” genes (Figure 4.7B). Furthermore, Ccl3, a secreted factors 
expressed from a “pre-activated” gene, did not show a significant change in 
protein secretion due to addition of crotonate (Figure 4.7C). 
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Figure 4.7: Increased Cellular Crotonyl-CoA Concentration Prior to LPS 
Stimulation Leads to Enhanced Cytokine and Chemokine secretion Upon LPS 
Stimulation.  
(A) RAW 264.7 cells were treated with either 10mM Acetate or 10mM Crotonate, 
or left untreated for 6 hours prior to LPS stimulation. Supernatants were 
collected at 0, 3hr, 6hr, or 16hr after LPS stimulation and the concentration of Il6 
was measure by standard ELISA. Data are presented as mean of technical 
replicates ± standard deviation. (B-C) Chemokine and cytokine protein 
abundance in supernatants from LPS-stimulated (16hr) RAW 264.7 cells pre-
treated with the indicated concentration of sodium crotonate. Data for four “de 
novo-activated” chemo/cytokines (Il6, Cxcl10, Cxcl1, and Ccl5) (B) and one 
“pre-activated” chemokine (Ccl3) (C) are represented here as the mean of two 
independent experiments ± standard deviation. Summary of p-value is as 
follows: ns (p>0.05), ** (p≤0.01), *** (p≤0.001), **** (p≤0.0001). 
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Knockdown of Acss2 Reduces H3K18Cr at the Promoters of “De Novo-
activated” Genes and Attenuates Gene Expression 
To test whether decreasing crotonyl-CoA available for histone crotonylation 
prior to LPS-stimulation would have a negative effect on “de novo-activated” 
genes, I performed siRNA knockdown of Acss2 in RAW 264.7 cells prior to a 120’ 
LPS stimulation. I confirmed knockdown of Acss2 both at the RNA level by RT-
qPCR (Figure 4.8A) and at the protein level by immunoblot (Figure 4.8B). I next 
performed ChIP for H3K18Cr in LPS-stimulated (120’) cells that had been 
transfected with either non-target or Acss2-specific siRNA. As expected, I 
observed significant decreases in H3K18Cr due to Acss2 knockdown in five “de 
novo-activated” genes (Il6, Gbp2, Ifit1, Rsad2, and Ccl5) and no significant change 
in the “pre-activated” gene (Ccl3) (Figure 4.8C). I next performed RT-qPCR 
under the same experimental conditions with three independent replicates and 
observed a reduction in mRNA abundance for the five “de novo-activated” 
genes tested (Il6, Gbp2, Ifit1, Rsad2, and Ccl5) and no change for the “pre-
activated” gene (Ccl3) (Figure 4.8D). Furthermore, under similar experimental 
conditions I observed a reduction in the LPS-induced secretion of Il6 and Ccl5, 
but no significant change in Ccl3 secretion, upon knockdown of Acss2 (Figure 
4.8E). These data support the notion that the cellular concentrations of crotonyl-
CoA regulates the levels of histone crotonylation, which in turn impacts the rate 
of gene activation. 
Based on these findings, I conclude that differential histone acylation 
(crotonylation vs. acetylation) at specific lysine residues (H3K18, in this study, 
and likely other histone sites) is regulated metabolically by a previously 
unappreciated balance in cellular levels of crotonyl-CoA and acetyl-CoA. I favor  
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Figure 4.8: Knockdown of Acss2 Prior to LPS Stimulation Leads to a 
Decreased Induction of H3K18Cr at, and Decreased Stimulation of, “De 
Novo-Activated” Inflammatory Genes Upon LPS Stimulation.  
(A-B) RAW 264.7 cells were transfected with control or Acss2-specific siRNAs, 
72 hours post-transfection cells were harvested for either RT-qPCR analysis 
(A) or immunoblot analysis (B) to assess knockdown efficiency. For (A) data is 
presented as mean fold change due to ACSS2 knockdown of technical 
replicates ± standard deviation. (C) qPCR analysis of H3K18Cr ChIP products 
from LPS-stimulated (120’) RAW 264.7 cells that had been transfected with 
either control siRNA or siRNAs specific for Acss2 72 hours prior to 
stimulation. ChIP-qPCR results for five “de novo-activated” genes (Il6, Gbp2, 
Ifit1, Rsad2, and Ccl5) and one “pre-activated” gene (Ccl3) are shown here.  
Data are represented as mean of % input of technical replicates ± standard 
deviation. (D) RT-qPCR analysis of LPS-stimulated (120’) RAW 264.7 cells 
previously transfected with either control or Acss2-specific RNAs, as in (C). 
Relative expression is normalized to Gapdh. RT-qPCR data are shown for the 
same set of genes as in (C). Data are represented as the mean fold-change in 
relative expression due to Acss2 knockdown from three independent 
experiments ± standard deviation. (E) Chemokine and cytokine protein 
abundance in supernatants from LPS-stimulated (16hr) RAW 264.7 cells 
transfected with the indicated RNAs, as in (C). Data for two “de novo-
activated” chemo/cytokines (Il6 and Ccl5) and one “pre-activated” chemokine 
(Ccl3) are represented here as the mean of two independent experiments ± 
standard deviation. Summary of p-value is as follows: ns (p>0.05), ** (p≤0.01), 
*** (p≤0.001), **** (p≤0.0001). 
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the view that the concentrations of crotonyl-CoA and acetyl-CoA (and likely 
other short-chain acylations) are “translated” by the co-activators p300 and CBP 
into the differential acylation states of local chromatin influencing transcriptional 
activation by mechanisms that remain unclear.  These findings lend support to 
emerging studies linking metabolism to the alteration of chromatin landscapes 
and thereby the regulation of gene expression.  
DISCUSSION 
Regulation of histone modifications, and thereby regulation of chromatin 
structure, by metabolite availability has been proposed as a potential mechanism 
for gene regulation under the premise that many chromatin-modifying enzymes 
utilize products of intermediary metabolism as cofactors essential for their 
activities (Gut and Verdin, 2013; Kaelin and McKnight, 2013; Meier, 2013). Our 
study introduces a new dimension to this paradigm in that fluctuations in both 
acetyl-CoA and crotonyl-CoA are shown to affect global and local chromatin 
landscapes leading to distinct functional outputs. While our study clearly 
establishes that the concentration of crotonyl-CoA influences transcriptional 
activation through its effects on differential acylation, it remains unclear whether 
the physiological concentrations of crotonyl-CoA are as dynamic as they are in 
our cell culture experiments where crotonate addition to media was used to 
experimentally alter the cellular concentration of crotonyl-CoA.  
The data presented here illustrate that the intra-and inter-cellular 
metabolic state of the cell can directly influence the local chromatin landscape by 
causing fluctuations in metabolite/cofactor concentrations required for histone 
crotonylation and acetylation. I put forward a proof-of-concept for the  
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Figure 4.9: Metabolic Regulation of Transcription Through Differential 
Acylation. 
A schematic of how acyl-CoA metabolism can impact transcription is 
presented here. The concentration of acyl-CoAs in the nucleus 
determines the state of differential acylation at p300-targetted genes, 
which in turn impacts transcriptional potential. The illustration was 
designed by Dr. Alexey Soshnev. 
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functional connection between acyl-CoA metabolism and transcriptional 
activation, operating through the differential acylation of histones (Figure 4.9). 
Future work as to the physiological range of acyl-CoA concentrations in a variety 
of cell-types, environments, and stress conditions will be critical to understand 
specifically how and for what biological process nature exploits this hitherto 
unexplored mechanism of gene regulation. 
These data corroborate the cell-free transcription assays presented in Chapter 
2 and demonstrate that the amount of histone crotonylation at a given regulatory 
elements correlates with transcription. While the direct mechanism by which 
histone crotonylation stimulates transcription is not resolved by these studies, a 
cell-based model of crotonylation-dependent transcription is established. This 
cell-based model is utilized in Chapter 5 to demonstrate the relevance of the AF9 
YEATS domain interaction with crotonyl-lysine in the context of gene expression. 
As discussed in Chapter 2 and the General Introduction, there are two main 
mechanisms by which histone PTMs function, namely in cis (e.g. biophysical 
modulation of the chromatin fiber) or in trans (e.g. recruitment or repulsion of 
“readers”). Current work in the lab led by Dr. Tanya Panchenko is exploring the 
role of histone crotonylation on chromatin fiber compaction, yet this work is too 
preliminary to discuss here. In collaboration with Dr. Haitao Li, major inroads 
have been made into the trans effects of histone crotonylation with the 
identification and characterization of the YEATS domain as a “reader” module 
for crotonyl-lysine, the subject of Chapter 5.  
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CHAPTER 5: MOLECULAR COUPLING OF HISTONE CROTONYLATION 
AND ACTIVE TRANSCRIPTION BY AF9 YEATS DOMAIN 
INTRODUCTION 
While I have demonstrated that histone crotonylation at the promoters of genes 
stimulates transcription (Chapter 4), the underlying mechanism(s) responsible 
for bringing this about remained unclear. As discussed in the general 
introduction (Chapter 1), there are two major mechanisms by which histone 
modifications exert their function: through biophysical modulation of the 
chromatin fiber or through the recruitment or occlusion of effector modules, 
often termed “readers.” For example, histone acetylation negates the positive 
charge of the modified lysine residue leading to the destabilization of both inter-
nucleosomal and intra-nucleosomal interactions. Histone acetylation also acts as 
a platform for the binding of reader modules, most famously bromodomains, 
which tend to be associated with protein and complexes involved in 
transcriptional regulation (Filippakopoulos et al., 2012). In principle, histone 
crotonylation could be working through both mechanisms in a similar fashion to 
histone acetylation, yet little is known about the biophysical consequences of 
histone crotonylation and a reader of crotonyl-lysine has not been identified. 
Furthermore, studies have demonstrated that bromodomain proteins bind with 
lower affinity to acyl chains more complex than acetyl and show minimal to no 
binding to crotonyl-lysine (Flynn et al., 2015; Vollmuth and Geyer, 2010). In this 
chapter I describe the identification and characterization of the YEATS domain as 
a reader of histone crotonylation.  
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The YEATS domain was identified as a conserved protein domain in 
proteins associated with transcriptional regulation (pfam accession: PF03366) 
and named as an acronym of the founding proteins from yeast and human (Yaf9, 
ENL, AF9, Taf14, and Sas5) (Le Masson et al., 2003). While only four human 
proteins contain a YEATS domain (AF9, ENL, GAS41, and YEATS2), they are all 
members of chromatin-modifying complexes associated with transcriptional 
activation (Schulze et al., 2009) (Figure 5.1A). GAS41 and YEATS2 are subunits 
within two multi-subunit HAT complexes, NuA4 and ATAC, respectively 
(Doyon et al., 2004; Suganuma et al., 2008). AF9 and ENL are paralogs and 
interchangeably inhabit two distinct nuclear complexes, the super elongation 
complex, thought to regulate RNAPII elongation, and the DOT1L complex, 
responsible for catalyzing methylation at H3K79, a modification associated with 
active transcription (Lin et al., 2010; Yokoyama et al., 2010) (Figure 5.1B). Human 
YEATS domain proteins are also implicated in cancer. GAS41 is amplified in 
both glioma and astrocytoma (Fischer et al., 1997; 1996) and recurrently mutated 
in serous endometrial tumors (Le Gallo et al., 2012). AF9 and ENL are the most 
recurrent translocation partners of MLL in MLL-rearranged leukemias, a 
pediatric acute leukemia with poor prognosis and poor response to conventional 
therapies (Krivtsov and Armstrong, 2007). The majority of this chapter will focus 
on the YEATS domain of AF9. 
The studies described in this chapter were conducted in close 
collaboration with Dr. Haitao Li and his group at Tsinghua University in Beijing 
and with Dr. Tanya Panchenko, a colleague in the Allis lab. Dr. Haitao Li’s group  
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Figure 5.1: YEATS Domain Proteins are Associated with 
Transcriptional Regulation. 
(A) Protein domain representation of the four human YEATS domain 
proteins. The coiled-coil domain (CC) in the c-terminus of AF9 and 
ENL is their interaction domain with both AFF4 and DOT1L. Not 
drawn to scale.  Adapted from (Schulze et al., 2009). (B) Complex 
subunit composition for the two AF9 and ENL containing complexes. 
Red asterisk designates MLL fusion partner and yellow star indicates 
proteins with small-molecule inhibitors currently in clinical trial. The 
illustration in Figure 5.1B was designed by Dr. Tanya Panchenko. 
86 
(from here on referred to as the Li group) has expertise in the structural biology 
of epigenetic factors, with a focus on reader domains. As such, the Li group 
conducted all the structural and biophysical experimentation and analysis. I 
performed the functional studies in close collaboration with Dr. Tanya 
Panchenko.  This work has recently been submitted for publication and is 
currently under review at Molecular Cell.  
Recognition of histone post-translational modifications (PTMs) by histone-
binding effectors constitutes a major mechanism for epigenetic regulation 
(Jenuwein and Allis, 2001). A wide-range of so-called “reader” modules has been 
characterized for type- and site-specific readout of histone PTMs (Musselman et 
al., 2012; Patel and Wang, 2013; Taverna et al., 2007). Following the ground-
breaking discovery of bromodomain (BrD) as an acetyl-lysine “reading” module 
(Dhalluin et al., 1999; Sanchez and Zhou, 2009), therapeutic applications of small-
molecule inhibitors that block BrD:ligand interactions are currently in clinical 
trials and show promise for the treatment of various cancers (Filippakopoulos 
and Knapp, 2014) .With the application of mass spectrometry-based proteomics, 
novel histone PTMs have been documented, including various types of non-
acetyl histone lysine acylations, such as propionylation, butyrylation, 
crotonylation, and succinylation among others (Huang et al., 2014; 2015). 
Alternations in cellular metabolism that, in turn, lead to shifts in the steady-state 
balance of non-acetyl histone acylations may function in coordinating particular 
transcription programs that govern cell growth and development. However, the 
downstream readout of histone acylations such as crotonyl-lysine is poorly 
understood in comparison to a wealth of knowledge on histone acetylation. 
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Like histone acetylation, histone lysine crotonylation has been detected 
from yeast to human and is primarily associated with active transcription (Tan et 
al., 2011). As well, crotonylation occurs on the ε-amino group of lysine, but 
distinguishes itself from acetylation by its planar orientation and four-carbon 
length. Histone crotonyl-lysine (Kcr) but not acetyl-lysine (Kac) was found to 
preferentially mark “escapee genes” during post-meiotic sex inactivation in 
mouse testis, providing an early indication for a unique role of histone 
crotonylation distinct from histone acetylation (Montellier et al., 2013; Tan et al., 
2011). Similarities between histone acetylation and crotonylation also exist 
blurring distinctions. For example, Kcr and Kac sites overlap in histones and are 
catalyzed by p300/CBP, a well-known histone acetyltransferase (HAT). Like 
histone acetylation, p300/CBP-mediated crotonylation directly stimulates 
transcription in vitro and in vivo albeit to varying degrees (Sabari et al., 2015). 
Moreover, Sirtuin family members (e.g. SIRT1-3), well-studied histone 
deacetylases (HDACs), remove Kcr in a site-specific manner (Bao et al., 2014; 
Feldman et al., 2013). A subset of bromodomains, such as BRD9 and TAF1, can 
tolerate Kcr but with compromised affinity as compared to that of Kac 
recognition (Flynn et al., 2015). Given these contrasting findings, a clear 
distinction between histone acetylation and histone crotonylation is lacking and 
structural and functional consequences between the two are poorly understood.  
Previously, the Li group has reported that YEATS domains constitute a 
novel family of histone acetylation readers (Li et al., 2014). Here, through a 
combination of structural, biochemical/biophysical binding, and cell-based 
transcription activation studies, we define the evolutionarily conserved YEATS 
domain as a family of Kcr-favorable readers that directly link histone 
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crotonylation to active transcription. Crystal structural studies of AF9 YEATS 
bound to H3K9cr and H3K18cr peptides revealed an extended aromatic 
sandwiching cage for crotonyl-specific readout. By contrast, structure analysis of 
BRD3 bromodomain bound to H3K18ac peptide revealed that the bulkier and 
more rigid Kcr would be occluded due to steric clash. By experimentally 
perturbing histone crotonylation levels, we show that AF9 co-localizes with 
H3K18cr and positively regulates gene expression in a YEATS-dependent 
manner. Furthermore, we show a previously unappreciated role of AF9 in the 
rapid gene activation in the context of the immune response. Collectively, our 
work describes a new epigenetic mechanism to regulate gene activity through 
the establishment and readout of histone crotonylation, highlighting a functional 
significance of non-acetyl histone acylations. 
RESULTS 
The YEATS Domain Has Histone Crotonyl-lysine Binding Activity 
Recently the Li group characterized the YEATS domain as a novel Kac reader 
module (Li et al., 2014). Based on their structural studies of AF9 YEATS bound to 
H3K9ac, they defined a serine-lined aromatic sandwiching cage for specific 
readout of Kac. The long Kac side chain is sandwiched by bulky aromatic 
residues with the flat acetyl group snugly clamped, well-oriented in position. 
Interestingly, although the Kac-binding channel is long and flat, it contains a 
clear opening at the end where the acetyl group protrudes (Figure 5.2A, pink 
arrow). Based on this observation, we hypothesized that this opening might 
permit the recognitions of bulkier and longer acyl-chain hydrocarbon lengths.   
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Figure 5.2: Identification of AF9 YEATS Domain as a Histone Crotonyl-
Lysine Reader.  
(A) Cut-away view of AF9 YEATS in complex with H3K9ac peptide. AF9 
YEATS is represented as green surface and histone peptide is shown as yellow 
stick. Pink arrow denotes the wide opening of Kac-reader pocket. (B) Chemical 
structures of known histone lysine acylations. Abbreviations and numbers 
correspond to data shown in (C). (C) Isothermal titration calorimetry (ITC) 
fitting curves of wild type AF9 YEATS titrated by a series of H31-15 peptides 
containing K9 acylations shown in (B).  (D) ITC fitting curves comparing Kcr 
and Kac binding preference at sites H3K18 (left) and H3K27 (right). (E) ITC 
titration and fitting curves of H3K9ac or H3K9cr bound by YEATS domains 
from human ENL, and yeast Yaf9 and Taf14. The data and analysis presented in 
Figure 5.2 were generated by the Li group. 
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To test this hypothesis, the Li group synthesized a series of acylated 
histone H31-15K9 peptides including formylation (fo), acetylation (ac), 
propionylation (pr), butyrylation (bu), crotonylation (cr), succinylation (su) and 
2-hydroxyisobutyrylation (hib) (Figure 5.2B), and performed isothermal titration 
calorimetry (ITC) using purified AF9 YEATS domain. Calorimetric titrations 
revealed that AF9 YEATS binds to lysine acylations in an order of K9cr (2.1 $M) > 
K9pr (2.7 $M) > K9bu (3.7 $M) > K9ac (5.0 $M) > K9fo (120 $M) > K9su (500 
$M) > K9hib (N.D.) (KD values shown in parenthesis, Figure 5.2C). Remarkably, 
the linear extension of the hydrocarbon chain beyond Kac resulted in 2.4-, 1.9-, 
1.4-fold binding enhancement for Kcr-, Kpr- and Kbu-modified peptides, 
respectively. By contrast, shortened (Kfo), acidified (Ksu) or branched (Khib) K9 
acylations caused a significantly reduced or complete loss of binding. These 
quantitative binding studies confirm that AF9 YEATS favors a subset of bulkier 
acyl-lysines with the strongest preference for the planar, four-carbon 
crotonylation (Figure 5.2C). 
Based on previous observations made with Kac peptides (Li et al., 2014), 
the Li group next tested the binding preference of AF9 YEATS for two other sites 
on the H3 tail, H3K18, and H3K27. For both sites AF9 YEATS bound with higher 
affinity to Kcr than to Kac (Figure 5.2D), suggesting that crotonylation can 
generally enhance the AF9 YEATS-H3 interaction as compared to acetylation, 
regardless of the site of modification. 
Crotonylation has been identified in budding yeast as well as human (Tan 
et al., 2011). In order to test if Kcr preference is conserved in YEATS across 
species, the Li group expressed and purified recombinant YEATS domains of 
human ENL and of yeast Yaf9 and Taf14. Calorimetric titrations using H31-15K9cr 
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vs H31-15K9ac peptides revealed 2.5- to 4.5-fold binding enhancement for Kcr than 
Kac (Figure 5.2E). Collectively, these results suggest that favorable Kcr readout is 
a common function of YEATS conserved from yeast to mammals. 
Structural Basis for Crotonyl-Lysine Recognition by AF9 YEATS 
To explore the molecular basis underlying Kcr readout by AF9 YEATS, the Li 
group first determined the co-crystal structure of AF9 YEATS bound to H31-15K9cr 
peptide at 2.7 Å resolution. In the complex structure, AF9 YEATS uses the same 
Kac-binding aromatic sandwich cage for Kcr recognition; and the crotonyl group 
takes on a trans-conformation with the extended hydrocarbon chain snugly 
stacking against F59 aromatic ring (Figure 5.3A). Comparison of Kcr-bound and 
Kac-bound AF9 YEATS binding pocket revealed nearly identical overall pocket 
arrangements except for slight conformational adjustments of aromatic residues 
Y78 and F28 (Figure 5.3B, left panel). The crotonylamide group is characteristic 
of a planar feature due to %-electron conjugation (Figure 5.3B, right panel). 
Besides the relayed hydrogen bonding interactions conserved in both Kac and 
Kcr amide recognition, preferential binding to Kcr is notably contributed by %-
aromatic interactions of the planar crotonylamide group with F59, Y78 aromatic 
rings, as evidenced by interplanar distances between 3.4-3.8 Å (Figure 5.3B, right 
panel). Moreover, additional hydrophobic contacts introduced by hydrocarbon 
chain extension further stabilize Kcr-AF9 recognition. Even though a 15 amino 
acid long H31-15 peptide was used for crystallization, only H3 T3-S10 could be 
modeled around a surface formed by loops connecting the core β-strands of AF9  
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Figure 5.3: Molecular Basis for H3K9cr and H3K18cr Readout by AF9 YEATS 
Domain.  
(A) Crystal structure of AF9 YEATS domain shows the insertion of the H3K9 
containing crotonyl-lysine (left) and acetyl-lysine (right) into its aromatic 
sandwich cage. K9ac and K9cr are depicted as space-filling spheres with the two 
additional hydrocarbon atoms of the crotonyl group highlighted green. (B) Left, 
detailed interaction map of the K9cr readout by AF9 YEATS shows a rotation of 
Y78 and F28 when compared to K9ac (pink arrows). For comparison, K9cr-bound 
structure (green, with key residues highlighted in light pink) was superimposed 
with K9ac-bound structure (white). Hydrogen bonds are shown as dashes. K9cr 
peptide is covered by 2Fo-Fc omit map (blue meshes) contoured at 2.5 σ. A 
sharpening B-factor of 75 was applied to obtain the most informative maps. Right, 
details of %-aromatic stacking between planar H3K9 crotonylamide and F59 
phenyl ring with distances denoted in magenta. (C) Overall structure of H3K9cr 
bound to AF9 YEATS. AF9 YEATS is depicted as green ribbons with key residues 
highlighted in pink. Histone H3 peptide is shown as yellow sticks. (D) 
Superimposition of H3K9cr- and H3K18cr-bound complexes. H3K9cr complex is 
colored white as a reference and H3K18cr peptide is shown as yellow sticks. 
Structure-based sequence alignment between H3K9cr and H3K18cr is shown 
below. (E) Mutagenesis and ITC titration assays using mutant and wild type AF9 
YEATS with H3K9cr (left) or H3K18cr (right) peptides. (F) Sequence conservation 
analysis of YEATS reader pocket residues from yeast to human. The data and 
analysis presented in Figure 5.3 were generated by the Li group. 
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YEATS (Figure 5.3C). Importantly, K9cr is stapled into a pocket formed by L1, L4 
and L6 loops of AF9, and the K9cr-flanking H3 residues are recognized by 
extensive polar or hydrophobic contacts including a signature “H3R8-AF9D103” 
hydrogen bonding pair (Figures 5.3C), demonstrating the critical importance of 
the -1R on the histone peptide.  
AF9 YEATS binds to H3K18cr with an affinity of 5.7 $M. Therefore, we 
next determined the co-crystal structure of histone AF9 YEATS bound to H31-
25K18cr peptide at 2.8 Å resolution. In the complex structure, H3 K14-L20 was 
modeled with K18cr anchored and was recognized essentially in the same mode 
as described above for K9cr (Figures 5.3D). H3K18cr peptide binds to AF9 
YEATS in the same orientation as H3K9cr such that residue H3R17 at -1 position 
interacts with acidic residue D103, recapitulating the importance of an “R-Kcr” 
signature motif for AF9 YEATS recognition (Li et al., 2014). Structural alignment 
of H3K18cr- and H3K9cr-bound AF9 complexes revealed that H3 segment “P16-
R17-K18cr” overlapped well with “A7-R8-K9cr”, while H3 K14-A15 and Q19-L20 
displayed large discrepancy (Figure 5.3D). Nevertheless, crotonylation brings 
H3K18cr binding by AF9 YEATS to single digit micromolar order - an affinity 
fairly strong compared to other known histone mark-reader pairs (Patel and 
Wang, 2013). 
Mutagenesis and Binding Studies 
We next performed mutagenesis and ITC titration studies to verify the 
importance of key Kcr binding residues. As summarized in Figure 5.3E, alanine 
mutation of pocket residues F28, H56, S58, F59, G77, and Y78 resulted in 5- to 
192-fold binding reduction for H3K9cr and 5- to 102-fold binding reduction for 
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H3K18cr peptides, respectively. Strikingly, F59A led to the most dramatic 
binding loss, highlighting its critical role in lysine crotonylation-specific readout 
by providing aromatic stacking interactions.. D103 plays an important role in “-1” 
arginine recognition within the “R-Kcr” motif. In support, AF9 D103A mutation 
caused 36- and 10-fold binding loss for H3K9cr and H3K18cr peptides. 
Consistently, histone H3 R8A mutation caused a binding loss of 31-fold for 
H3K9cr readout (Figure 5.3E, left panel), further validating the contribution of 
“H3R8-D103” hydrogen bonding pair. Sequence alignment reveals that all the 
pocket residues from L4 and L6 loops tested above are highly conserved among 
YEATS domains (Figure 5.3F), consistent with the conserved Kcr reader activity 
observed for YEATS from yeast to human. 
YEATS Domain Is a Crotonyl-Lysine Reader in the Cellular Context 
To confirm the AF9 YEATS-Kcr interaction in a cellular context, Dr. Tanya 
Panchenko performed immunoprecipitation (IP) of AF9 to determine whether 
crotonylated nucleosomes would co-IP. Using HeLa cell lines expressing FLAG-
tagged constructs of AF9 or AF9 with the F59A point mutant shown to ablate 
YEATS-Kcr binding (Figure 5.3E), Dr. Panchenko generated mono-nucleosome 
containing nuclear extracts by MNase digestion and performed FLAG-IPs in this 
context. Immunoblot analysis of IP material revealed that while ELL2 and AFF4 
(complex component members with mapped interaction domains in the C-
terminus of AF9) were insensitive to the F59A mutation, both H3K9cr and 
H3K18cr nucleosomes only co-IP with the wild-type AF9 (Figure 5.4A). These 
data demonstrate that AF9 binds nucleosomes marked by H3K9cr and H3K18cr 
and that this interaction is YEATS-dependent. 
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Dr. Panchenko next performed nucleosome pulldowns with pre-modified 
nucleosomes generated via amber suppression. Recombinant pre-modified 
H3K9ac, H3K9cr, H3K18ac, and H3K18cr histones were generated by amber 
suppression, as previously described (Gattner et al., 2013; Kim et al., 2012). The 
modification statuses of these pre-modified histones were validated by MS/MS 
analysis, which showed the expected modification at >90% purity (Figure 5.4B). 
These pre-modified H3 histones, in conjunction with unmodified recombinant 
core histones, were assembled into nucleosomes by standard salt dialysis (Dyer 
et al., 2004) with a biotinylated 601 DNA template, allowing the nucleosomes to 
be immobilized by streptavidin. The immobilized nucleosomes either 
unmodified, acetylated, or crotonylated (at either H3K9 or H3K18) were then 
incubated in HeLa nuclear extract and interacting proteins were affinity purified. 
Immunoblot analysis of pulldown material, focusing on the YEATS domain 
proteins AF9 and ENL, revealed that while the acylated nucleosomes at either 
site pulled down more AF9 and ENL than unmodified nucleosomes or control 
pulldowns, nucleosomes bearing H3K9cr and H3K18cr purified more AF9 and 
ENL from extract than nucleosomes bearing H3K9ac or H3K18ac (Figure 5.4C). 
These data corroborate the biophysical data that the YEATS domain of AF9 has a 
stronger preference for Kcr than Kac. 
Bromodomains Do Not Exhibit YEATS-Like Preference for Crotonyl-lysine 
Bromodomains constitute a major family of histone acetylation readers 
(Filippakopoulos et al., 2012). To explore whether bromodomains have crotonyl-
lysine reader activity, the Li group expressed a variety of bromodomains and 
compared their binding affinity to Kac- and Kcr-containing peptides. Based on 
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Figure 5.4: The YEATS Domain Prefers Kcr to Kac Marked Nucleosomes.  
(A) AF9 co-immuno-precipitates nucleosomes marked by H3K9cr and 
H3K18cr in a YEATS-dependent manner. MNase nuclear extracts were 
derived from HeLa cells expressing either a wildtype FLAG-tagged AF9 
construct (FLAG-AF9-WT) or a F59A mutant FLAG-tagged AF9 (FLAG-AF9-
F59A). Immunoblot analysis with the indicated antibodies was performed on 
the IP eluate of WT and F59A AF9 constructs. (B) MS/MS analysis of 
recombinant histones pre-modified via amber suppression demonstrates the 
purity of the expected product. (C) Immunoblot analysis for AF9 and ENL of 
indicated pulldowns. Site-specific pre-acetylated or pre-crotonylated H3-
containing nucleosomes were used as bait in pulldown assays. Direct Blue 
staining of the membrane documents comparable input material. The 
streptavidin monomer co-migrates with histone H4 at this resolution. The data 
and analysis presented in Figure 5.3 were generated by Dr. Tanya Panchenko. 
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the classification of bromodomains (Filippakopoulos et al., 2012), representative 
members from seven major BrD sub-families were chosen for ITC titration assay. 
While all the bromodomains tested here exhibited reported Kac binding activity 
at their respective target sites, cognate Kcr binding was not detected for most 
bromodomains (Figures 5.5A). Though the second bromodomain of TAF1 
(abbreviated TAF1BrD2 and in an analogous manner hereafter for other multi-
bromodomain proteins) displayed an H4K5crK8cr binding activity, its binding 
affinity was three times weaker than the H4 acetylation counterpart (117 $M vs 
52 $M, Figure 5.5A). 
The Li group next synthesized a series of histone acylation peptides 
bearing Kac, Kpr, Kbu, and Kcr marks (Figure 5.5B) at sites H4K8, H3K14, and 
H3K18, and performed quantitative ITC titrations for BRD4BrD1:H4K8ac/pr/bu/cr, 
BAZ2A-H3K14ac/pr/bu/cr, BRD3BrD2-H3K18ac/pr/bu/cr, as well as AF9YEATS-
H3K18ac/pr/bu/cr pairs. Interestingly, all bromodomains exhibited reduced 
binding following chain extension from acetylation to crotonylation (Figure 5.5C), 
suggesting that bromodomains are primarily evolved towards Kac readout with 
restricted tolerance to Kpr, Kbu and Kcr.  By contrast, AF9-YEATS exhibited 
enhanced binding following chain extension with tightest binding for Kcr 
(Figures 5.5C). The above observations on BrD acyl-lysine readout are in 
agreement with a recent profiling study, in which 49 bromodomains tested 
displayed compromised binding to non-acetyl acylations (Flynn et al., 2015). 
Collectively, these data suggest that bromodomains do not exhibit YEATS-like 
preference for non-acetyl acylation, especially crotonyl-lysine. 
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Structural Basis for Differential Recognition of H3K18 Acylation by BRD3 and 
AF9 
The above data suggest that BRD3 and AF9 recognize H3K18 acetyl versus 
crotonyl with distinct acylation type preference. To better explore the underlying 
structural basis, the Li group determined the co-crystal structure of BRD3BrD2 
bound to H310-24K18ac peptide at 2.6 Å resolution. In the complex structure, H3 
“A15-P16-R17-K18ac-Q19-L20-A21-T22” could be modeled with K18ac inserted 
into the well-established Kac reader pocket formed by loops LZA and LBC (Figures 
5.5D). Interaction analysis revealed that Kac is notably stabilized by hydrophobic 
contacts and hydrogen bonding interactions involving an invariant asparagine 
N391 as well as Y348 and P333 (mediated by water) (Figures 5.5D). Moreover, 
H3K18ac flanking sequences contributed multiple hydrogen bonding and 
hydrophobic contacts with BRD3BrD2. Notably, histone H3R17 at -1 position formed 
a hydrogen-bond with D394 and histone H3L20 at +2 position is inserted into a 
hydrophobic pocket formed by W332, P333, H395, V397 and M400, collectively 
accounting for H3K18 site preference (Figures 5.5D). 
It is interesting to note that both BRD3BrD2 and AF9 adopt a similar strategy 
to recognize a signature “R-K” motif around H3K18ac/cr, in which the “-1R” is 
stabilized by an aspartate residue (D394 in BRD3 and D103 in AF9), while 
K18ac/cr is inserted into an adjacent reader pocket (Figures 5.5E and 5.5G). The 
Kac pocket of BRD3BrD2 is formed at the center of the four-helical bundle of the 
bromodomain (Figures 5.5D and 5.5E). This configuration, with its tight network 
of hydrogen bond stabilized water molecules (Figure 5.5E, blue balls) is 
perfectly suited for Kac binding, but would be restrictive to any further extension 
of the hydrocarbon chain. Conceivably, in order to fit into the reader pocket, 
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Figure 5.5: Bromodomains Do Not Exhibit Crotonyllysine Preference and 
the Underlying Molecular Basis.  
(A) Summary of Kcr- and Kac-binding affinities by select bromodomains 
from seven phylogenetic families (Filippakopoulos et al., 2012). Cognate 
modification sites are listed in the last column of the table. (B) Comparison 
of chemical structures of lysine acetylation (Kac), propionylation (Kpr), 
butyrylation (Kbu) and crotonylation (Kcr). The planar part due to %-
conjugation is box-shaded. (C) ITC fitting curves comparing Kac, Kpr, Kbu 
and Kcr binding affinities of H4K8 readout by the first bromodomain of 
BRD4 (BRD4BrD1), of H3K14 readout by BAZ2A bromodomain, of H3K18 
readout by the second bromodomain of BRD3 (BRD3BrD2) and AF9 YEATS. (D) 
Histone H3K18ac binding by BRD3BrD2. BRD3BrD2 is presented as ribbon covered 
by its half-transparent surface. H3K18ac peptide is shown as yellow sticks. 
Water molecules are shown as cyan balls. (E) Recognition of H3 “R17-K18ac” 
by BRD3BrD2. BRD3BrD2 is shown as surface view. Note the spatial restraints 
around the K18 acetylamide group caused by the side-open pocket. (F) Steric 
clash between F334 of BRD3BrD2 and a modeled K18cr. The experimental K18ac 
group is shown in yellow and overlaid for reference. The extended 
hydrocarbon group of crotonylation is colored green. Red disk indicates 
steric clash. (G) Recognition of H3 “R17-K18cr” by AF9 YEATS. Note the 
position of crotonylamide group in the extended and end-open pocket. The 
data and analysis presented in Figure 5.5 were generated by the Li group. 
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bulkier acylations such as propionylation and butyrylation have to adopt a bent 
conformation at the cost of binding energy. This may account for about 4- and 
38-fold reduced affinity for H3K18pr and H3K18bu readout by BRD3BrD2, 
respectively. Furthermore, given the planar feature of crotonylation, H3K18cr 
may be too rigid and bulky to fit into the BRD3BrD2 reader pocket, thus causing 
total loss of binding.  In support, the modeled Kcr hydrocarbon chain directly 
clashes against the phenyl ring of F334, a residue highly conserved in 
bromodomains (Figures 5.5F) (Filippakopoulos et al., 2012). In contrast, the 
extended AF9 YEATS reader pocket is a flat and open ended, ideal dimension for 
acyl chains bulkier than Kac, especially Kcr (Figure 5.5G).  
Kcr and AF9 YEATS Co-Localize Genome-Wide 
To assess the functional role of the AF9 YEATS-Kcr interaction I returned to the 
lipopolysaccharide (LPS)-induced inflammatory response as a model of gene 
activation. In Chapter 4, I describe a role for p300-catalyzed H3K18cr in 
inflammatory gene activation by studying the macrophage-like cell line 
RAW264.7 (Sabari et al., 2015). To assess the role of AF9 in LPS-driven gene 
activation I first compared cells pre and post LPS stimulation by chromatin 
immunoprecipitation followed by high throughput sequencing (ChIP-seq) for 
AF9 and in parallel generated a RAW264.7 cell line expressing a FLAG-tagged 
AF9 and performed FLAG ChIP-seq under the same conditions. Both ChIP-seq 
data sets showed that AF9 is recruited to LPS-induced genes upon LPS 
stimulation, demonstrating that AF9 is involved in the process of inflammatory 
gene activation (Figures 5.6A and 5.6B). Both datasets showed that AF9 peaks 3’  
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Figure 5.6: ChIP-Seq for AF9 and FLAG-AF9. 
(A-B) AF9 is recruited to LPS stimulated genes. Average profile of (A) AF9 
ChIP-seq  and (B) FLAG-AF9 ChIP-seq data from unstimulated or LPS-
stimulated RAW264.7 cells plotted  ±5kb TSS of LPS-stimulated genes 
(log2(fold)>2; 890 genes). (C) Comparison of endogenous AF9 (grey) and 
FLAG-AF9 (purple) ChIP-Seq from RAW264.7 cells at two genes with 
endogenous AF9 peaks, Slfn2 and Ccl3. (D) The FLAG-AF9 transgene is 
expressed at levels lower than endogenous AF9. Whole cell lysates from the 
indicated RAW 264.7 cell lines were resolved by SDS-PAGE and subject to 
immunoblot with an antibody against AF9. The FLAG tagged AF9 migrated 
slower due to increased molecular weight. The asterisk denotes a non-specific 
band.  
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of the transcription start site (TSS) and exhibited a tail that stretches into the gene 
body, as can be observed in average profiles of genes (Figures 5.6A and 5.6B) or 
at specific loci (Figure 5.6C). While ChIP-seq for the endogenous AF9 exhibited 
the same trends as the FLAG ChIP-seq, the endogenous AF9 data set suffered 
from high levels of background signal. Furthermore, the FLAG-AF9 protein was 
expressed at levels comparable to, if not lower than endogenous AF9 (Figure 
5.6D), mitigating concerns about artifactual localization due to hyper over-
expression. For these reasons the remainder of the analysis was performed with 
the higher-quality FLAG-ChIP-seq data. 
I next asked whether AF9 and H3K18cr co-localize across the genome. 
Using ChIP-seq data for FLAG-AF9 from LPS-stimulated cells I generated a list 
of 4735 genes with high confidence AF9 peaks ± 1kb from their TSS and plotted 
FLAG-AF9 and H3K18cr (Sabari et al., 2015) at these genes around the TSS 
(Figure 5.7A). From this global analysis, the 3’ peak of H3K18cr co-localized with 
the peak of AF9. Additionally, 95% of AF9 bound genes were also marked by 
H3K18cr (4511 out of 4735) (Figure 5.7B). The co-localization of AF9 and 
H3K18cr can be further appreciated locally at representative genes Ccl3 and Slfn2 
(Figures 5.7D). Having shown that H3K18cr co-localizes with AF9 across genes 
marked by AF9, I next asked whether the levels of H3K18cr correlate with the 
levels of AF9. To do this I ranked genes marked by H3K18cr by number of read 
bases normalized to total reads (RPKM) ± 1kb TSS (8480 genes) and grouped 
these genes into quintiles Q1-Q5, with Q1 genes exhibiting the most reads for 
H3K18cr and Q5 the lowest (1696 genes per group). FLAG-AF9 data was then 
plotted for these quintiles around TSS and the highest FLAG-AF9 signal was  
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Figure 5.7: Genome-Wide Co-Localization of H3K18cr and AF9.  
(A) H3K18cr and AF9 co-localize at genes marked by AF9. Average profile 
of FLAG-AF9 and H3K18cr ChIP-seq data from LPS-stimulated cells plotted 
+/- 5kb TSS of genes occupied by AF9 (4735 genes). (B) Venn diagram 
showing the overlap of AF9 occupied (purple) and H3K18cr marked (blue) 
genes. H3K18cr marks 95% of genes occupied by AF9. (C) Genome-browser 
view of FLAG-AF9 (purple) and H3K18cr (blue) at three representative AF9-
occupied genes. (D) Venn diagram showing the overlap of FLAG-AF9 
occupied (purple), H3K18cr marked (blue), and H3K18ac marked (red) 
genes.  
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found on genes with the highest H3K18cr and vice versa (Figure 5.7D). In a 
similar analysis, RPKM values ± 1kb for genes in Q1-Q5 were counted for FLAG-
AF9 and then graphed in box and whisker plots (Figure 5.7E). Each successive 
group of ranked genes exhibited significantly higher FLAG-AF9 reads 
demonstrating the correlation between AF9 and H3K18Cr levels at active genes. 
The same trend was observed by plotting and counting RPKM values for 
H3K18cr for groups ranked by levels of FLAG-AF9 (Figures 5.7F and 5.7G). 
These data demonstrate the co-localization of AF9 and H3K18Cr across the 
genome and specifically 3’ of the TSS of active genes.   
The AF9-Kcr Interaction Positively Regulates Gene Expression in a YEATS-
Dependent Manner 
Having shown that AF9 is recruited to LPS-stimulated genes and that AF9 co-
localizes and correlates with H3K18cr genome-wide, I next asked whether this 
co-localization is H3K18cr- and/or YEATS-dependent. I have previously 
reported that by increasing the cellular concentration of crotonyl-CoA prior to 
LPS stimulation I could directly increase the levels of H3K18cr thereby increasing 
expression of a number of p300-targetted genes (Sabari et al., 2015) (see Chapter 
4). Based on our findings that the YEATS domain exhibits preferential binding to 
Kcr, I hypothesized that this interaction and subsequent recruitment of YEATS-
containing complexes could be the molecular mechanism driving the enhanced 
stimulation capacity of Kcr. To understand the impact of increasing H3K18cr on 
AF9 recruitment I performed ChIP-seq for FLAG-AF9 from cells pre-treated with 
crotonate (10mM) followed by LPS stimulation. Utilizing previously published 
RNA-seq data sets (Sabari et al., 2015), I generated two groups of LPS-stimulated  
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Figure 5.8: FLAG-AF9 ChIP-Seq. 
(A) AF9 is further recruited to genes transcriptionally responsive to 
increased crotonyl-CoA concentration by crotonate pre-treatment. FLAG-
AF9 ChIP-seq data from RAW264.7 cells unstimulated (green), LPS-
stimulated (orange), or pre-treated with 10mM sodium crotonate and then 
LPS-stimulated (purple) ±5kb TSS of genes either responsive to crotonate 
(log2(fold-FPKM)>1.0; 52 genes) shown in left panel, or genes unresponsive 
to crotonate (log2(fold-FPKM)<0.01; 233 genes) shown in right panel. 
Sequenced input from crotonate treated and LPS stimulated cells is plotted 
in pink. (B) Box and whisker plot (10-90th percentile) of fold change due to 
crotonate pre-treatment in FLAG-AF9 RPKM ±1kb TSS of crotonate 
responsive and crotonate unresponsive genes. ****: t-test derived p-value < 
0.0001. (C) Genome-browser view of FLAG-AF9 ChIP-seq (purple) and 
RNA-seq (black) data from cells unstimulated, LPS-stimulated, or 
crotonate pre-treated and LPS-stimulated for a representative responsive 
gene (Rsad2) and representative unresponsive gene (Ccl3). 
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genes (log2(fold)>1.0; ± LPS), those that were crotonate responsive (log2(fold)>1.0; 
LPS ± crotonate) and those that were unresponsive to crotonate (log2(fold)<0.01; 
LPS ± crotonate). FLAG-AF9 ChIP-seq data from unstimulated, LPS-stimulated, 
and LPS-stimulated plus crotonate pre-treatment conditions were plotted around 
the TSS of these two sets of genes (Figure 5.8A). Consistent with a role for AF9 in 
crotonate-responsiveness, FLAG-AF9 signal was higher with crotonate treatment 
only at crotonate responsive genes. By comparing FLAG-AF9 RPKM ± 1kb TSS of 
genes in each group and calculating the fold change induced by crotonate pre-
treatment for each gene, I observed a mean fold-change in AF9 of 1.58 for 
responsive genes compared to 0.92 in unresponsive genes (Figure 5.8B). The 
increase in AF9 localization due to increased Kcr by crotonate treatment can be 
seen at Rsad2, a representative crotonate responsive gene, whereas at Ccl3, a 
representative unresponsive gene, there was no change to AF9 localization 
(Figure 5.8C). Together these data support a role for enhanced AF9 localization 
at genes that have enhanced H3K18cr levels and expression.  
To test whether the increase in AF9 upon increased Kcr is dependent upon 
the YEATS-Kcr interaction Dr. Panchenko generated a RAW264.7 cell line 
expressing FLAG-AF9(F59A), a point mutation which ablates H3K18cr binding 
in vitro and in cells (Figures 5.3E and 5.4C), and I compared this line to FLAG-
AF9(WT) by FLAG-ChIP under pre-treatment of increasing concentrations of 
sodium crotonate. The two transgenes were expressed at equivalent levels, as 
demonstrated by immunoblot and qRT-PCR (Figures 5.9A and 5.9B). Using 
primers designed at AF9 peaks, ChIP-qPCR analysis at a number of crotonate-
responsive genes (Rsad2, Il6, Ifit1, Cmpk2, and Gbp2) showed that while AF9 
signal increased with increasing concentrations of crotonate, the F59A mutant  
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Figure 5.9: The Increased Recruitment of AF9 Due to Crotonate Pre-Treatment 
is YEATS-Kcr Dependent.  
(A) Immunoblot analysis for AF9 protein levels of whole cell lysates from the 
indicated cell lines. Top band is the FLAG-tagged AF9, the middle band is 
endogenous AF9, and the band marked by an asterisk is a non-specific protein. 
(B) qRT-PCR analysis of FLAG-AF9 expression in the indicated cell lines. Data 
is presented as mean relative expression with standard deviation. (C) FLAG-
ChIP was performed from RAW264.7 cells expressing a wild type AF9 (FLAG-
AF9(WT)) construct or an AF9 construct with the YEATS-Kcr abrogating F59A 
mutation (FLAG-AF9(F59A) under the conditions indicated followed by qPCR 
analysis of ChIP product and appropriate inputs. Data are plotted as mean 
percent input + standard deviation. ***: t-test derived p-value = 0.0001; ****: 
<0.0001; ns >0.05. 
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was unresponsive (Figure 5.9C). Together these data support the model that the 
AF9-YEATS interaction with H3K18cr is capable of enhancing AF9 recruitment.  
Interestingly, the F59A mutant was recruited to tested loci upon LPS 
stimulation to comparable levels as the wild-type protein suggesting that it was 
integrated into its associated complexes and recruited by YEATS-independent 
means, yet it lost the capability to “read” H3K18cr and was not further recruited 
upon crotonate treatment (Figure 5.9C).  
The increase in H3K18cr by crotonate pre-treatment is associated with 
increased gene expression. To test whether AF9 is responsible for crotonate-
enhanced expression, Dr. Panchenko engineered a RAW264.7 cell line with 
genetic knockout of AF9 by CRISPR-Cas9 (Figure 5.10A) and I tested whether 
previously described genes were still crotonate responsive in this genetic context. 
By pre-treatment of parental cells with crotonate, the crotonate-responsive genes 
tested (Rsad2, Il6, Ifit1, Cmpk2, and Gbp5) exhibited between a 3 to 4-fold increase 
in gene expression over LPS-induction, while cells lacking AF9 demonstrated a 
significantly reduced response, as measured by qRT-PCR (Figures 5.10C-5.10G). 
Importantly, this reduction could be rescued by addback of wildtype AF9 but not 
by AF9 (F59A), demonstrating the gene selectivity of the phenotype and the 
functional importance of the YEATS-Kcr interaction in this process (Figures 
5.10C - 5.10G). Ccl3, as a representative non-responsive gene, was unaffected by 
crotonate pre-treatment (Figure 5.10H). Both the AF9 and AF9 (F59A) transgenes 
were expressed at the same level (Figure 5.10B). Taken together these findings 
establish a functional role for the YEATS-Kcr interaction in the positive 
regulation of gene expression.  
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Figure 5.10: The Transcriptional Response to Increased Crotonyl-CoA 
is Dependent on AF9 and the YEATS-Kcr Interaction.  
(A) Sequence verification of AF9 knockout by CRISPR-Cas9. The guide 
RNA used to target AF9 is indicated. Nucleotide deletions leading to a 
frameshift mutation are observed on both alleles at the predicted cut site. 
(B) qRT-PCR analysis of FLAG-AF9 expression in the indicated cell lines. 
Data is presented as mean relative expression with standard deviation. 
(C-H) The fold change in mRNA abundance, as measured by qRT-PCR, 
due to crotonate pre-treatment under 120’ LPS stimulation was compared 
across four RAW264.7 cell lines: 1) wild type control (no guide), 2) 
CRISPR-Cas9 mediated AF9 genetic knockout (AF9 KO), 3) AF9 KO 
expressing a wild type construct of FLAG-AF9 (AF9KO + WT), and 4) 
AF9 KO expressing a F59A mutant construct of FLAG-AF9 (AF9KO + 
F59A). Data for five crotonate responsive genes (C-G) and one crotonate 
unresponsive gene (H) are presented. Data are plotted as mean fold 
change of two biological replicates + standard deviation. ****: t-test 
derived p-value < 0.0001; ns: >0.05. 
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DISCUSSION 
Although a variety of histone lysine acylations have been identified, diverse in 
both chemical structure and site of modification, it remains unclear how they are 
functionally distinct from acetylation, the archetypal histone acylation. Focusing 
on Kcr, we have previously reported the enzymatic and metabolic means by 
which Kcr is regulated independently of Kac and the enhanced transcriptional 
response when the balance is shifted towards Kcr (Sabari et al., 2015). Driven by 
insights gleaned from the co-crystal structure of AF9 YEATS domain in complex 
with H3K9ac (Li et al., 2014), we postulated that the YEATS binding pocket 
would prefer Kcr. This hypothesis was confirmed by ITC with purified 
components as well as by the “designer nucleosomes” pulldowns. The 
underlying molecular basis for YEATS-Kcr recognition was further revealed by 
co-crystal structural studies. In addition, utilizing a cell-based model of 
transcriptional activation wherein histone crotonylation levels can be perturbed, 
we showed that AF9 positively regulates gene expression in a YEATS-Kcr 
dependent manner. Collectively, our work reported here establishes that the 
YEATS domain, originally annotated as a novel family of Kac effector proteins, 
exhibits an evolutionarily conserved preference for Kcr over Kac. This provides 
the mechanism by which Kcr stimulates transcription, further highlighting the 
functional distinction between Kcr and Kac. 
YEATS Possesses a Unique Mechanism for Preferential Crotonyl-lysine 
Readout 
Crotonyl-lysine sets itself apart from other acylation marks by its %-electron 
conjugation of its crotonylamide group, thus being rigid and planar in shape 
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(Figure 5.3B). Structural analysis of AF9 YEATS domain bound to H3K9cr or 
H3K18cr demonstrates the crotonylamide plane is sandwiched by aromatic 
residues Y78 from the top and F59 from the bottom, and %-aromatic stacking and 
hydrophobic contacts contribute to preferential crotonylation readout (Figure 
5.3B).  Among them, Y78 is primarily responsible for the amide group 
recognition, while F59 provides critical stacking contacts with the extended 
crotonyl hydrocarbon chain. An aromatic feature at positions 59 and 78 is highly 
conserved among YEATS domain proteins from yeast to human (F and Y at 
position 59, or Y and W at position 78) (Figure 5.3F), accounting for the 
conserved crotonyl-lysine reader activity among YEATS family members. 
Following crotonyl-lysine insertion, AF9 F28 from the L1 loop displayed 
adaptive side chain flip, suggesting a role of F28 in sensing the tip part of the 
longer chain acylations. Thus, the occurrence of F28 may partly account for the 
binding loss observed for the branched Khib and acidified Ksu marks. 
Interestingly, residues at position 28 displayed large discrepancy across species, 
ranging from small side chain residue serine in YEATS2 to basic residue arginine 
in Sas5 (Figure 5.3F), which suggests that different YEATS domains may display 
fine-tuned acylation type sensitivity in addition to the common Kcr preference. 
Comparison between the co-crystal structures of BRD3-H3K18ac and AF9-
H3K18cr highlights the ways in which YEATS is distinct from bromodomains. 
The reader pocket of bromodomain is generated at the center of a four-helical 
bundle and side-open (Figure 5.5D). Acetyl-lysine is perpendicularly inserted 
into the pocket positioned in such a way that any extension of the acylation chain 
would be restricted by the pocket dimension (Figure 5.5E). As supported by 
previous structural studies (Flynn et al., 2015; Vollmuth and Geyer, 2010), longer 
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acylation chains such as propionylation and butyrylation, must  be rotated to 
protrude out of the pocket from the side opening, compromising affinity. 
Crotonyl-lysine, due to its bulky and planar feature cannot be rotated and is 
therefore occluded from binding most bromodomains. By contrast, the reader 
pocket of YEATS is elongated and open ended, being ideal to positively sense a 
large repertoire of acyl-lysine marks with extended acylation chains (Figure 
5.5G). 
AF9 YEATS Regulates the Response of Inflammatory Genes to Histone 
Crotonylation 
We demonstrate here that AF9 is recruited to activated genes in the LPS-induced 
inflammatory response. AF9 is a member of two distinct transcription-associated 
complexes, the Super Elongation Complex (SEC) and the Dot1L complex 
(DOT1LC) (Lin et al., 2010; Yokoyama et al., 2010).  While this is the first direct 
demonstration that AF9 is recruited to LPS stimulated genes, it is not entirely 
surprising given that the inflammatory response requires the recruitment and 
activity of multiple remodeling and elongation complexes (Medzhitov and 
Horng, 2009; Smale et al., 2014). Furthermore, it has been previously 
demonstrated that components of the SEC (ELL2 and AFF4) are recruited to 
regulatory elements of activated genes in the context of EGF-stimulation (Lai et 
al., 2015).  AF9 localization is enhanced beyond levels attained by signal-induced 
recruitment by crotonate pre-treatment. This crotonate enhanced AF9 
localization is dose-dependent and occurs specifically at genes that have been 
previously shown to exhibit dose-dependent increases in H3K18cr, decreases in 
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H3K18ac, and increases in gene expression under the same crotonate pre-
treatment and stimulation conditions (Sabari et al., 2015). AF9 is recruited to sites 
of gene activation in a YEATS-independent manner (Figure 5.9C, compare 0 mM 
crotonate, ± LPS), likely driven there by its known interactions with multiple 
components of the DOT1LC or SEC. The interaction of AF9 with its complex 
members is known to be YEATS independent, with mapped interaction domains 
in AF9’s C-terminus (Biswas et al., 2011; He et al., 2011; 2010; Li et al., 2014; 
Yokoyama et al., 2010). These observations suggest that robust and coordinated 
signal-induced recruitment can override the need for the YEATS-Kcr/Kac 
interaction, yet still the YEATS domain allows AF9 to “read” the chromatin 
landscape and respond to increases in histone crotonylation. (Figure 5.9C, 
compare increasing crotonate treatment WT vs. F59A). Furthermore, the 
enhanced expression observed with crotonate pre-treatment is dependent on 
AF9 and a fully functional YEATS domain (Figure 5.10C - 5.10G).  
Our data support a role for the AF9 YEATS-Kcr interaction in the positive 
regulation of gene expression, but also suggest that Kcr exerts its function 
through other pathways as well. CRISPR-mediated knockout of AF9 significantly 
reduces the crotonate response in our model system, but does not abolish it 
completely (Figure 5.10). This residual response could be due to another YEATS 
domain protein (ENL, GAS41, or YEATS2) or another as of yet unidentified Kcr 
reader domain (trans-effects). Histone Kcr could also cause changes to 
nucleosome stability or inter-nucleosomal interactions, thereby promoting 
transcription in a reader-independent manner (cis-effects). In support of 
potential cis-effects, a recent study demonstrated that H3-H4 tetrasomes 
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comprised of H3K122cr were less stable in solution than tetrasomes with 
unmodified H3 (Suzuki et al., 2015). As such, we anticipate that future studies 
will uncover other pathways mediated by Kcr. 
In this Chapter, in close collaboration with the Drs. Haitao Li and 
Yuanyuan Li from the Li group, and Dr. Tanya Panchenko, my colleague in the 
Allis lab, I demonstrate that the YEATS domain has an expanded acyl-binding 
repertoire with highest binding to Kcr. This Kcr preference prompted us to focus 
on the functional role of the YEATS-Kcr interaction within the context of gene 
activation. The enhanced affinity for Kpr or Kbu as compared to Kac for the 
YEATS domain is likely functional and we anticipate that perturbations to these 
histone modifications will impact YEATS domain localization proportional to the 
measured binding affinities. The preferential binding of YEATS to Kcr as 
compared to Kac, reported here, makes YEATS unique among acetyllysine 
readers, so far tested, demonstrating that specific protein folds have evolved to 
functionally exploit the diversity of lysine acylations. This work supports the 
general view that the wide range of lysine acylations being uncovered in histone 
proteins function to expand the cell’s repertoire of transcriptional responses 
through the selective engagement of acyl-specific reader proteins. 
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CHAPTER 6: IDENTIFICATION AND CHARACTERIZATION OF 
DECROTONYLASE ACTIVITIES 
INTRODUCTION 
The steady-state balance of a PTM is regulated by the counteracting activities of 
the catalytic addition and removal of the modification. For histone acetylation 
this balance is regulated by the activities of the HATs and HDACs. For 
mammals, four classes of HDACs have been described.  Classes I, II, and IV 
represent HDACs 1-11, which all share a similar Zn2+-dependent catalytic 
mechanism. These are considered the “classic” HDACs with homology to the 
yeast Rpd3, the first characterized HDAC (Taunton et al., 1996). Class III HDACs 
represent the sirtuin proteins (SIRT1-7), NAD+ dependent deacetylases with 
catalytic domain homology to the yeast sir2, described as a deacetylase by 
Guarente and colleagues (Imai et al., 2000).  The sirtuin enzymes are catalytically 
and structurally distinct from the classic HDAC enzymes and for the purposes of 
this thesis we will consider the two major classes of HDACs as classic HDACs 
and sirtuins.  
The classic HDACs are the enzymes inhibited by butyrate and other 
HDAC inhibitors that demonstrate intriguing cancer-specific toxicities. The 
NAD+ dependency of the sirtuins has sparked interest in how these enzymes 
could be used as sensors of the metabolic redox state of the cell. Many intriguing 
observations have been made about the sirtuins role in DNA-damage, cancer, 
and aging (Guarente, 2007). Given the interesting biology of both classes, these 
proteins have been the subject of pharmacological interest for discovery of both 
inhibitors and activators. A small molecule inhibitor of Class I and II HDACs, 
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SAHA/Vorinostat was the first epigenetic therapy to be approved for clinical 
trial and is currently used in the treatments of T cell lymphoma. Several other 
HDAC inhibitors have been approved or are in clinical trial for the treatment of 
various malignancies (Falkenberg and Johnstone, 2014). As the sirtuin proteins 
have been implicated as anti-aging factors (Guarente, 2007; 2012) , efforts have 
been focused on developing sirtuin activators for the treatment of aging and age-
related diseases (Sinclair and Guarente, 2014). 
Several findings led me to focus on the sirtuin enzymes as potential 
decrotonylases. SIRT1, 2, and 3 were shown to have depropionylase and 
debutyrylase activities (Smith and Denu, 2007). SIRT5 was shown to have highly 
specific de-succinylase and de-malonylase activity in vitro and in vivo (Du et al., 
2011). These studies suggested that the sirtuin family of enzymes might have 
acyl-specific roles. During the time of my thesis work other papers were 
published to further demonstrate the unique capacity of sirtuin enzymes to 
remove various acylations. SIRT6 was shown to have activity for long-chain 
acylations, specifically lysine palmitoylation (16 carbon) and myristoylation (14 
carbon) (Jiang et al., 2013). SIRT5 was shown to have activity on glutarylation 
(Tan et al., 2014b). While these studies focused on non-histone substrates, they 
suggested a role for the sirtuin enzymes in removal of acylation more complex 
than acetyl-lysine.  
During the time of my thesis work two independent studies have shown 
that sirtuins have decrotonylase activity.  The first study from John Denu’s lab 
carried out a systematic screen for the capacity of the sirtuin enzymes to remove 
a large variety of lysine acylations from histone peptides (Feldman et al., 2013). 
This study assayed all seven mammalian sirtuins against twelve different 
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acylations from short-chain to long-chain at position H3K9, and included 
crotonyl-lysine. This study provided quantitative rate measurements for all 
reactions assayed. In relation to crotonyl-lysine, they showed that both SIRT1 
and SIRT2 have broad deacylation activity, which includes decrotonylation. They 
did not detect any decrotonylation activity from the other five sirtuins assayed 
and they do not observe any activity from SIRT7 (Feldman et al., 2013). The 
second study utilized a peptide crosslinking strategy to purify proteins 
interacting with crotonyl-lysine and isolated SIRT1, SIRT2, and SIRT3 from 
nuclear extracts. Although previous reports have demonstrated SIRT3’s 
mitochondrial localization, they proceed to characterize SIRT3 as a nuclear-
localized decrotonylase (Bao et al., 2014). Intriguingly, they demonstrated that 
knockdown of SIRT3 increased global and local levels of histone crotonylation, 
while knockdown of SIRT1 and SIRT2 had no measurable effect.  
Here, I present data demonstrating decrotonylase activities of SIRT1, 2, 6, 
and 7. Intriguingly, SIRT6 and SIRT7 only exhibit substrate-specific activities, in 
that they only have deacetylase or decrotonylase activity on nucleosomal 
substrates. I also demonstrate that HDAC1 has decrotonylase activity. Unlike the 
HATs, where most families tested could not catalyze crotonylation, making 
p300/CBP unique, the HDAC families appear to be generally promiscuous to 
decrotonylation. Further kinetic analysis is required to distinguish the rates of 
deacetylation and decrotonylation for these described activities.  
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Figure 6.1: Purification of Recombinant Sirtuins.  
cDNA for SIRT1, SIRT2, SIRT6, and SIRT7 were FLAG-tagged and cloned 
into pFastbac1. Baculovirus were generated through the bac-to-bac protocol 
and viral particles were added to sf9 cultures in exponential growth. FLAG-
tagged protein was purified from nuclear extract by immuno-affinity 
chromatography with M2 resin (Invitrogen).  Shown here are coomassie 
stained SDS-PAGE gels of the serial elutions (e1-e4), the column flow 
through (FT), the cytoplasm fraction from the nuclear preparation (cyto), 
and the whole cell extract (WCE).  
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RESULTS 
Nuclear Localized Sirtuins Exhibit Substrate Dependent Decrotonylase 
Activities  
The seven mammalian sirtuin proteins have specific cellular localizations. SIRT1 
and SIRT2 localize to the nucleus and the cytosol, SIRT3, 4, and 5 localize to the 
mitochondria, and SIRT6 and SIRT7 localize to the nucleus and nucleolus 
(Michishita et al., 2005). In my efforts to identify a histone decrotonylase activity 
I focused my attention on the nuclear localized sirtuins, SIRT1, 2, 6, and 7. I first 
generated recombinant protein via the sf9/baculovirus expression system. 
Baculovirus were generated encoding FLAG-tagged cDNA for all four of these 
sirtuins and full-length protein was purified from nuclear extracts of infected sf9 
cells (Figure 6.1). 
To test the decrotonylase activity of the nuclear-localized sirtuins, I 
established a decrotonylase activity assay where the readout was reduction in 
immunoblot signal from crotonyl-specific antibodies. As an initial test of the 
decrotonylase activities, histones acid extracted from crotonate treated cells were 
used as generically hyper-crotonylated substrate. Under identical reaction 
conditions, with all reactions containing the necessary cofactor NAD+, SIRT1 and 
SIRT2 exhibited decrotonylase activity while SIRT6 and SIRT7 were inert (Figure 
6.2). SIRT1 and SIRT2 reduced the amount of histone crotonylation to levels 
below detection on all four core histones. I next sought to test whether these 
sirtuins could specifically decrotonylate p300-catalyzed crotonylation or 
acetylation. 
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Figure 6.2: Sirtuin Activity Assay with Acid Extracted Histones as 
Substrate.  
Histones were acid extracted from crotonate treated HeLa cells (as in 
Chapter 3) and used as substrate for the recombinant sirtuin enzymes. All 
reactions contain NAD+. Reaction products were immunoblotted with 
panKCr antibody. 
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I prepared both recombinant histone octamers and oligonucleosomes 
purified by sucrose gradient from MNase digested nuclei. The oligonucleosomes 
were previously used as substrate in the histone crotonyltransferase (HCT) 
purification (Figure 2.1) and the octamers were used as substrate in the 
validation of HCT activity (Figures 2.3 and 2.4). The oligonucleosomes contain a 
wide range of nucleosome lengths from mononucleosomes to >12mers  (Figure 
6.3A). Because the oligonucleosomes are purified by sedimentation from 
complex extract they do contain contaminating proteins (Figure 6.3B). The 
octamers were assembled in vitro from recombinant histones purified under 
stringent conditions from bacteria essentially as in (Dyer et al., 2004), with slight 
modifications taken from (Ruthenburg et al., 2011). As such, these octamer 
preparations did not contain unknown contaminating proteins. The only 
contaminant was trace amounts of the rhinovirus 3C protease used during the 
processing of recombinant histones, which co-elutes with histone octamers 
(Figure 6.3C). Under the salt concentrations used in all reaction conditions, these 
octamers were in fact tetramers of H3-H4 and dimers of H2A-H2B. Octamers 
were used because several HATs, specifically GCN5, cannot modify nucleosomal 
substrates unless they are within their respective multi-subunit complex 
(Brownell et al., 1996; Grant et al., 1997). p300 can modify either substrate.   
Octamer or oligonucleosomes were acetylated or crotonylated by p300 
and then diluted and added as substrate to sirtuin reactions containing NAD+ 
and SIRT1, SIRT2, SIRT6, or SIRT7. Deacylase activity was measured by 
reduction in signal from immunoblot with antibodies against H3K18Cr and 
H3K18Ac, the dominant p300-catalyzed acylation. The reactions with acylated 
octamers looked very similar to the reactions with acid extracted histones, SIRT1  
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Figure 6.3: Composition of Oligonucleosome and Octamer Substrates.  
(A) The DNA purified from sucrose gradient fractions resolved over a 2% 
agarose gel and stained with ethidium bromide. The fractions pooled as 
oligonucleosomes are indicated. (B) Increasing volume of purified 
oligonucleosomes resolved over SDS-PAGE and coomassie stained. High 
molecular weight contaminants can be observed. (C) Increasing volume of 
recombinant histone octamers assayed as in (B). The asterisk designates 
trace amounts of rhinovirus 3C protease used in HIS-tag cleavage that co-
elutes with histone octamers. 
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Figure 6.4: Sirtuin Activity Assay with p300-catalyzed Octamers or 
Oligonucleosomes as Substrate. 
(A-B) Histone octamers (A) or oligonucleosomes (B) are crotonylated by 
p300 and then added as substrate to reactions with the designated 
sirtuin. Unmodified substrate and modified substrate in the absence of a 
sirtuin are included. Immunoblot of reaction products are shown here. 
(C-D) same as (A-B) except substrate are acetylated by p300.  (E) anti-
FLAG immunoblot of reactions with FLAG-tagged sirtuins. 
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and SIRT2 exhibited decrotonylase and deacetylase activity (Figures 6.4A and 
6.4C). Surprisingly, the activities of the sirtuins changed when nucleosomal 
substrates were used. SIRT1 was substantially inhibited and SIRT6 and SIRT7 
gained deacylase activity, all while SIRT2 remained the dominant deacylase 
(Figures 6.4B and 6.4D). These experiments did not detect a dramatic difference 
between the decrotonylase and deacetylase activities. More thorough 
investigation and development of quantitative activity assays will be required to 
compare the rates of the two activities. An immunoblot with FLAG antibody 
demonstrated the loading differences of the FLAG-tagged sirtuins (Figure 6.4E). 
Overexpression of SIRT2, SIRT6, or SIRT7 Reduces Global Levels of H3K18Cr 
To test whether these in vitro reactions were predictive of the sirtuins cellular 
activity, I overexpressed SIRT2, SIRT6, and SIRT7 in 293T cells by transient 
transfection. I also generated cDNA for catalytically dead SIRT2, SIRT6, and 
SIRT7 by mutating the conserved histidine within the catalytic pocket to a 
tyrosine (HY-mutants), and overexpressed these constructs in parallel along with 
an empty vector control. Immunoblots of extracted histones demonstrated that 
global levels of both H3K18Ac and H3K18Cr were reduced upon transfection of 
SIRT2, SIRT6, and SIRT7, but not upon transfection of the respective HY-mutants 
or empty vector (Figure 6.5). The reductions for SIRT2 and SIRT6 were more 
pronounced than the slight reduction observed with SIRT7 overexpression, but 
SIRT2 and SIRT6 were expressed at higher levels (Figure 6.5). SIRT1 
overexpression did not lead to a marked reduction in global histone acylation, 
but the protein was not effectively expressed upon transient transfection (data 
not shown). The reductions in immunoblot signal from cells transfected with  
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Figure 6.5: Overexpression of SIRT2, SIRT6, and SIRT7 in 293T 
cells Reduces Global Levels of H3K18Cr and H3K18Ac. 
293T cells were transfected with pCDNA3.1 containing FLAG-
tagged wildtype or HY-mutant SIRT2, SIRT6, or SIRT7, or an 
empty vector. Histones were acid extracted and whole cell extracts 
were prepared. Immunoblots with the indicated antibodies are 
shown here.  
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sirtuin cDNA mirrored the in vitro reactions with oligonucleosome substrates, 
demonstrating that the nucleosome is most likely the physiological substrate for 
these enzymes. The levels of both H3K18Ac and H3K18Cr showed the same 
trend in response to sirtuin overexpression. 
HDAC1 Exhibits Decrotonylase Activity 
To test whether decrotonylase activity was unique to sirtuins, I purified 
recombinant HDAC1, the best-studied member of the Class I HDACs, from 
baculovirus infected sf9. I performed several in vitro reactions comparing 
HDAC1 to SIRT2. First, I used histones acid extracted from crotonate treated cells 
as a source of acetylated and hyper-crotonylated substrate and immunoblotted 
the products with either acetyl-specific antibodies to detect deacetylation or 
crotonyl-specific antibodies to detect decrotonylation. As expected, HDAC1 and 
SIRT2 deacetylated acid extracted histones as measured by immunoblot with 
panKAc and H3K18Ac antibodies (Figure 6.6A). HDAC1 also decrotonylated 
this substrate and reduced immunoblot signal for both panKCr and H3K18Cr 
antibodies to below detection levels, as did SIRT2 (Figure 6.6A). Next, p300-
acetylated or –crotonylated octamers were used as substrate and both SIRT2 and 
HDAC1 were able to effectively decrotonylate and deacetylate these substrates, 
as measured by reduction in H3K18Cr and H3K18Ac immunoblot signal (Figure 
6.6B). To test whether HDAC1 exhibited decrotonylation activity in cells, I 
overexpressed HDAC1 in 293T cells and, in parallel, transfected cells with SIRT2 
and an empty vector control. Immunoblots of acid extracted histones 
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Figure 6.6: HDAC1 has Decrotonylase Activity. 
(A) Acid extracted histones from crotonate treated cells were used as substrate 
in reactions with SIRT2 or HDAC1. Reaction products were immunoblotted 
with the indicated antibodies. Reactions with SIRT2 contained NAD+. (B) 
p300-acetylated or –crotonylated histone octamers were used as substrate in 
reactions with SIRT2 and HDAC1 as in (A). (C) 293T cells were transfected 
with FLAG-tagged cDNA for SIRT2, HDAC1 or an empty vector.  Acid 
extracted histones or whole cell extract were immunoblotted with the 
indicated antibody.  
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showed that overexpression of both SIRT2 and HDAC1 led to global reduction of 
both H3K18Ac and H3K18Cr (Figure 6.6C). While quantitative kinetics of 
HDAC1 or SIRT2 decrotonylation or deacetylation cannot be derived from these 
qualitative immunoblot-based activity assays, these data clearly demonstrated 
that decrotonylation is not a unique property of the sirtuin enzymes. 
DISCUSSION 
The physiological substrate for the sirtuin and HDAC enzymes is presumably 
the nucleosome. Histone peptides, free histones, and histone octamers are all 
used as convenient proxies for the nucleosome, yet the data presented in this 
chapter suggest that the form of the substrate is critical for enzymatic activity. 
This is not a new phenomenon for chromatin modifying enzymes, as enzymes 
such as PRC2 and NSD2 have been shown to require the nucleosome structure 
for activity (Cao et al., 2002; Li et al., 2009b). Yet for the sirtuin field, peptides 
have been the dominant substrate since the discovery of sir2 deacetylase activity 
(Imai et al., 2000). Peptides are very convenient substrates for HDAC activity 
assays as they can be synthesized to carry any modification at any site at high 
purity. A recent systematic survey of the sirtuin enzymes’ capacity to remove 
various histone acylations missed the activity of SIRT6 and SIRT7 described here 
presumably because peptides were used as substrates (Feldman et al., 2013).  
The nucleosome dependency of SIRT6 deacetylation has been described 
(Gil et al., 2013) and the nucleosome enhanced deacetylase activity of SIRT7 has 
been implied without direct statement (Barber et al., 2012), neither group tested 
whether the enzymes could decrotonylate. A recent publication demonstrated 
that a measurable enhancement of SIRT2 deacetylates activity was observed with 
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nucleosome over peptide substrates (Hsu et al., 2016). Although my assays were 
not sensitive enough to observe a substrate effect for SIRT2, this study 
corroborates my findings that the sirtuin enzymes have substrate-dependent 
activities. 
The results presented here are preliminary and many experiments should 
be conducted to explore these observations further. For example, unknown 
proteins and possibly chemical matter contaminate the oligonucleosomes I use in 
my reactions. It is a formal possibility that the difference in SIRT6 and SIRT7 
activity is due to an unknown contaminating activity.  Of potential concern is the 
observation made by Denu and colleagues that long-chain fatty acids activate 
SIRT6 activity (Feldman et al., 2013). It is possible that long-chain fatty acids or 
trace lipids contaminate my oligonucleosome preparation. Experiments 
comparing recombinant octamers with recombinant nucleosomes could solve 
this problem. Furthermore, experiments with recombinant nucleosomes 
acetylated or crotonyl via amber suppression (as in Chapter 5) would facilitate 
more quantitative assessment of rates for SIRT6‘s and SIRT7’s decrotonylation 
and deacetylation reactions.  A major limitation with the experiments presented 
here is the source of modified substrate. Neither acid extracted histones nor 
p300-modified octamers or oligonucleosomes begin with equivalent acetylation 
and crotonylation; even more reason to use pre-acylated histones via amber 
suppression.  
The paper describing the discovery of histone crotonylation compared the 
activities of HDACs 1-11 on acetylated or crotonylated peptide substrates by a 
quantitative fluorometric assay (Tan et al., 2011). They did observe 
decrotonylation activity for HDAC1, but it was just above background signal and 
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~10x weaker than its deacetylation activity. As I do not measure rates of activity, 
but only end-point analysis, it is possible that the HDAC1 activity I observe is 
negligible compared to its deacetylase activity.  It remains unclear whether a 
particular enzyme or enzyme family is solely responsible for decrotonylation. 
The data presented here point to broad promiscuity for HDACs and sirtuins in 
relation to deacetylation and decrotonylation.  
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CHAPTER 7: GENERAL DISCUSSION 
The discovery of histone lysine crotonylation prompted interest in the regulation 
and function of this novel histone PTM. In my thesis work I have identified and 
characterized the writers, readers, and erasers of histone crotonylation. I have 
demonstrated that the modification is regulated metabolically by the relative 
concentration of crotonyl-CoA and acetyl-CoA and that shifts in acyl-CoA 
metabolism are read out on the differential acylation state of chromatin. 
Furthermore, this change in levels of histone crotonylation affects gene 
activation, in part through the recruitment of YEATS domain containing 
proteins, readers of crotonyl-lysine (Figure 7.1). These studies establish a 
previously unrecognized link between acyl-CoA metabolism and potency of the 
transcriptional response. Many questions still remain unresolved and new 
questions are introduced by the results of these studies. In the general discussion 
I will go through a few potential future directions and address open questions 
that have not been sufficiently addressed in individual chapter discussions.  
Histone Crotonyltransferase(s) 
The initial purification of HCT activity from HeLa cells yielded p300 as a known 
HAT with HCT activity. Other HATs tested did not exhibit HCT activity. While I 
have been able to make fundamental observations about Kcr by studying p300’s 
HCT activity in vitro and in cells, it is likely not the sole HCT activity in the cell 
for the reasons described below. From MS/MS analysis of p300 reaction 
products, there are specific lysine residues that p300 prefers to crotonylate, yet 
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Figure 7.1: The Regulation and Function of Histone Crotonylation. 
Schematic of the pathways involved in the regulation and function of 
histone crotonylation. The model presented here is a summary of the 
experiments described in the previous chapters of this thesis. 
p300/CBP (writer) catalyze histone crotonylation (Chapter 2), which is 
regulated by the relative concentration of acetyl-CoA and crotonyl-CoA 
(acyl-CoA metabolism) (Chapter 3). Enhanced levels of histone 
crotonylation lead to a boost in gene activation (Chapter 4), which is in 
part mediated through the increased localization of AF9 (reader) 
(Chapter 5). This process is reversible by the activity of decrotonylase 
activities (erasers) (Chapter 6). This illustration was designed by Dr. 
Tanya Panchenko. 
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this only explains a small percentage of the 37 known sites of crotonylation 
(Huang et al., 2014). Furthermore, while knockdown of p300 in cells ablates 
levels of the modifications identified as p300 targets (e.g. H3K18), it does not 
remove all histone crotonylation, as measured by immunoblot with a pan-Kcr 
antibody (Figure 7.2A). These observations suggest that there are other 
unidentified HCTs. Indeed, in unpublished data from the purification of HCT 
activity I have observed “side fractions” that contain unassigned 
crotonyltransferase activities (Figure 7.2B). Further purification and 
identification of these activities could yield other, as of yet unidentified, HCTs.  
The field has not yet identified an enzyme that is solely a 
crotonyltransferase without any acetyltransferase activity. It is possible that these 
side fractions contain such an activity, but as HAT activity was also observed in 
these side fractions (data not shown) the HCT activity is most likely due to 
another HAT. It would be of interest to identify this HAT. If it were one of the 
HATs that tested negatively for HCT activity in its recombinant form, then it 
would be interesting to understand whether HCT activity was dependent upon 
complex formation or upon being covalently modified. If it were one of the 
HATs not tested, it would be interesting to compare the catalytic domain with 
that of p300 and CBP to better understand the mechanisms of crotonyltransferase 
activity.  
During my thesis work, I explored the potential regulation of p300’s HAT 
and HCT activities by PTM-induced conformational change, but with only 
inconclusive results. The hypothesis was that only a fraction of the recombinant 
p300 purified from sf9 cells was active as an HCT. If this were true it would most 
likely be due to a covalent modification that may allow for separation of the  
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Figure 7.2: Unidentified Histone Crotonyltransferase(s). 
(A) While knockdown of p300/CBP ablates H3K18cr signal, pan-
Kcr signal persists. HeLa S3 cells were transfected with the 
indicated siRNA. 72 hours post transfection lysates were 
prepared and immunoblotted by the indicated antibodies. (B) At 
least two side fractions of HCT activity of unknown identity 
were observed through the partial purification of p300/CBP. 
HCT activity assays of fractions from the three column-
chromatography stages are shown here. Arrowed line designates 
path of activities reported in Chapter 2, while the dashed line 
highlights the unexplored side fractions.  
139 
modified isoform by high-resolution ion-exchange chromatography. To this end, 
I loaded FLAG-purified p300 onto a Mono S column (cation-exchange) and 
eluted over a shallow KCl gradient collecting fractions along the broad peak of 
p300 elution. HAT and HCT assays were performed on every other fraction in 
order to detect whether any fraction contained more HAT or HCT activity than 
the rest. After several attempts at this line of experimentation, the separation of 
p300’s HAT and HCT activities was not observed (Figure 7.3). Yet, these results 
do not conclusively show that there is no such isoform, but only that the 
potential isoform was not separable by ion-exchange chromatography. It is also a 
possibility that a modification occurring in the cell may not be recapitulated in 
baculovirus infected sf9 cells.  
Another line of experimentation that could yield an HCT specific enzyme 
would be protein engineering of the p300 catalytic pocket, either by rationale 
design or by screening of random mutagenesis. Generation of a p300 or CBP with 
heightened preference or selectivity for acetylation or crotonylation would be an 
invaluable experimental tool for studying differential acylation in cells and 
potentially in vivo. It would also be interesting to explore how the cancer-
associated mutations within the catalytic domain of p300/CBP affect the choice 
between acetyl-CoA and crotonyl-CoA.  
In vivo experimentation as to the function of histone crotonylation has 
been hampered by the shared enzymology with histone acetylation. For example, 
it is unclear whether the effects of knockout or knockdown of p300/CBP are due 
in any part to the loss of histone crotonylation. ACSS2, while implicated in my 
cell culture models in the generation of crotonyl-CoA is also known to be critical  
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Figure 7.3: Ion-Exchange Chromatography of p300 Does Not Separate its 
HCT and HAT Activities. 
HAT and HCT activity assays were conducted with the indicated source of 
enzyme and immunoblotted with the indicated antibodies. Reactions 
blotted with H3K18cr contained only crotonyl-CoA, while reactions blotted 
with H3K18ac contained only acetyl-CoA. L is the column input/load, FT 
is the column flow through, and 1-12 are the eluted fractions. Equal 
volumes of all fractions were assayed.   
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for acetate derived acetyl-CoA for histone acetylation and fatty acid synthesis. 
Therefore it will be difficult to determine whether effects of ACSS2 knockout or 
overexpression are mediated in any part by histone crotonylation. The 
identification of crotonyl-specific enzymes or the engineering of enzymes to 
prefer or reject crotonylation is needed for the field to expand. To make specific 
statement about histone crotonylation in the cell, my experiments have mainly 
relied on the selective regulation of histone crotonylation by crotonyl-CoA. This 
was mainly accomplished by the addition of supraphysiological concentrations 
of crotonate, a convenient method for cell culture, but one a bit trickier for mouse 
based models. Further development of tools for the selective perturbation of Kcr 
is required. 
Intracellular Concentrations of Crotonyl-CoA and other Acyl-CoAs 
A major outstanding question remains whether the concentrations of crotonyl-
CoA fluctuate in the cell or in tissues to a degree where differential acylation and 
its influence on gene expression could be expected to impact physiological 
processes. Quantitative measurements of acetyl-CoA, CoA-SH, and the various 
acyl-CoAs have been hampered by the lability of these molecules in complex 
extracts (Theodoulou et al., 2014). These molecules are heavily derivatized 
during standard methanol extraction used in a majority of metabolomic studies. 
Specific extraction protocols for the purification, isolation, and stabilization of 
acyl-CoA species have been developed and used in combination with LC-MS to 
measure whole cell concentrations of various acyl-CoAs (Tsuchiya et al., 2014) 
and have been successfully utilized to study the levels of acyl-CoAs in cell 
culture and their impact on histone modification (Lee et al., 2014; Sabari et al., 
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2015). Whole cell measurements include mitochondrial pools of acyl-CoA, which 
are distinct from cyto/nuclear pools regulating the modification of histones, yet 
subcellular measurements of small molecules are hampered by diffusion 
between organelles upon cell lysis. Even so, whole cell measurements of the 
various acyl-CoAs across tissue types would provide valuable information as to 
the physiological dynamic range of the lesser-studied acyl-CoAs, including 
crotonyl-CoA.  
Measuring the concentrations of acyl-CoA pools and in parallel 
characterizing histone acylation in tissues from mice following metabolic stress 
such as starvation or variation in diet composition will be a major first step in 
understanding the dynamic range possible for acyl-CoAs and their impact on 
histone acylation. Low calorie, low carbohydrate, or ketogenic diets are known to 
cause major rewiring on metabolic pathways in a number of organs.  Verdin and 
colleagues showed that the short chain fatty acid (SCFA) and product of 
ketogenesis, 3-hydroxybutyric acid, has effects on chromatin leading to the 
activation of FOXO3A and protection from oxidative stress (Shimazu et al., 2013). 
3-hydroxybutyric acid was elevated in the serum of mice fasted or under caloric 
restriction which correlated with increased histone acetylation in a number of 
organs including kidney, brain, liver, and large intestine. The authors concluded 
that the effects are due to 3-hydroxybutyrate’s activity as an HDAC inhibitor. 
The results from my thesis work suggest that these effects could be due to 
changes in acyl-CoA metabolism. While histone lysine 3-hydroxybutyrylation 
has not yet been described in the literature, the effects observed by Verdin and 
colleagues could be due to enhanced levels of 3-hydroxybutyryl-CoA or butyryl-
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CoA leading to increased levels of the respective acylation. The potential impact 
of SCFAs is discussed in the next section. 
Various differentiation pathways as well as the process of maintaining 
pluripotency would be interesting conditions to profile. Histone crotonylation 
has been implicated in spermatogenesis (Chapter 1) (Tan et al., 2011). It is of 
interest to understand whether a unique metabolic state exists in the testis to 
facilitate histone crotonylation. Studies with mouse embryonic stem cells have 
observed that pluripotency is associated with a unique metabolic state (Wang et 
al., 2009) with intriguing consequences for the chromatin landscape and its 
regulation of transcriptional networks  (Carey et al., 2014; Shyh-Chang et al., 
2013). 
While unbiased profiling of primary tissue or cells under the discussed 
conditions will likely yield useful associative data, a more rationale approach 
would be to study acyl-CoA metabolism in established cell lines under genetic 
depletion of various metabolic enzymes known to interact with either crotonyl-
CoA or acetyl-CoA. For example, siRNA knockdown of enzymes known to be 
involved in the metabolism and catabolism of acetyl-CoA (ACC1, ACAT, PDH, 
ACLY) and crotonyl-CoA (ACSS2, GCDH, HADHA, ECHS1) followed by 
immunoblot of cell lysates with acyl-specific antibodies and measurements of 
acyl-CoAs by LC-MS would extend the observation made in Chapter 3 for 
ACSS2. Acetyl-CoA metabolism was already discussed in Chapter 1 (Figure 1.4). 
Crotonyl-CoA can be synthesized as an intermediate in both beta-oxidation and 
lysine and tryptophan degradation (Lin et al., 2012). In beta-oxidation, acyl-CoA 
dehydrogenase (ACAD) generates crotonyl-CoA from butyryl-CoA, which is  
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Figure 7.4: Metabolic Enzymes Involved in Acetyl-CoA or Crotonyl-CoA 
metabolism. 
A simplified metabolic network of enzymes responsible for metabolism of 
acetyl-CoA (AcCoA) and crotonyl-CoA (CrCoA) is presented here. The 
enzymes listed followed by abbreviations in parentheses used are as follows: 
acyl-CoA dehydrogenase (ACAD), glutaryl-CoA dehydrogenase (GCDH), 
ATP-citrate lyase (ACLY), pyruvate dehydrogenase (PDH), hydroxylacyl-
CoA dehydrogenase (HADHA), enoyl-CoA hydratase (ECHS1), acetyl-CoA 
carboxylase (ACC1), and acetyl-CoA acetyltransferase (ACAT). 
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followed by hydroxylation to form 3-hydroxy-butyryl-CoA catalyzed by either 
hydroxyacyl-CoA dehydrogenase (HADHA) or enoyl-CoA hydratase (ECHS1). 
Crotonyl-CoA can also be derived from glutaryl-CoA by glutaryl-CoA 
dehydrogenase (GCDH) in the degradation of lysine and tryptophan. See Figure 
7.4 for a simplified metabolic network, highlighting the roles of these candidate 
enzymes. These experiments could lead to the discovery of other metabolic 
enzymes critical to the production of crotonyl-CoA used for histone 
crotonylation.  
The Influence of Environmental Short Chain Fatty Acids 
A major outstanding question from my thesis work is how crotonate is generated 
in the cell. If in fact ACSS2 knockdown decreases histone crotonylation then the 
assumed source of crotonyl-CoA will be from crotonate (Chapter 3). There are no 
obvious enzymatic reactions that would generate crotonate in mammalian 
metabolic pathways. Short chain fatty acids (SCFA) in general are thought of 
more as products of microbial metabolism than mammalian. The majority of my 
cellular studies rely on the addition of exogenous crotonate to cells, a potentially 
physiological situation for luminal cells of the mammalian large intestine, which 
are exposed to the diverse ecology of the microbiota and its secretions.  The 
microbes that reside in the large intestine secrete a large variety of SCFA, the 
most abundant of which tend to be acetate (2-carbon), propionate (3-carbon), 
butyrate (4-carbon), and valerate (5-carbon). While the luminal cells of the large 
intestine are in direct contact with microbial-secreted SCFA, these compounds 
are also found in hepatic, portal, and peripheral blood, suggesting they could 
have influence outside of the gut (Besten et al., 2013; Cummings et al., 1987).  
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Differences in the concentrations and makeup of SCFAs from environmental 
sources have been implicated in a variety of physiological and disease states 
ranging from gut microbiota dysbiosis leading to obesity, colitis, and cancer 
predisposition to the regulation of immune cell development (Lee and Hase, 
2014; Tan et al., 2014a). SCFAs have numerous roles outside of feeding acyl-CoA 
pools used for histone modifications. SCFAs can also be utilized in host 
metabolism, particularly in colonocytes where they are the cell’s major energy 
source (Roediger, 1980). SCFAs can also influence host fatty acid, glucose, and 
cholesterol metabolism (Besten et al., 2013). SCFA are also implicated in 
signaling pathways as they have been described as ligand activators of the G-
protein coupled receptors GPR41 and GPR43 (Brown et al., 2003). Yet, whether 
observed fluctuations in SCFA lead to an increase or decrease in their 
corresponding histone acylation, as we have shown here with crotonate and 
histone crotonylation remains largely untested.  
One way to test this hypothesis would be to compare specific pathogen 
free (SPF) mice from different vendors to germ free (GF) mice by both SCFA 
composition in serum and feces as well as measurement of crotonylation and 
acetylation in histone extracted from various tissues. SPF mice from different 
vendors or breeding centers are known to exhibit variation in their gut 
microbiota (Hufeldt et al., 2010) presumably with consequences on the SCFA 
composition. GF mice will not have any microbial-derived SCFA and 
comparisons with SPF mice as to the levels of histone acylations will reveal the 
extent to which these modifications are derived from environmental SCFAs. 
Tissue from various sections of the gut, including colon, cecum, small intestine 
and stomach, as well as other tissues including thymus, liver, kidney, and 
147 
pancreas could be collected and lysates generated for immunoblot detection 
and/or mass spectrometry. If differences in histone crotonylation are observed 
between SPF and GF mice, further experimentation could be carried out to 
inoculate GF mice with specific bacteria in an effort to identify the strain 
responsible for the effect.  These types of gnotobiotic mouse models have been 
successfully utilized to study the effects of butyrate secreting bacteria on the 
activation of TH17 immune cells (Arpaia et al., 2013) and in the protection against 
colorectal cancer under high-fiber diet (Donohoe et al., 2014), both studies 
implicate the compounds HDAC inhibitor activity as the mechanism of action.  
Conclusion 
The regulation of histone crotonylation or the functional consequence of a 
histone being acetylated versus crotonylated (differential acylation) has 
remained unclear since the discovery of the modification was reported. During 
my thesis work I have had the privilege of working with exceptional colleagues 
and together we have shown that histone crotonylation is regulated both 
enzymatically, by p300/CBP, and metabolically, by the relative concentration of 
crotonyl-CoA and acetyl-CoA. We established a role for histone crotonylation in 
transcription in both cell-free and cell-based models of transcriptional activation. 
We demonstrated that part of this transcriptional response is mediated through 
AF9 YEATS as a reader of crotonyl-lysine and characterized several 
decrotonylase activities. In conclusion, we have demonstrated that the 
differential acylation state of histones is an integration of environmental and 
metabolic information, which serves a functional role in the regulation of gene 
expression.  
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CHAPTER 8: METHODS 
HeLa S3 Nuclear Extract Preparation 
For nuclear extract, HeLa S3 cells were grown in suspension culture in DMEM 
supplemented with 10% FBS. Eight liters of HeLa S3 suspension culture 
(~1x10^10 cells) were harvested by centrifugation and then washed in cold PBS. 
The pellet was resuspended in hypotonic lysis buffer (20 mM HEPES pH 7.9, 10 
mM KCl, 5 mM MgCl2, 0.5 mM EGTA, 0.1 mM EDTA, 5 mM βME, 1 mM sodium 
metabisulfite, 1 mM benzamidine, 0.8 mM PMSF) and dounced ten times with 
pestle A and ten times with pestle B or until >90% of cells were determined lysed 
by trypan blue staining. Lysed cells were centrifuged at 3000 rpm to pellet intact 
nuclei. Nuclei were resuspended in a nuclear resuspension buffer (20 mM 
HEPES pH 7.9, 110 mM KCl, 2 mM MgCl2, 0.1 mM EDTA, 5 mM BME, 1x 
complete protease inhibitor (Roche), 0.4 mM PMSF) and dounced ten times with 
pestle A to homogenize the suspension. Solid ammonium sulfate was added to a 
final concentration of 400 mM, samples were immediately mixed by inversion, 
and left rotating at 4°C for 30 minutes. The samples were then clarified by 
centrifugation at 35,000 rpm for 1 hour. The supernatant is the soluble nuclear 
extract. The soluble nuclear extract was then subject to ammonium sulfate 
precipitation/salting out to 60% saturation. The precipitate was collected and 
gently resuspended in buffer D (20mM HEPES pH 7.9, 100 mM KCl, 1 mM 
EDTA, 10% glycerol, 1 mM DTT, 1 mM PMSF) and dialyzed twice against 2 L of 
Buffer D for 2 hours. The dialyzed extract is the crude nuclear extract that was 
subject to further fractionation.  
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Chromatographic Fractionation 
Column chromatography was performed using the AKTA Purifier system with 
the following columns: in-house packed POROS Heparin 50 uM (Invitrogen), 
Mono Q 5/50 GL (GE Healthcare), and Mono S 5/50 GL (GE Healthcare). 
Fractions were collected over a linear potassium chloride gradient from 0.15 M to 
1 M. 
Immunoblot Analysis 
Histones were purified from cells using a standard acid extraction protocol 
(Shechter et al., 2007). Whole cell lysates were prepared by boiling cell pellets in 
2x Laemmli sample buffer for 5 minutes followed by brief vortexing. The 
following antibodies were used in this study: Pan-KCr (PTM-Biolabs 501), 
H3K18Cr (PTM-Biolabs 517), pan-KAc (PTM-Biolabs 105), H3K18Ac (Abcam 
1191), H3K27Ac (Active Motif 39685), H3K56Ac (Abcam 76307), H3 (Abcam 
1791), p300 (Santa Cruz 584), CBP (Santa Cruz 7300), ACSS2 (Cell Signaling 
3658), alpha-actin (Sigma A2066), beta-actin (Abcam 8224), and lamin-A (Abcam 
26300). The ACL antibody was a gift from the Thompson Lab.  
Cell Culture and Transfections 
HeLa S3, HEK 293T, and RAW 264.7 cells were cultured in DMEM, 
supplemented with 10% FBS, and 1% GlutaMAX (Gibco) at 37°C under 5% CO2. 
Sodium crotonate was prepared by dissolving solid crotonic acid (MP 207938) in 
water, followed by titration with sodium hydroxide to pH 7.4. Sodium acetate 
was prepared similarly with acetic acid. siRNA transfections were performed 
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using Dharmafect 1 (Dharmacon) as per manufacturer’s instruction. The 
following siRNAs were used at the following concentrations: non-target control 
(Dharmacon D-001810-10, 25nM), p300 (Dharmacon L-003486, 25nM), CBP 
(Dharmacon L-003477, 25nM), ACSS2 #1 (Ambion s31745, 20nM), ACSS2 #2 
(Ambion s31746, 20nM), ACSS2 #3 (Ambion s31747, 20nM), ACSS2 #4 
(Dharmacon L-010396, 20nM), ACL #1 (Ambion s915, 10nM), ACL #2 (Ambion 
s916, 10nM), ACL #3 (Ambion s917, 10nM), PDHE1α (Ambion s10245, 20nM), 
mouse ACSS2 (Dharmacon L-065412, 25nM). DNA transfections were performed 
using lipofectomine 2000 as per manufacturer’s instruction. For LPS stimulation, 
RAW 264.7 cells were plated at ~25% density >24 hours prior to stimulation. LPS 
from Salmonella typhosa (Sigma L2387) was added at 100 ng/mL and samples 
were collected at indicated time points. 
Recombinant Enzymes 
Recombinant p300, MOF, Sirtuins and HDAC1 were expressed in Sf9 cells by 
baculovirus infection and purified by FLAG immuno-precipitation (IP) of 
nuclear extracts, described in next section. Recombinant p300 and p53 used in 
transcription assays were purified by Dr. Zhanyun Tang as described previously 
(Tang et al., 2013). SIRT1 (addgene #1791), SIRT2 (addgene #13813), SIRT6 
(addgene #13817), SIRT7 (Open Biosystems MHS6278-202832829) cDNA were 
cloned into pFastbac1 with C-terminal FLAG tags. MOF cDNA (MHS6278-
202808687) was cloned into pFastbac1 with an N-terminal FLAG tag. Baculovirus 
was generated by the Bac-to-bac system per manufacturer’s instructions (Life). 
Amplified baculovirus was used to transduce sf9 cells and protein was purified 
by FLAG-IP, as described in the following section. The catalytic domains of 
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GCN5 (residues 505-670) and TIP60 (residues 181-462) were cloned from HeLaS3 
cDNA libraries into pGEX6p1 to generate GST-fusion proteins. 
Rosseta2(DE3)pLysS were transformed, induced by IPTG, and soluble protein 
was purified by standard glutathione-sepharose chromatography.  
FLAG Purification from Baculovirus Infected Sf9 Cells 
Baculovirus were generated by the Bac-to-Bac recombination strategy (Life). 
Baculovirus were amplified by serial infection of sf9 cells. 20-30 mL of high-titer 
baculovirus was added to 1 L of sf9 suspension culture in exponential growth 
(~0.6x106 cells/ml). Three days post-infection, cells were harvested by 
centrifugation and washed in cold PBS. The washed cell pellets were then 
resuspended (~2x107 cells/ml) in hypotonic lysis buffer (20 mM HEPES, 10 mM 
KCl, 5 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 1x Complete Protease inhibitor 
(Roche)) and dounced 10 times with pestle A and 10 times with pestle B, or until 
>90% of cells were lysed as detected by trypan blue staining. Samples were 
centrifuged at 3000 rpm to pellet intact nuclei. Pellets were resuspended (~4x107 
cells/ml) in Buffer B (20 mM HEPES, 300 mM KCl, 1 mM EDTA, 0.1% TritonX-
100, 1 mM DTT, 0.4 mM PMSF) and dounced with pestle A to homogenize. 
Samples were incubated rotating at 4°C for 30 minutes followed by 
centrifugation at 35,000 rpm for 1 hour. The supernatant is the soluble nuclear 
extract. Equilibrated Anti-FLAG M2 conjugated to agarose beads (Sigma A2220) 
were added to soluble nuclear extract and incubated rotating at 4°C for 4 hours. 
The FLAG M2 agarose beads were washed on column twice with ten times 
column volume (CV) Buffer W (Buffer B/0.01% TritonX-100, 10% glycerol). 
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Protein was eluted with four 0.5CV elutions of buffer E (Buffer W + 300 $g/mL 
3X FLAG peptide). Peak fractions were pooled and dialyzed to buffer W.  
In Vitro Assays
HAT/HCT assays were incubated at 30°C for 1 hour in Buffer A (50 mM Tris pH 
8.0, 10% glycerol, 1 mM DTT, 0.2 mM PMSF). When extract was used as an 
enzyme source 10mM Sodium Butyrate was included in Buffer A. 2-100 $M of 
either crotonyl-CoA or acetyl-CoA (Sigma 28007 and A2181) was used as the 
high-energy acyl donor. Unless otherwise noted, 100 $M was used in initial 
purifications, 2 $M in subsequent HAT and HCT in vitro assays, and 50 uM in 
the transcription assays. The oligonucleosome substrate was sucrose-gradient 
purified from micrococcal nuclease-digested HeLaS3 nuclei, as previously 
described (Fang et al., 2003). Recombinant chromatin used in p300 reactions and 
transcription assays was prepared as described (Tang et al., 2013). Recombinant 
histone proteins were purified and assembled into octamers as previously 
described (Ruthenburg et al., 2011). Under reaction conditions the “octamers” are 
most likely present as H3-H4 tetramers and H2A-H2B dimers, while 
oligonucleosome and recombinant chromatin substrate will maintain their 
structure. Sirtuin reactions were incubated at 30°C for 2 hours in Buffer S (10 mM 
Tris-HCl, pH 8.0, 5 mM NAD+, 150 mM NaCl, 0.2 mM DTT).  Fluorescence-based 
HDAC assays were performed using an HDAC Assay Kit (Active Motif 56200) 
according to manufacturer’s instruction. p53-dependent in vitro transcription 
assays were performed as previously described (Tang et al., 2013). Densitometry 
of autoradiographs was performed with ImageJ.  
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H3K18Ac and H3K18Cr ChIP 
Cross-linking ChIP was performed with anti-H3K18Ac (Abcam 1191) and anti-
H3K18Cr (PTM-biolabs 517). RAW 264.7 cells were grown in full media, 
pretreated with the indicated concentration of crotonate for six hours, and then 
stimulated with 100 ng/mL of LPS for two hours. Chromatin from ~5x107 cells 
was used per immuno-precipitation. Media was aspirated and cells washed with 
PBS followed by addition of 1% formaldehyde (in PBS). Cells were cross-linked 
directly on the plate for 10 minutes with gentle shaking. Glycine was added to a 
final concentration of 125 mM to quench the crosslinking and allowed to 
incubate for 5 minutes. Cells were scraped off the plates, pelleted, and washed in 
PBS plus 1x Complete protease inhibitors (Roche), 10 mM Butyrate, and 10 mM 
nicotinamide.  Pellets were resuspended in 10mL LB1 (50 mM HEPES, 140 mM 
NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP40, 1% TritonX-100, 1x Complete 
protease inhibitor (Roche), 10 mM Butyrate, 10 mM nicotinamide) and incubated 
rotating at 4°C for 20 minutes. Samples were centrifuged and pellets were 
resuspended in 10 mL LB2 (10 mM Tris pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 
mM EGTA, 1x Complete protease inhibitors (Roche), 10 mM butyrate, 10 mM 
nicotinamide). Samples were incubated rotating at 4°C for 10 minutes and then 
centrifuged. Pellets were resuspended in 1.2 mL LB3 (10 mM Tris pH 8.0, 100 
mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% sodium-deoxycholate, 0.5% sodium 
lauroyl sarcosinate, 1% TritonX-100, 1x Complete protease inhibitors (Roche), 10 
mM butyrate, 10 mM nicotinamide) and passed through a 27-gauge needle until 
suspension was homogenized. The samples were then sonicated in a Bioruptor 
cooled water bath sonicator (Diagenode) for 60 cycles of 30’ on 30’ off on high 
intensity. Samples were clarified by centrifugation at 16,000 g for 15 minutes. The 
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supernatant is the soluble chromatin extract. 5% of input volume was set aside. 
7.5 $g of H3K18Cr or H3K18Ac antibody were conjugated to 75 $L protein A 
Dynabeads (Novex) per immuno-precipitation. After unbound antibody was 
washed away, the beads were added to the clarified soluble chromatin extract 
and incubated rotating overnight at 4°C. A magnetic stand was used to separate 
beads from the extract and beads were washed under the following conditions: 
three times with 1 mL wash buffer 1 (50 mM HEPES, 100 mM LiCl, 1 mM EDTA, 
1% NP-40, 0.7% sodium deoxycholate, 10 mM butyrate, 10 mM nicotinamide), 
three times with 1mL wash buffer 2 (20mM Tris-HCl pH 8.0, 350mM NaCl, 1% 
TritonX-100, 0.1% SDS, 2mM EDTA, 10 mM butyrate, 10 mM nicotinamide), and 
once with 1 mL buffer TE plus 50 mM NaCl. The washed beads were 
resuspended in 210 $L elution buffer (50 mM Tris pH 8.0, 10 mM EDTA, 1% 
sodium dodecyl sulfate) and incubated at 65°C for 30 minutes while shaking to 
prevent beads from settling. The eluate was transferred to a new tube, 5% inputs 
were brought up to equal volume with elution buffer, and both were incubated 
at 65°C overnight to reverse crosslinks. The samples were then treated with 
RNase and Proteinase K. DNA was recovered using the Qiagen PCR purification 
kit according to manufacturer’s instruction. A 1/100 dilution of each sample was 
used for qPCR analysis as described in experimental procedures.   
ChIP-qPCR 
ChIP products and inputs were diluted 1/100 and then analyzed by qPCR using 
Power SYBR Green (Life) and StepOnePlus Real-Time PCR system (Applied 
Biosystems).  
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The sequences of ChIP-qPCR primer pairs used for H3K18Ac and H3K18Cr ChIP 
are:  
Forward Reverse 
Il6 AATGTGGGATTTTCCCATGA GCTCCAGAGCAGAATGAGCTA 
Gbp2 GCCCAGGGCTAGGTGACA TGTGAAGTCTTCTTTCCCAGAGTTT 
Ifit1 GCCATCCTAAGACCCCCTAGTG TCTGCAGTTCCTCCTTGGAAGT 
Pim1 CTGGCCTCGGTGTGCAA GGCGAAGGCTGTGCAAGA 
Rsad2 CAATCCCAACTCCTTTCCCAACA TCTGACCTCCATAACCAAATGAACT 
Ccl3 ATCTCCAGCTCGAGCAATGG AGTCACTTTGCGGCTGATGA 
Ccl5 TGAGCCTTTGAGGAGGTTGG CACTGCAAGTCACGGCCATA 
The sequences of ChIP-qPCR primer pairs used for FLAG-AF9 ChIP are: 
Forward Reverse 
Rsad2 GGTCCAGGAACTTACCAGCC TCCACACAGCCAAGACATCC 
Il6 CTGCTCACTTGCCGGTTTTC AGCATCAGTCCCAAGAAGGC 
Ifit1 CCTGAGGGTCCAGGGAGTTT TCCAGCACCAGGCACACA 
Cmpk2 TGTTAGACACGGATGCTGCC GGTAGGTGTTGGATGCACGA 
Gbp2 GCCCAGGGCTAGGTGACA TGTGAAGTCTTCTTTCCCAGAGTTT 
Melt-curve analysis along a dilution series was carried out to ensure unique 
product amplification for all primer pairs. All statistical analysis was performed 
using PRISM v6.0 (Graph Pad). 
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RT-qPCR 
RAW264.7 cells were plated at ~25% confluency >24 hours prior to harvest. 
Sodium crotonate was added 12-16 hours prior to harvest. LPS was added to a 
final concentration of 100ng/ml 2 hours prior to harvest. Total RNA was 
extracted using the RNeasy Kit (Qiagen) and Dnase treated on column according 
to manufacturer’s instructions (Qiagen). cDNA was prepared using the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to 
manufacturer’s instructions. cDNA fragments were analyzed by qPCR using 
Power SYBR Green (Life) and StepOnePlus Real-Time PCR system (Applied 
Biosystems). A standard curve for each primer pair was used to ensure linear 
dilution and to quantitate cDNA abundance. Relative expression values were 
derived by normalization to Gapdh quantity for each sample. The sequences of 
RT-qPCR primer pairs with forward followed by reverse are: 
Forward Reverse 
Il6 GTTCTCTGGGAAATCGTGGA TTTCTGCAAGTGCATCATCG 
Gbp2 CTCTACCGCACAGGCAAATC GATGCCCTTGGTGTGAGACT 
Ifit1 AGTGAGGTCAACCGGGAATCT TCTAGGTGCTTTATGTAGGCCA 
Pim1 TCAAGGACACAGTCTACACGG AGCGATGGTAGCGAATCC 
Rsad2 AACCCCCGTGAGTGTCAACTA AACCAGCCTGTTTGAGCAGAA 
Ccl3 TACAGCCGGAAGATTCCACG TCAGGAAAATGACACCTGGCT 
Ccl5 GTGCCCACGTCAAGGAGTAT CCCACTTCTTCTCTGGGTTG 
Cmpk2 GACCTAGTTGACCAGTGCCC AGTGTGGTCTTACCAGTGGC 
Cxcl10 ATGACGGGCCAGTGAGAATG TCGTGGCAATGATCTCAACAC 
Ifnb TGGGAGATGTCCTCAACTGC CCAGGCGTAGCTGTTGTACT 
Gapdh TGGTGAAGGTCGGTGTGAAC CCATGTAGTTGAGGTCAATGAAGG 
157 
Gbp5 CGGACCTCGTCTAGAAAGCC CCGGGCCAAGGTTACTACTG 
FLAG-
AF9 
TGGACTACAAAGACCATGACGG GGCACGTCGTAGGGGTATC 
Melt-curve analysis along a dilution series was carried out to ensure unique 
product amplification for all primer pairs. All statistical analysis was performed 
using PRISM v6.0 (Graph Pad). 
RNA-seq 
RNA-seq libraries were prepared using the TruSeq RNA Sample Prep Kit 
(Illumina) as per manufacturer’s instruction. The procedure includes purification 
of poly-adenylated RNAs. Libraries were sequenced with 50bp single read 
sequencing on the HiSeq2500 (Illumina). Sequencing data was processed and 
analyzed as described in (Trapnell et al., 2012). RNA-seq data sets are available 
through GEO under the accession number GSE63889.  
ChIP-seq for H3K18Ac and H3K18Cr 
ChIP-seq libraries were prepared using the TruSeq ChIP Sample Prep Kit 
(Illumina) as per manufacturer’s instruction. Libraries were sequenced with 50bp 
single read sequencing on the HiSeq2500 (Illumina). 50bp reads were aligned 
using bowtie (v1.0.1) to the mouse mm9 reference assembly reporting only 
unique reads in the best stratum, with up to 2 mismatches (bowtie -p 8 -S -q -v 2 -
m 1 -k 1 --best –strata). Samtools (v0.1.19) was then used to convert files to bam 
format, sort, and remove PCR duplicates (Li et al., 2009a). For genome browser 
representation, tdf files were generated by IGVtools (v2.3.7) and data were 
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visualized using IGV (v2.1.28) (Thorvaldsdottir et al., 2013). Ngs.plot (v2.08) was 
used to generate average profiles of ChIPseq reads (Shen et al., 2014). MACS 
(v1.4.2) was used to call peaks (Zhang et al., 2008). BEDOPs (v2.4.1), bedmap --
basses function, was used for read counting within specified genomic regions 
(Neph et al., 2012). ChIP-Seq data sets (H3K18Ac, H3K18Cr, and inputs) are 
available through GEO under the accession number GSE63889. The p300 ChIP-
seq data presented here were reanalyzed from publically available data available 
through GEO at accession number GSE19553 (Ghisletti et al., 2010). 
Immuno-detection of Secreted Inflammatory Mediators 
Supernatants from RAW 264.7 cells under indicated conditions and for indicated 
length of LPS stimulation were assayed by two distinct immuno-assays. A 
standard immobilized ELISA for mouse Il6 (Life KMC0061) was used as per 
manufacturer’s instruction. And a bead-based assay that uses the principles of 
sandwich ELISA to quantify soluble analytes using a flow cytometer (Biolegend: 
Legendplex assay) was used to quantify the concentration of a number of 
secreted chemokines and cytokines, as per manufacturer’s instruction.  
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Mass Spectrometry Analysis of p300 Reaction Products  
[The methods described here were carried out by He Huang and members of the 
Zhao group] 
Recombinant chromatin was acetylated or crotonylated by p300 in the presence 
of p53 and reaction products were resolved on an 8% Tris-Glycine SDS-PAGE 
gel. The gel bands of core histone proteins were excised and subjected to in-gel 
tryptic digestion. The tryptic digests were desalted with Ziptip C18 and loaded 
onto a homemade capillary column (10 cm length with 75 um inner diameter) 
packed with Jupiter C12 resin (4 µm particle size, 90 Å pore size, Phenomenex 
Inc.) connected to a NanoLC-1D plus HPLC system (Eksigent Technologies LLC, 
Dublin, CA).  Peptides were eluted with a gradient of 5% to 90% HPLC buffer B 
(0.1% formic acid in acetonitrile, v/v) in buffer A (0.1% formic acid in water, 
v/v) at a flow rate of 300 nL/min over 76 min. The eluted peptides were ionized 
and introduced into a LTQ-Orbitrap Velos mass spectrometer (Thermo Fisher 
Scientific Inc., Waltham, MA) using a nanospray source. Full MS scans were 
acquired in the Orbitrap mass analyzer over the range m/z 300-1800 with a mass 
resolution of 60000 at m/z 400. Twenty of the most intense ions were isolated for 
MS/MS analysis. Database searching was performed against the NCBI protein 
sequence database, using Mascot. The database searching parameters included: 
lysine acetylation, protein N-terminal acetylation, lysine crotonylation, lysine 
trimethylation, lysine/arginine di-methylation, lysine/arginine mono-
methylation, and methionine oxidation as variable modifications. All the 
identified peptides were manually verified. 
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Mass Spectrometry Analysis of Mono S Fractions 
[The methods described here were carried out by Dr. Henrik Molina] 
50 $L of each fraction was precipitated overnight using 500 $L ice cold acetone. 
Same process was followed for the ‘input’ sample with the exception that sample 
volume was 100 $L and 1000 $L ice cold acetone was used for precipitation. 
Acetone was carefully removed, first by suction, then by evaporation.  
Precipitates was dissolved in 30 $L 8M Urea/0.1M ammonium 
bicarbonate/10mM Dithiothreitol and vortexed at room temperature for 45 
minutes. Reduced proteins was alkylated in the dark by adding 7 $L 100mM 
iodoacetaminde to each vial. Samples was then diluted 2-fold with 0.1M 
ammonium bicarbonate and 1ug Endopeptidase Lys-C  (Wako Chemicals USA, 
Inc, Richmond, VA) in 10 $L in 0.1M ammonium bicarbonate was added to each 
vial. Digestion was allowed to proceed for 6h. Samples were further diluted by 
adding 80 $L 0.1M ammonium bicarbonate prior to the addition of 1ug trypsin 
(Promega, Madison, WI, USA) dissolved in 20 $L 0.1M ammonium bicarbonate. 
Trypsination of the samples was allowed to proceed overnight, and the digestion 
was halted by adding 2 $L trifluroacetic acid. Half of each sample was desalted 
using in-house SPE columns made with Empore C18 (Rappsilber et al., 2003). 
Generated peptides were measured by nano LC-MS/MS using a Q-Exactive 
mass spectrometer (Thermo, Bremen, Germany) coupled to a Dionex NCP3200RS 
HPLC setups (Thermo, Sunnyvale, CA, USA). Samples were desalted and 
concentrated on a trap column prior to separation on a packed-in-emitter C18 
column (75 $m by 12 cm, 3 $m particles - Nikkyo Technos Co., Ltd. Japan). The 
analytical gradient was generated at 300 nL/min increasing from 10% Buffer B 
(0.1% formic acid in acetonitrile) / 90% Buffer A (0.1% formic acid) to 45% Buffer 
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B / 55% Buffer A in 137 minutes, followed by a wash step with 90% Buffer B / 
10% Buffer A for 16 minutes and conditioning for 10 minutes with 1% Buffer B / 
99% Buffer A Buffer B. Data Dependent Acquisition experiment: MS survey 
scans was scanned from m/z 300 to m/z 1400 at resolution of 70,000@200 Th 
(AGC: 5e5 and maximum IT: 100 ms). Up to the 20 most abundant ions were 
subjected to MS/MS and measured at a resolution of 17,500 (AGC: 5e5 and 
maximum IT: 60 ms) with m/z 100 as lowest mass. Precursor ions were isolated 
at 2.0 Th. Lock mass of m/z 371.10123 was used for all measurements. All 
samples were analyzed in technical duplicates. Data were searched and 
quantified using MaxQuant 1.5.30 (Cox et al., 2014). Technical replicates were 
merged for the analysis. The Uniprot Complete Proteome human protein 
database (July 2014) was queried. Match between runs was utilized. Combining 
all samples approximately 3,700 proteins were matched at 1% protein and 
peptide False Discovery Rate. For the comparison of the data set intensity Based 
Absolute Quantitation (iBAQ) (Schwanhäusser et al., 2011) was used. MaxQuant 
‘proteinGroups.txt’ output is available in Table S1. 
Mass Spectrometry Analysis of Acetyl-CoA and Crotonyl-CoA 
[The methods described here were carried out by Drs. Justin Cross and Vladimir 
Yong-Gonzalez] 
HeLa S3 and RAW 264.7 cells were maintained in DMEM medium 
supplemented with 10% FBS, 2 mM of L-glutamine, 100 units/mL penicillin and 
100 $g/mL streptomycin at 37°C under an atmosphere of 5% of CO2. The acyl-
CoA extraction procedure was based upon the method previously described by 
(Basu and Blair, 2011), with minor modifications. Cultured cells were washed 
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once with cold deionized water and metabolites extracted by the addition of 1 
mL of ice cold 10% trichloroacetic acid (TCA). Following 15 seconds incubation 
on ice, cells were collected by scrapping and transferred to a 1.5 mL Eppendorf 
tube. Cell extracts were sonicated for 3 x 30 seconds (Bioruptor, Diagenode) and 
then centrifuged at 14,000 rpm for 5 minutes at 4°C to remove protein. Acyl-
CoAs were further purified using a HLB 96-well plate solid phase extraction 
plate (30 mg) and vacuum manifold (Waters Corporation). SPE wells were 
conditioned with 1 mL of methanol, and equilibrated with 1 mL of water. 
Supernatants were applied and then SPE wells were washed with 1 mL of water; 
acyl-CoAs were eluted using three successive applications of 0.5 mL of methanol 
containing 25 mM ammonium acetate. Eluted acyl-CoAs were dried for 5 hours 
in a bench top solvent evaporator (Genevac EZ-2 Elite).  Dried samples were 
stored at -80°C and re-suspended in 100 µL of 5% 5-sulfosalicylic acid (SSA) 
immediately prior to analysis by liquid chromatography/mass spectrometry 
(LC/MS). 
Acyl-CoA were separated using a Phenomenex Luna C18 column (2.0 mm 
x 50 mm, 5 µm) using 10 mM ammonium acetate in water, pH 8 as the aqueous 
mobile phase and 90% acetonitrile, 10% water with 10 mM ammonium acetate, 
pH 8 as the organic phase. The injection volume was 15 µl (Accela Open 
Autosampler, Thermo Fisher Scientific) and a constant column temperature was 
maintained at 30°C using a thermostatically controlled column oven (MayLab). 
LC-20A pumps (Shimadzu) were used for the primary LC gradient: 0 min, 3% B; 
1 min, 3% B; 6 min, 40% B; 7 min, 40% B; with an additional 6 min allowed for 
column re-equilibration between injections.  A constant flow rate of 0.2 mL/min 
was maintained, with an additional 0.1 mL/min of 90% acetone, 10% dimethyl 
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sulfoxide added post-column by means of an Accela 1250 pump (Thermo Fisher 
Scientific) and PEEK tee, to increase the sensitivity of acyl-CoAs detection. 
Acyl-CoAs were detected using a TSQ Vantage triple quadrupole mass 
spectrometer (Thermo Fisher Scientific) equipped with H-ESI II probe, operating 
in positive ionization mode. MS parameters were: spray voltage, 3000 V; sheath 
gas pressure, 35 psi; auxiliary gas pressure, 30 psi; capillary temperature, 270°C; 
and vaporizer temperature, 250°C. Data acquisition was performed in single 
reaction monitoring (SRM) mode using S-lens of 200 V, collision energy of 26 eV, 
50 millisecond scan time and compound specific parameters: Acetyl-CoA 810.1 
! 303.1 m/z, Crotonyl-CoA 836.1 ! 329.1 m/z. Data was acquired and analyzed 
using TraceFinder 3.1 software (Thermo Fisher Scientific). 
Crystallization, Data Collection, and Structure Determination  
[The methods described here were carried out by members of The Li group] 
Crystallization was performed via the sitting or hanging drop vapor diffusion 
method under 18°C or 4°C  by mixing equal volumes (0.2-1.0 $l) of AF9 YEATS-
H3K9cr/18cr (1:2 molar ratio, 6–8 mg/ml) or BRD3BrD2-H3K18ac (1:10 molar ratio, 
6–8 mg/ml) and reservoir solutions: 20% (w/v) polyethylene glycol 4000, 0.2 M 
ammonium sulfate, and 0.1 M sodium citrate 
tribasic dihydrate, pH 5.6, supplemented with 3% MPD (AF9-H3K9cr) or with 
0.1 M copper chloride dihydrate (AF9-H3K18cr); 30% (w/v) polyethylene glycol 
methyl ether 5000, 0.2 M ammonium sulfate, 0.1 M MES, pH 6.5, plus 0.1 M 
guanidine hydrochloride (BRD3-H3K18ac).The complex crystals were briefly 
soaked in cryoprotectant containing the reservoir solution supplemented with 
20% glycerol and then flash frozen in liquid nitrogen for data collection. The 
164 
diffraction data set was collected at the beamline BL17U or BL19U of the 
Shanghai Synchrotron Radiation Facility at 0.9791 Å. All diffraction images were 
indexed, integrated, and merged using HKL2000 (Otwinowski and Minor, 1997). 
The structure was determined by molecular replacement using MOLREP (Vagin 
and Teplyakov, 2010) with the AF9-H3K9ac structure (PDB ID: 4TMP) as the 
search model. Structural refinement was carried out using PHENIX (Adams et 
al., 2010), and iterative model building was performed with COOT (Emsley and 
Cowtan, 2004). Detailed data collection and refinement statistics are summarized 
in Table S1. Structural figures were created using the PYMOL 
(http://www.pymol.org/) program. 
FLAG-ChIP 
RAW264.7 cells were plated at ~25% confluence >24 hours prior to harvest. 
Sodium crotonate was added 12-16 hours prior to harvest. LPS was added to a 
final concentration of 100ng/ml 2 hours prior to harvest. Cells were fixed on 
plate with 1% PFA in PBS for 10 minutes. Glycine was added to a final 
concentration of 125mM. Cells were scraped off the plates, pelleted, and washed 
in PBS plus 1x Complete protease inhibitors (Roche), 10 mM Butyrate, and 10 
mM nicotinamide.  Pellets were resuspended to 1x10^7cells/mL LB1 (50 mM 
HEPES, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP40, 1% TritonX-100, 
1x Complete protease inhibitor (Roche), 10 mM Butyrate, 10 mM nicotinamide) 
and incubated rotating at 4°C for 20 minutes. Samples were centrifuged and 
pellets were resuspended to 1x10^7cells/mL LB2 (10 mM Tris pH 8.0, 200 mM 
NaCl, 1 mM EDTA, 0.5 mM EGTA, 1x Complete protease inhibitors (Roche), 10 
mM butyrate, 10 mM nicotinamide). Samples were incubated rotating at 4°C for 
165 
10 minutes and then centrifuged. Pellets were resuspended to 6x10^7 cells/mL 
LB3 (10 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% 
sodium-deoxycholate, 0.5% sodium lauroyl sarcosinate, 1% TritonX-100, 1x 
Complete protease inhibitors (Roche), 10 mM butyrate, 10 mM nicotinamide) and 
passed through a 27-gauge needle until suspension was homogenized. Samples 
were then sonicated using Covaris ultrasonicator model S220 for 20 minutes with 
the following settings: 140W peak power, 5% duty, 200 cycles per burst. Samples 
were clarified by centrifugation at 16,000 g for 15 minutes. The supernatant is the 
soluble chromatin extract. 400ug of soluble chromatin was used per ChIP. For 
FLAG ChIP, soluble chromatin extract was mixed 1:1 with LB4 (10mM Tris pH 
8.0, 100mM NaCl, 1mM EDTA, 0.5mM EGTA, 0.1% NP40, 1% TritonX-100, 1x 
Complete protease inhibitors (Roche), 10mM butyrate, and 10mM nicotinamide) 
to dilute FLAG-incompatible buffer components. FLAG-M2 (SIGMA F1804) was 
conjugated to Protein G Dynabeads (Novex) at 7.5ug antibody to 75ul bead 
slurry per IP. M2-beads were added to diluted extract and incubated rotating 
overnight at 4°C. A magnetic stand was used to separate beads from the extract 
and beads were washed six times with FLAG-ChIP wash buffer (50mM Hepes, 
500mM NaCl, 1% TritonX-100, 0.1% NP40, 1x Complete protease inhibitor 
cocktail, 10mM butyrate, and 10mM nicotinamide) and then once with 1 mL 
buffer TE plus 50 mM NaCl. The washed beads were resuspended in 210 $L 
elution buffer (50 mM Tris pH 8.0, 10 mM EDTA, 1% sodium dodecyl sulfate) 
and incubated at 65°C for 30 minutes while shaking to prevent beads from 
settling. The eluate was transferred to a new tube, inputs were brought up to 
equal volume with elution buffer, and both were incubated at 65°C overnight to 
reverse crosslinks. The samples were then treated with RNase and Proteinase K. 
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DNA was recovered using the Qiagen PCR purification kit according to 
manufacturer’s instruction.  
ChIP-Seq Analysis for FLAG-AF9 
ChIP-seq libraries were prepared using the TruSeq ChIP Sample Prep Kit 
(Illumina) as per manufacturer’s instruction. Libraries were sequenced with 75bp 
single read sequencing on the NextSeq 500 (Illumina) for FLAG-AF9 or 50bp 
single read sequencing on the TruSeq 2500 for endogenous AF9. Reads were 
aligned using bowtie (v1.0.1) to the mouse mm9 reference assembly reporting 
only unique reads in the best stratum, with up to 2 mismatches (bowtie -p 8 -S -q 
-v 2 -m 1 -k 1 --best –strata). Samtools (v0.1.19) was then used to convert files to 
bam format and sort (Li et al., 2009). For genome browser representation, tdf files 
were generated by IGVtools (v2.3.7) and data were visualized using IGV 
(v2.1.28) (Thorvaldsdottir et al., 2013). Ngs.plot (v2.08) was used to generate 
average profiles of ChIPseq reads (Shen et al., 2014). BEDOPs (v2.4.1), bedmap --
basses function, was used for read base counting within specified genomic 
regions (Neph et al., 2012). RPKM values were derived as follows: [(read-
bases)/(region-length in kb)]/(total mapped reads in Mb). FLAG-AF9 marked 
genes were defined by RPKM value +/- 1kb TSS >70. H3K18cr and H3K18ac 
marked genes were defined by RPKM value +/- 1kb TSS >50. Different cutoffs 
were used due to the different levels of background noise between FLAG-AF9 
and H3K18ac/cr ChIP-Seq. Publically available H3K18cr ChIP-Seq, H3K18ac 
ChIP-Seq, and RNA-seq data used in this study can be accessed through GEO 
accession number GSE63889.  
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Protein Production Related to Chapter 5 
[The methods described here were carried out by members of The Li group] 
Recombinant wild type and mutant AF9 YEATS (residues 1-138) was produced 
as previously described (Li et al., 2014). Briefly, AF9 YEATS was expressed in E. 
coli strain BL21 (DE3) (Novagen) with 0.4 mM IPTG induction at 16°C. After cell 
lysis by an Emulsiflex C3 (Avestin) high-pressure homogenizer thrombin and 
centrifugation, the supernatant was kept and applied to a HisTrap (GE 
Healthcare) nickel column and the protein was eluted with a linear imidazole 
gradient from 20 mM to 500 mM. After thrombin (Sigma) digestion overnight for 
His-tag removal, AF9 YEATS was further purified by a HiTrap SP (GE 
Healthcare) cation-exchange column and a HiLoad 16/60 Superdex 75 (GE 
Healthcare) gel filtration column using AKTA Purifier 10 systems (GE 
Healthcare). AF9 YEATS proteins were stored in 500 mM NaCl, 25 mM Tris, pH 
7.5, and 2 mM b-ME at ~ 10 mg/ml in an -80°C freezer. All chromatographic 
steps were performed using AKTA Purifier 10 systems (GE Healthcare). 
Recombinant YEATS domains of human ENL (1-138), and yeast Yaf9 (1-171), 
Taf14 (1-136) were constructed based on the pET28b vector. All above proteins 
were expressed and purified essentially the same as WT AF9 YEATS. 
       Recombinant bromodomains were constructed into pET28b vector, 
expressed with N-terminal 6xHis tag, and purified as previously described 
(Filippakopoulos et al., 2012; Li et al., 2014). After removal of the N-terminal His 
tag, purified Bromodomains were stored in buffer containing 150 mM NaCl, 25 
mM HEPES, pH 7.5 for future use, except that the second bromodomain of TAF1 
was stored in buffer containing 150 mM NaCl, 25 mM HEPES, pH 7.0). 
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Isothermal Titration Calorimetry (ITC) 
[The methods described here were carried out by members of The Li group] 
ITC measurement was performed as previously described (Li et al., 2014). 
Briefly, synthetic pre-modified histone H3 peptides (SciLight Biotechnology, 
LLC) and the recombinant YEATS and Bromodomain proteins were extensively 
dialyzed against ITC buffer: 500 mM NaCl, 25 mM Tris, pH 7.5, and 2 mM β-ME 
for YEATS proteins; 150 mM NaCl and 25 mM HEPES, pH 7.5 for Bromodomain 
proteins (except that 150mM NaCl and 25 mM HEPES, pH 7.0 used for TAF1BrD2). 
The concentrations of peptides and proteins were measured using A205nm and 
A280nm, respectively. The titration was performed using MicroCal iTC200 
system (GE Healthcare) at 15°C for YEATS proteins and 25°C for Bromodomain 
proteins. Each ITC titration consisted of 17 successive injections with 0.4 $l for 
the first and 2.41 $l for the rest. Usually, H3 peptides at 1.0-1.2 mM were titrated 
into YEATS or Bromodomain proteins at 0.07-0.1 mM.  The resultant ITC curves 
were processed using the Origin 7.0 software (OriginLab) according to the “One 
Set of Sites” fitting model. 
MNase Digestion and FLAG AF9 IP 
[The methods described here were carried out by Dr. Tanya Panchenko] 
The micrococcal nuclease (MNase) IP was performed essentially as described 
(Bailey et al., 2013). Briefly, approximately 5 × 107 HeLa cells stably expressing 
FLAG tagged AF9 (Li et al., 2014) were harvested and resuspended in hypotonic 
lysis buffer (3.75 mM Tris at pH 7.5, 20 mM KCl, 0.5 mM EDTA, 0.5 mM DTT, 
0.05 mM spermidine, 0.125 mM spermine, 1 mM PMSF, and 0.1% digitonin). All 
buffers contained 20 mM nicotinamine, 10 mM sodium butyrate, cOmplete, 
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EDTA-free protease inhibitor and phosSTOP phosphatase inhibitor cocktails 
(Roche). Cells were homogenized to release the nuclei and then pelleted at 300 g. 
The pellets containing the nuclei were resuspended in Wash Buffer A (20 mM 
HEPES at pH 7.5, 20 mM KCl, 0.5 mM EDTA, 0.5 mM DTT and 1 mM PMSF , 
pelleted and resuspended in Wash Buffer B (Wash Buffer A supplemented with 
300 mM NaCl). Nuclei were resuspended in Wash Buffer B supplemented with 3 
mM CaCl2. Chromatin was digested for 5 minutes at 37oC using 2000 units of 
MNase (Worthington). The MNase digestion was stopped by adding 5 mM 
EGTA and 0.05% TritonX and pelleted at 10,000 g for 15 min at 4°C. The 
supernatant contained predominantly mono-nucleosomes as confirmed by 
agarose gel electrophoresis was used for FLAG IP.  FLAG M2 agarose (Sigma) 
was used to bind the mononucleosome containing nuclear extract overnight at 
4oC. Beads were washed 3 times using Wash Buffer B and boiled in SDS loading 
buffer for western blot analysis. The following antibodies were used for analysis 
of the IP: anti- H3K9cr and H3K18cr (PTM Biolabs PTM-516 and PTM-517), anti-
ELL2 (Bethyl A302-505A), anti-AFF4 (ab103586), anti-FLAG (Sigma A8592). 
Generation of Pre-modified Histones by Amber Suppression 
[The methods described here were carried out by Dr. Tanya Panchenko] 
All histones not containing site specifically modified lysines were expressed and 
purified as previously described by A. J. Ruthenburg (Ruthenburg et al., 2011). 
For site specific incorporation of crotonylated lysine, amber suppression system 
developed by Peter Schultz’s lab was used (Kim et al., 2012). Briefly, an 
orthogonal Methanosarcina barkeri tRNA/pyrrolysyl-tRNA synthetase (Mb-
PylRS) pair was used where Mb-PylRS was mutated to accept crotonylated 
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lysine (Kim et al., 2012). The crotonylated lysine was synthesized as described by 
Gattner M. J. (Gattner et al., 2013) as was used to supplement bacterial culture at 
5 mM in the presence of 20mM nictonamide expressing H3 from a plasmid 
containing an amber stop codon “TAG” at either lysine 9 or lysine 18. Similarly, 
an amber suppression system developed by the Chason Chin lab was used in 
order to generate site specifically acetylated histones. Here an Mb-PylRS was 
mutated to accept acetylated lysine (Neumann et al., 2009). N-e-Acetylated lysine 
was purchased from Sigma and was used to supplement bacterial culture at 5 
mM in the presence of 20 mM nictonamide expressing H3 from a plasmid 
containing an amber stop codon “TAG” at either lysine 9 or lysine 18. 
Nucleosome Assembly 
Octamers were reconstituted as described (Ruthenburg et al., 2011). The 601 
nucleosome positioning sequence was used for nucleosome reconstitution 
(Lowary and Widom, 1998). The DNA was amplified by PCR using primers 
containing a biotin tag on the 5’ end to produce 189 bp linear DNA and purified 
using QIAEXII kit (Qiagen). Nucleosomes were assembled using the standard 
step-wise dialysis method (Dyer et al., 2004).  
Generation of AF9 Transgenic and Mutant Cell Lines 
[The methods described here were carried out by Dr. Tanya Panchenko] 
For overexpression and rescue studies, PCDH plasmids containing 3xFLAG 
tagged AF9 or AF9 F59A were used (Li et al., 2014).  All lentivirus construct 
plasmids were packaged into virus using HEK293-T cells as packaging cell lines 
together with helper plasmids VSV-G (envelope) and psPAX2 (packaging, gag-
171 
pol) following standard protocols. Primary cells were spin infected with 
concentrated virus-containing media supplemented with 8 $g/mL Polybrene for 
1.5 hours at 2500 rpm at 37°C and then selected with 5 $g /ml blasticidin. For 
knockout of AF9 in RAW264.7 mouse macrophage cells, several CRISPR guides 
were designed using the CRISPR design tool (http://crispr.mit.edu/) and cloned 
into the pSpCas9(BB)-2A-GFP (PX458) plasmid (Ran et al., 2013). Plasmids were 
transfected into RAW264.7 cells using LipofectamineLTX (ThermoFisher) and 
FACS sorted 24 hours after transfection. Single clones were selected and tested 
for AF9 expression using anti-AF9 specific antibody (Bethyl A300-595A) and 
genotyped for the deletion (Figure S7D). The guide RNA sequence used in this 
study targeted the 3rd exon of AF9 which corresponds to the YEATS domain. The 
guide RNA sequence is GTAGAAGAGTCCGGGTACGC. The sequencing 
primers to test the AF9 deletion were: TGAGCTACACTCCACTCAGA (forward) 
and TTCAGAATGGCAATCACTCTTCA (reverse).  
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